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ABSTRACT 
 
DANIEL COONEY: Development of Novel Diesel Exhaust Particle Aerosolization and 
Deposition Methods for In Vitro Toxicology Studies 
(Under the direction of Anthony Hickey) 
 
 
 
 The influence of diesel exhaust particles (DEP) on the lungs and heart is currently a 
topic of great interest in inhalation toxicology.  Epidemiologic data and animal studies have 
implicated airborne particulate matter and DEP in increased morbidity and mortality due to a 
number of cardiopulmonary diseases including asthma, chronic obstructive pulmonary 
disorder, and lung cancer.  The pathogeneses of these diseases are being studied using cell 
culture techniques.  The current prevalent methodology for evaluating the effects of DEP on 
cells in culture (exposure to particles suspended in culture media) does not reflect lung 
delivery of these materials to human lungs.  Consequently, the effects of DEP exposure may 
be difficult to elucidate.  A method of in vitro DEP deposition that more closely mimics the 
in vivo dosing and deposition would be a desirable and useful alternative.  It was proposed 
that DEP delivered as aerosols to cells in culture is physiologically relevant and would result 
in measurable inflammatory responses of toxicological significance.  The specific aims of 
this dissertation were addressed by: (i) generating DEP aerosols in a size range relevant to 
lung deposition and characterizing those aerosols; (ii) formulating methods for deposition of 
those aerosols onto cells in culture; (iii) studying the effects of DEP exposure following this 
type of deposition on reactive oxygen species formation, the production of pro-inflammatory 
 iii
mediators, and viability.  Several commercial particle sizing instruments and a novel device 
were used to deposit DEP aerosols onto the apical surface of Calu-3, A549, and/or 
16HBE14o- cells by inertial impaction.  Deposition of DEP aerosols onto A549 cells in the 
novel device elicited a cellular response that precludes their use in studies of toxicity.  
Deposition by inertial impaction did not appear to affect Calu-3 cells, and the response of 
these cells to exposure to DEP aerosols was shown to be different from the response to 
exposure to DEP as a media suspension.  Methods of re-dispersing aerosols of DEP, 
sampling onto cell surfaces, and studying their effect were established and demonstrate the 
utility and relevance of this approach. 
 iv
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1 GENERAL INTRODUCTION 
 
 It is important to understand the deleterious effects of diesel exhaust particles (DEP) 
on health, in particular with respect to cellular mechanism of toxicity, and to adopt 
appropriate methods to study these undesirable phenomena.  To fully comprehend the 
significance of this branch of toxicology each element of the science requires exposition.  
The following sections describe pulmonary biology, aerosol deposition and clearance, air 
pollution with specific reference to DEP, and summarize the current understanding of the 
nature of toxicity associated with pulmonary exposure to the particles.  The chapter 
concludes with the hypotheses and specific aims for the following research. 
1.1 Respiratory Physiology 
 The human respiratory system has evolved to be an effective means of exchanging 
gas necessary for life.  The respiratory tract directs air that has been inhaled through the nose 
or mouth though the pharynx and larynx to the trachea.  The trachea branches into the 
primary bronchi, which lead to the lungs.  Further branching occurs within the lungs: the 
bronchi lead to bronchioles and then to the alveoli, where gas exchange occurs.  The 
branching in the lungs is similar to the branching of a tree.  Each airway gives way to the 
next generation of airways until, at the most distal, or peripheral, part of the lungs, the 
alveolar sacs are reached.  Also like a tree, the dimensions of the individual branches change 
with generation.  The average diameter and length of the airways decreases with each 
increasing generation, but because of the doubling in number, the total surface area of the 
airways increases with increasing generation.  The large surface area of the alveolar region is 
sufficient for gas exchange to occur.  The exact morphology of the respiratory tract varies for 
each individual, but several simplified, representative, models have been developed. 
 The Weibel A model of airway branching was a seminal model of symmetric airway 
branching which has been commonly used as a reference (Weibel 1963).  The Weibel A 
model describes 24 generations of dichotomously branching cylindrical airways, from the 
generation 0 trachea to generation 23, the most distal alveolar sacs.  Generations 0-16 
represent the tracheo-bronchial (TB) region, generations 17-19 the respiratory bronchioles, 
and generations 20-23 the alveoli.  The numbers, average lengths and diameters, and total 
cross sectional areas of the airways from the Weibel A model are shown Table 1.1.  Other 
models have proposed different levels of symmetry and values for airway length, diameter, 
and generation number (Horsfield and Cumming 1968; Hansen and Ampaya 1975) and the 
Weibel model has been updated to more accurately reflect actual dimensions (Haefeli-Bleuer 
and Weibel 1988).  Aspects of the various models have been reviewed elsewhere (Finlay 
2001).  The dimensions of the airways are of particular importance when they are used to 
predict deposition of aerosols, as discussed in Section 1.2.  With the increase in computing 
power and the use of single photon emission computed tomography imaging, modeling of the 
precise morphologies of the human lungs may soon be possible (Martonen, Isaacs et al. 
2005). 
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 Generation  Diameter (cm) 
Length 
(cm) Number 
Total cross-
sectional 
area (cm2) 
Surface 
area (cm2)
Trachea 0 1.80 12.0 1 2.54 102 
1 1.22 4.8 2 2.33 
2 0.83 1.9 4 2.13 10
3
 
3 0.56 0.8 8 2.00 
Bronchi 
↓ 
↓ 
Bronchioles 4 0.45 1.3 16 2.48 
↓ 
Terminal 
bronchioles 
5 
↓ 
16 
0.35 
↓ 
0.06 
1.07 
↓ 
0.17 
32 
↓ 
6 x 104 
3.11 
↓ 
180.0 
Respiratory 
bronchioles 
17 
↓ 
19 
↓ 
0.05 
↓ 
0.10 
↓ 
5 x 105  
 
↓ 
103
103
Alveolar 
ducts 
20 
↓ 
22 
↓ ↓ ↓ ↓ 
Alveolar 
sacs 23 0.04 0.05 8 x 10
6
  
 
104
106
Table 1.1. Average values for characteristics of airway generations (Adapted from 
(Weibel 1963)). 
 
 The entire surface of the respiratory tract is lined with various epithelial cells, which 
are covered by a liquid layer of varying thickness, that is in turn covered with a very thin 
phospholipid surfactant layer (Patton 1996).  The surfactant layer serves as interface with the 
air in the lungs and lowers the surface tension of the aqueous layer underneath.  This lower 
surface tension reduces the work required to expand the lungs during inhalation.  At the air 
interface, the surfactant layer is also the first point of interaction with any deposited material 
in the lungs.  The surfactant may affect particle aggregation or other surface-related particle 
properties.  Below the surfactant layer in the upper airways is a two phase liquid layer.  The 
top phase is composed primarily of water, glycoproteins, and ions (commonly referred to as 
the mucus layer).  The glycoproteins increase viscosity of the liquid, allowing it to be moved 
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by the beating of the cilia of the epithelial cells.  Below the mucus layer is a less viscous 
periciliary layer, through which the cilia beat.  The mucus layer may provide a significant 
barrier to the interaction of deposited material and the cells residing underneath (Hanes, 
Dawson et al. 2004).  The thickness of the mucus layer decreases distally within the airways, 
going from 5-10 µm in the upper airways to less than 1 µm as the alveolar region is 
approached (Patton 1996).  The alveolar region is covered in a much thinner (50-80 nm) 
liquid layer that does not contain mucus and is not moved by cilia.  This thin layer in the 
alveolar region allows the necessary gas diffusion to occur.  The cells of the epithelium are 
positioned under the liquid layer. 
 The type and function of epithelial cells that line the airways of the lungs are different 
in different regions (Patton 1996; Mills, Davies et al. 1999).  The airways are lined with 
basal, secretory, and ciliated cells.  The basal cells serve as the progenitor cells for both 
secretory and ciliated cells.  There are two main types of secretory cells, goblet cells and 
Clara cells, which secrete mucus and surfactant, respectively.  The ciliated cells function in 
the clearance of mucus and associated foreign particles.  The coordinated beating of cilia to 
move the mucous layer towards the throat for swallowing is called mucociliary clearance 
(MCC).  The size and proportion of ciliated cells, like the thickness of the mucus layer, 
decrease distally in the airways (Stannard and O'Callaghan 2006).  The alveolar epithelium is 
composed of progenitor Type II cells and Type I cells.  Type I alveolar cells are not ciliated 
and much broader and thinner than the columnar ciliated cells of the upper airways.  This 
adaptation facilitates gas exchange.  Macrophages are located throughout the respiratory 
epithelial surface.  These macrophages serve as the main clearance mechanism for foreign 
particles in the alveoli because of the lack of ciliation in that region.  Immune cells, including 
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dendritic cells, mast cells, and other white blood cells, are also present in the epithelium of 
the respiratory tract. 
 The primary physiologic function of respiration is gas exchange, but, because of the 
large surface area and the constant interaction with the atmosphere, the lungs also serve as a 
site for the deposition of airborne particulates.  This includes therapeutic agents, such as 
pharmaceutical and biotechnologic agents, and potentially harmful agents, such as infectious 
microorganisms and air pollutants. 
1.2 Particle Deposition in the Lungs 
 Particle deposition in the respiratory system is dependant on the morphology of the 
airways, the ventilation parameters, and the characteristics of the particle.  The ventilatory 
parameters that affect aerosol deposition are the inspiratory and expiratory flow rates, tidal 
volume, and duration of breath holding (Martonen and Katz 1993; Bennett, Scheuch et al. 
1999; Martonen and Schroeter 2003).  Morphological and ventilatory parameters affect the 
air flow in the lungs and are specific to the individual, while the particle characteristics are 
specific to the aerosol.  The particle characteristic that has the most influence on deposition 
in the lungs is the aerodynamic diameter (Da).  Da is particle dimension that takes into 
account the actual size of the particle, its shape, and its density, which affect how it behaves 
in air.  Da is diameter of a spherical particle with unit density (1 g/cm3) that has the same 
inertial properties in the gas as the particle of interest (Hinds 1999).  Da may differ greatly 
from geometric diameter if the particle is non-spherical or highly porous, but it is the most 
important characteristic of an aerosol particle and is usually the reference dimension (i.e. a 1 
µm particle is a particle with Da = 1 µm, unless otherwise noted). 
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 The specific equations governing deposition of particles in an air stream are described 
in Chapter 3 (Section 3.1), but an introduction is given below.  Aerosols are deposited in the 
lungs by inertial impaction, sedimentation, diffusion, interception, and electrostatic 
precipitation (Figure 1.1) (Gonda 2004).  Inertial impaction occurs when a particle does not 
follow the air stream around an obstacle, but instead impacts on a surface.  Deposition by 
inertial impaction takes place when the momentum (mass x velocity) of a particle or droplet 
is sufficiently large to overcome the forces keeping it in the air stream.  The velocity of air 
flow, and, thus, particle momentum, is higher in the upper than in the lower airways.  The 
higher momentum means that impaction is more likely to occur in the upper than lower 
airways.  Impaction also occurs only in segments of the airways where a change in air flow 
direction occurs, such as points of bifurcation (Hofmann and Martonen 1982; Martonen and 
Hofmann 1986; Martonen and Hofmann 1991).  This leads to uneven distribution of particles 
over the epithelial surface of the lung. 
 Sedimentation occurs when the force of gravity moves a particle to a surface.  
Deposition by sedimentation takes place when the gravitational force (mass x acceleration 
due to gravity) of a particle or droplet is greater than the forces keeping it in the air stream.  
Sedimentation is dependant on the settling velocity of the particle, the distance needed to 
reach a surface, and the time that the particle has to travel the needed distance.  Impaction 
and sedimentation are usually the dominant forms of deposition particles > 1 µm because of 
the influence of mass. 
 Diffusion occurs when random collisions with air molecules cause a particle to move 
(Brownian motion) and to come into contact with a surface.  The magnitude of Brownian 
motion is inversely related to square root of particle diameter, so small particles are affected 
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to a greater extent than large ones (Finlay 2001).  The effect of Brownian motion is 
negligible compared to other forces for particles larger than 1 µm.  Diffusion is more likely 
in the lower airways than the upper because of the shorter distance to the tissue surface and 
the longer residence time. 
 Interception occurs when a particle’s center of mass follows the air stream, but its 
diameter is sufficiently large to cause an outer portion to touch a surface.  This mechanism is 
only relevant for spherical particles when the diameter approaches the airway diameter.  
Interception is particularly important for elongated particles that gyrate about their longest 
axis and may therefore approach the walls of the airway with a higher probability than 
spherical particles.  Electrostatic deposition is caused by attraction of charged particles to an 
oppositely charged surface and plays a small role in the overall deposition of most aerosols. 
 A number of theoretical and empirical aerosol deposition models have been 
developed.  The theoretical models are based on the airflow in the airways and particle 
physics.  These models allow the effects of small changes, such as airway diameters or 
particle properties, on overall deposition to be examined (Finlay 2001).  Theoretical models 
are becoming more prevalent, concurrent with lung morphology models, as computing power 
increases. 
 Empirical models are useful in predicting deposition when the variables are similar to 
those used in the experiments.  Empirical deposition data can be gathered by inhalation of 
radio-labeled aerosols.  The inhalation of radiotracers to monitor deposition has been 
reviewed (Dolovich 2001).  The most commonly referenced aerosol deposition model is that 
of the International Commission on Radiological Protection (ICRP), first published in 1966 
(Bates, Fish et al. 1966) and revised in 1994 (ICRP 1994).  The revised ICRP model (ICRP 
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66) describes the deposition probability of particles in different compartments of the 
respiratory system based on Da.  An approximation of this model is shown in Figure 1.2.  
This model predicts nasopharyngeal deposition greater than 80% for very small (< 1nm) and 
large (>5 µm) particles, with the least deposition of particles from 10 nm to 1 µm.  Predicted 
alveolar deposition is almost opposite, with a local maximum of approximately 20% at 1-2 
µm and a global maximum of deposition of almost 50% between 10 and 100 nm.  Predicted 
TB deposition is approximately 10% for particles from 100 nm to 10 µm, with increased 
deposition for smaller particles. 
 Total deposition can also be determined experimentally by comparing an inhaled 
aerosol to an exhaled aerosol.  Deposition of combustion aerosols was determined using this 
method by counting particles as function of size (using a scanning mobility particle sizer) 
before and after inhalation (Morawska, Hofmann et al. 2005).  This data showed close 
correlation to that predicted by the ICRP 66 model.  Regional deposition can also be 
experimental determined by aerosol delivery to casts of the human respiratory tract.  
Nasopharyngeal deposition of up to 90% occurred in a nasal replicate cast for particles from 
1-2 nm (Swift, Montassier et al. 1992) and significant deposition for particles of 3-100 nm 
(Cheng, Cheng et al. 1995).  This data correlates well with theoretical modeling using a 
combination of turbulent and laminar flows (Martonen, Zhang et al. 2003).  The type of flow 
(turbulent or laminar) used in a computational fluid dynamic model affects correlation with 
deposition data gathered from a replica of the mouth and throat (Stapleton, Guentsch et al. 
2000).  Theoretical modeling also generally agrees with data gathered from casts made from 
the TB airways of cadavers (Zhou and Cheng 2005).  It is clear from aerosol deposition 
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models of all types that particle size heavily influences deposition in the lungs and particle 
size also impacts the fate of the particles following deposition. 
1.3 Fate of Deposited Particles 
 The fate of a particle once it has deposited in the respiratory system depends on 
deposition location, particle composition, and the health of the lungs.  For the purposes of 
discussion, a distinction is made between soluble and insoluble particles, and only the fate of 
insoluble particles is addressed in the following sections.  However, some of the clearance 
mechanisms may apply for both types of particles, especially for particles with limited 
solubility.  The fate of particles deposited in each region of the respiratory tract is discussed 
separately, although there is some overlap in mechanisms and the regions are not rigidly 
defined.  A diagram of clearance mechanisms for insoluble particles that deposit in the lungs 
is shown in Figure 1.3.  
1.3.1 Oro- and Naso-Pharyngeal Region 
 Particles that deposit in nasal cavity are generally cleared to the back of the throat by 
MCC and subsequently swallowed along with particles that deposit in the mouth and throat.  
The time from deposition in the oro- or naso-pharyngeal region to clearance to the 
gastrointestinal tract is dependant on the location of deposition and the individual, but an 
average of 12-15 minutes, or 8 mm/min, has been reported (Andersen and Proctor 1983).  
This is enough time for at least a fraction of particles to be transported across the nasal 
epithelium or endocytized by nasal epithelial cells or resident nasal macrophages.  
Translocation from the nasal passage to the brain via the olfactory nerve may occur for very 
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small particles, as suggested by an increase in ultrafine (< 100 nm) carbon particle 
concentration in the olfactory bulb following inhalation (Oberdorster, Sharp et al. 2004). 
1.3.2 Tracheo-Bronchial Region 
 Particles that deposit in the TB region of the airways are primarily cleared by MCC 
and cough.  MCC from the TB region to the throat is frequently referred to as the mucociliary 
escalator.  Escalation rates vary by deposition location and individual, but are in general on 
the order of hours.  Lung retention of magnetic iron particles (Da = 4 µm) exhibited an 
average half-life of 3 hours following bronchial deposition (Moller, Haussinger et al. 2004).  
It might be assumed that smaller particles, penetrating deeper into the lungs, would exhibit 
longer clearance rates.  MCC has been reported to be altered by inhalation of certain toxins 
including cigarette smoke (Verra, Escudier et al. 1995) and air pollution (Gong 1992), and by 
disease states including asthma (O'Riordan, Zwang et al. 1992), COPD (Rogers 2005), and 
perhaps cystic fibrosis (Robinson and Bye 2002).  Coughing rapidly moves large volumes of 
mucus and associated particles toward the throat and can significantly supplement MCC. 
 Phagocytosis occurs in the TB region and may serve as a low-rate clearance 
mechanism.  Airways macrophages are the primary phagocyte in the TB region, residing on 
the epithelial surface under the mucous layer.  Not much is known about TB macrophages, 
but significant phagocytosis has been seen by histology as quickly as 1 hour post-inhalation 
(Geiser 2002).  The basic functions of phagocytosis by TB macrophages are also applicable 
to alveolar macrophages (AM) and will be discussed in more depth in Section 1.3.3.  The 
translocation of ultrafine particles through the TB epithelium will also be discussed in 
conjunction with the alveolar epithelium in Section 1.3.3., although it is a less prominent 
mechanism in the TB region due to the high rate of MCC. 
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1.3.3 Alveolar Region 
 There are no ciliated cells in the alveolar region, so AM serve as the primary 
clearance mechanism for deposited insoluble particles.  Clearance by phagocytosis is a much 
slower process than MCC, proceeding with a half life of months or years (Garg, Singh et al. 
2003).  The extent and rate of phagocytosis by AM is a function of particle size and particle 
surface characteristics.  The surface chemistry of the particle affects the interaction with the 
macrophage and the ability of the surfactant or other compounds present on the epithelial 
surface to attach to the particle.  Surfactant protein A, for example, has been shown to 
increase AM phagocytosis (Mariencheck, Savov et al. 1999; Schagat, Wofford et al. 2001).  
One phenomenon that may have an impact on macrophage phagocytosis is particle overload 
(Morrow 1988).  Macrophages are said to be overloaded when an increase in particle 
concentration no longer corresponds to an increase in phagocytosis.  This occurs because the 
large numbers of particles have overwhelmed the maximum phagocytic capacity of the 
macrophages. 
 There is evidence that ultrafine particles are translocated to the interstitium of the 
alveoli (Ferin and Oberdorster 1992).  This translocation may be via transcytosis across 
epithelial cells (Oberdorster, Sharp et al. 2002).  Interstitial particles may then translocate to 
the blood or other organs.  Some suggest that translocation of ultrafine particles may be a 
significant factor in the toxicity of air pollution (Oberdorster, Oberdorster et al. 2005).  
1.4 Air Pollution and Particulate Matter 
 Air pollution refers to gases and airborne particles that have an undesired health 
effects for humans or other organisms.  The gases of particular interest include nitrogen 
dioxide, carbon monoxide, sulfur dioxide, and ozone.  These gases, with PM and lead, make 
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up the six principal, or criteria, pollutants that are regulated by the United States 
Environmental Protection Agency (EPA).  The Clean Air Act of 1970 (amended in 1977 and 
1990) requires the EPA to establish National Ambient Air Quality Standards (NAAQS) to 
serve as maximum acceptable levels for these six criteria pollutants and to review these 
standards every 5 years (U.S.EPA 2004). 
 The origins of the different pollutants are varied, as are their effects on human health.  
The oxides of nitrogen, carbon, and sulfur are primarily produced by the combustion of fossil 
fuels and are emitted directly into the atmosphere (U.S.EPA 2004).  Ozone is primarily 
formed in the atmosphere when oxides of nitrogen and volatile organic compounds react with 
sunlight.  PM is a heterogeneous mixture of solid particles and liquid droplets generated from 
various sources.  Because of its heterogeneity, airborne PM is classified by particle size 
instead of composition.  PM levels were traditionally determined by passing air through a 
filter and measuring the blackness of that filter (Hinds 1999).  This sampling method 
included particles in a wide size range that had no upper limit.  More recently, the size range 
of interest has been narrowed and the measurement of PM has been based on the Da of the 
particles.  The reason for the use of Da in regulation of airborne particles relates to the 
probability that the different sized particles will deposit in the lungs if inhaled and to size 
specific composition of those particles. 
 The size distribution of PM in the atmosphere has been shown to be remarkably 
consistent and trimodal, with each of the modes consisting of different types of particles 
(Whitby 1978; Wilson and Suh 1997; Hinds 1999; U.S.EPA 2004) (Figure 1.4).  Nuclei 
mode particles represent the smallest particles in the atmosphere, with particle sizes from 10-
50 nm.  These particles are either emitted directly, through exhaust from fossil fuel 
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combustion, or are formed in the atmosphere from nucleation of combustion gases.  Nuclei 
mode particles may form aggregates of 100-1000 nm in the atmosphere, leading to the 
accumulation mode of PM.  The nuclei and accumulation mode particles are often partially 
composed of incomplete combustion byproducts that may be toxic or carcinogenic to 
humans.  Particles that are larger than a few micrometers (coarse mode particles) are 
generated mostly by mechanical means and consist mainly of solids such as dirt and dust that 
are considered relatively nontoxic.  Because particles smaller than a few micrometers have a 
higher probability of depositing in the lungs and are composed of material that is potentially 
toxic, they are potentially more dangerous to human health than coarse mode particles.  This 
logic is used in the regulation of PM.  The EPA and other regulatory agencies in the US and 
throughout the world monitor and regulate amounts of PM with a Da smaller than 10 µm 
(PM10) and/or 2.5 µm (PM2.5).  The current PM NAAQS, established in 1997, is 65 µg/m3 
for 24 hours and 15 µg/m3 annual average for PM2.5 and 150 µg/m3 for 24 hours and 50 
µg/m3 annual average for PM10. 
1.5 Physical and Chemical Composition of Diesel Exhaust Particles 
 Diesel exhaust particles (DEP) are a significant constituent of PM, making up 
approximately 6% of nationwide ambient PM2.5 mass and considerably more in some urban 
areas (U.S.EPA 2002).  DEP are emitted along with a gaseous component of diesel exhaust 
(DE) that includes carbon dioxide and monoxide, nitrogen, oxygen, water vapor, and 
hydrocarbons.  DEP are formed by nucleation and accumulation during and after the 
combustion of diesel fuel.  These particles consist of a carbon core with a number of 
adsorbed organic compounds, salts, and trace elements on the surface (Figure 1.5).  The 
organic compounds make up a considerable portion of the total particle weight, averaging 20 
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to 40% for most DEP (U.S.EPA 2002).  The hundreds of compounds adsorbed to their 
surfaces include at least 15 polyaromatic hydrocarbons (PAHs) or nitro-polyaromatic 
hydrocarbons (N-PAHs) that are considered to be potential or probable carcinogens by the 
US National Toxicology Program (Sauvain, Vu Duc et al. 2003).  The PAHs and their 
derivatives comprise about 1% or less of the total DEP mass (U.S.EPA 2002).  DEP in the 
atmosphere, like PM, have a trimodal size distribution with the smallest particles (10-50 nm) 
in the nuclei mode comprising the numerical majority and the aggregates of those primary 
particles (100-1000 nm) comprising most of the mass (Figure 1.6) (Kittelson 1998).  The 
coarse particle mode (1-10 µm) is less significant in terms of number and mass.  With sizes 
ranging from 10 nm to more than 1 µm, DEP are easily respirable and likely to deposit 
throughout the lungs. 
1.6 Toxicity of Particulate Matter and Diesel Exhaust Particles 
 Chronic and acute exposure to airborne PM and DEP have been linked to human 
health hazards.  The World Health Organization’s Global Burden of Disease Initiative 
estimated in 2002 that urban PM2.5 and PM10 cause almost 800,000 premature deaths 
annually with another 356,000 deaths due to occupational exposure to airborne particulates 
(Ezzati, Lopez et al. 2002).  As a significant constituent of PM, DEP certainly contribute to 
these deaths. 
1.6.1 Chronic Exposure 
 Chronic exposure to PM is considered to be a likely risk factor in the formation of 
lung cancer as well as a potential non-cancerous respiratory hazard.  Cohort epidemiology 
studies have shown that every 10 µg/m3 increase in PM2.5 has been associated with a 4% 
 14
increase in general mortality, a 6% increase in cardiopulmonary mortality, and an 8% 
increase in lung cancer mortality (Pope, Burnett et al. 2002).  This is certainly an indication 
of the hazards of DEP, but not direct evidence, as they are only one component of PM.  
Epidemiological studies have been conducted that focus on occupational exposure to DE.   
 The ambient air in the populated U.S. has a DEP concentration of approximately 2-5 
µg/m3, with higher numbers seen in some urban areas (Ma and Ma 2002).  Individuals who 
work near or on diesel fuel burning transportation or machinery, especially in enclosed 
spaces, are exposed to elevated atmospheric concentrations of particulates.  The level of DEP 
exposure for underground miners has been reported as exceeding 1 mg/m3 (U.S.EPA 2002).  
Two large meta-analyses of DE and lung cancer in occupational groups with elevated 
exposure have been published and have shown a smoking-adjusted relative risk (RR) of 1.33 
(95% confidence interval (CI) = 1.24-1.44) and 1.47 (95% CI = 1.29-1.67) (Bhatia, Lopipero 
et al. 1998; Lipsett and Campleman 1999).  Other studies have shown increased RR of lung 
cancer for the individual occupations of bus garage workers, mechanics, and truckers 
(Sauvain, Vu Duc et al. 2003).  Some indication of decreased pulmonary function (Gamble, 
Jones et al. 1987) and increased mortality from cardiovascular disease (Edling and Axelson 
1984) has also been noted in chronically exposed workers.  Chronic DE and DEP exposure 
has had a number of effects on laboratory animals.  These effects include changes in survival, 
pulmonary function, inflammation, histopathology, and cancer rates (Table 1.2).  It is 
important to note that while numerous health effects have been seen in animal studies, a 
comparable number of studies have seen no effect of DE or DEP exposure (U.S.EPA 2002). 
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Category Effect Species Source 
Reduced weight Rat (Schreck, Soderholm et al. 1981) Growth and 
Survival Increased mortality Rat (Nikula, Snipes et al. 1995) 
Decreased expiratory flow Monkey (Lewis, Green et al. 1986) 
Decreased vital capacity Hamster (Vinegar, Carson et al. 1981) 
Decreased residual volume Hamster (Vinegar, Carson et al. 1981) 
Pulmonary Function 
Increased airway resistance Hamster (Heinrich, Muhle et al. 1986) 
Alveolar macrophage 
accumulation Monkey 
(Lewis, Green et al. 
1986) Inflammation 
Increase in lung PMNs Rat (Henderson, Pickrell et al. 1988) 
Type II cell proliferation Rat (Iwai, Udagawa et al. 1986) 
Bronchial hyperplasia Rat (Iwai, Udagawa et al. 1986) 
Cell growth and 
differentiation 
Interstitial fibrosis Rat (Karagianes, Palmer et al. 1981) 
Cancer Increase in lung tumors Rat (Iwai, Udagawa et al. 1986) 
Table 1.2. Examples of effects of chronic diesel exhaust or diesel exhaust particle 
exposure in animals. 
 
1.6.2 Acute Exposure 
 Time series studies have shown that short term increases in levels of PM are 
associated with increased mortality and morbidity (Bell, Samet et al. 2004).  Acute asthma 
exacerbation, marked by increased hospitalizations due to asthma and increased use of 
asthma medications, has also been recorded (Penttinen, Timonen et al. 2001; von Klot, 
Wolke et al. 2002).  Based on a number of similar time series epidemiological studies, the 
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EPA Air Quality Criteria Document for PM concluded that a 24-hour increase in PM10 of 50 
µg/m3 was associated with a 1 to 8% increase in mortality and a 24-hour increase in PM2.5 of 
25 µg/m3 was associated with a 2 to 6% increase in mortality (U.S.EPA 2004). 
 Studies of the short term effects of DE or DEP have been restricted to smaller scale 
human exposure studies and animal studies.  After 4 weeks of exposure, rats showed alveolar 
macrophage aggregation and an increase in polymorphonuclear leukocytes in the airways 
(White and Garg 1981).  Similar inflammation was seen in other animals following short 
term exposures to DE (U.S.EPA 2002).  A single exposure of rats to DEP elicited an increase 
in inflammation as shown by increase in granulocytes (Yang, Barger et al. 1999).  
Intratracheal instillation of DEP led to lung inflammation and activation of platelets in 
hamsters (Nemmar, Hoet et al. 2003).  Mice exposed to DE for 6 hours per day, for seven 
days, showed an increased inflammatory response following respiratory syncytial virus 
infection (Harrod, Jaramillo et al. 2003).  Lung clearance rates of Pseudomonas aerugiosa 
were decreased in mice in response to 1 week DE exposure, but not for 6 month exposures 
(Harrod, Jaramillo et al. 2004).  Exposure of healthy human volunteers to DE or DEP was 
shown to cause an increase in neutrophils and interleukin-8 (IL-8) in bronchoalveolar lavage 
fluid (Rudell, Blomberg et al. 1999; Salvi, Blomberg et al. 1999; Salvi, Nordenhall et al. 
2000).  These acute exposure data point to an inflammatory pathway for the increased 
mortality and morbidity due to short term PM or DEP exposure as well as potentially 
decreased infection defense mechanisms. 
1.7 In Vitro Effects of Diesel Exhaust Particle Exposure 
 In addition to the epidemiologic and animal studies, a large number of in vitro studies 
have been conducted using various cells types in order to determine the effects of exposure to 
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DEP and their components.  Experiments utilizing: human (Li, Wang et al. 2002; Amakawa, 
Terashima et al. 2003) and animal (Hiura, Kaszubowski et al. 1999; Amakawa, Terashima et 
al. 2003) primary alveolar macrophages; the human monocyte/macrophage cell lines THP-1 
(Hiura, Kaszubowski et al. 1999; Don Porto Carero, Hoet et al. 2001; Li, Wang et al. 2002; 
Verheyen, Nuijten et al. 2004) and MM6 (Nilsen, Hagemann et al. 2003); and the murine 
macrophage line RAW 264.7 (Hiura, Kaszubowski et al. 1999; Li, Wang et al. 2002; Saxena, 
Saxena et al. 2003; Xiao, Wang et al. 2003) have been conducted.  Human primary epithelial 
cells of bronchial (Bayram, Devalia et al. 1998; Takizawa, Ohtoshi et al. 1999; Li, Wang et 
al. 2002; Aufderheide, Knebel et al. 2003; Doornaert, Leblond et al. 2003; Matsuo, Shimada 
et al. 2003; Takizawa, Abe et al. 2003) and nasal (Boland, Baeza-Squiban et al. 1999; 
Takizawa, Ohtoshi et al. 1999; Baulig, Garlatti et al. 2003) origin have also been employed.  
A number of human airways and alveolar epithelial cell lines including BEAS-2B 
(Steerenberg, Zonnenberg et al. 1998; Hiura, Kaszubowski et al. 1999; Takizawa, Ohtoshi et 
al. 1999; Li, Wang et al. 2002; Pohjola, Lappi et al. 2003), 16HBE14o- (HBE) (Boland, 
Baeza-Squiban et al. 1999; Marano, Boland et al. 2002; Baulig, Garlatti et al. 2003; Baulig, 
Sourdeval et al. 2003; Doornaert, Leblond et al. 2003), A549 (Don Porto Carero, Hoet et al. 
2001; Bommel, Haake et al. 2003; Cheng, Malone et al. 2003), and BET-1A (Abe, Takizawa 
et al. 2000; Takizawa, Abe et al. 2003) have also been used. 
 In vitro exposure to DEP or organic extracts of DEP (OE-DEP) leads to the formation 
of reactive oxygen species (ROS) in a dose dependant manner in both pulmonary epithelial 
cells and macrophages.  The predominant ROS formed is different for the different cell types, 
however, with hydrogen peroxide (H2O2) the main ROS in macrophages and superoxide 
anion (O2¯) for epithelial cells (Li, Hao et al. 2003). While some of the ROS formation in 
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macrophages may be due to general activation following phagocytosis, the majority is 
attributed to the action of the adsorbed compounds.  Similar effects seen by exposing cells in 
vitro to DEP and OE-DEP, but not to particles that do not contain the adsorbed compounds 
(carbon black) (Hiura, Kaszubowski et al. 1999; Li, Wang et al. 2002).  There is some 
evidence that metals in DEP contribute to ROS production (Donaldson, Brown et al. 1997; 
Park, Nam et al. 2006), but it is thought that the adsorbed PAHs, N-PAHs and quinones are 
responsible for the formation of the majority of intracellular ROS formation in vitro (Li, Kim 
et al. 2002) and in vivo (Ma and Ma 2002).  ROS are formed in cells by a number pathways 
which are largely dependant on PAH metabolism. 
 PAHs, which are lipophilic, are metabolized to more water soluble compounds by 
inducible xenobiotic-metabolizing enzymes (Shimada 2006).  Expression of cytochrome P-
450 1A1 (CYP1A1), a phase I metabolizing enzyme, was significantly increased after 
exposure to DEP or extracts (Takano, Yanagisawa et al. 2002; Baulig, Garlatti et al. 2003).  
The induction of metabolizing enzymes is linked to the cytosolic aryl hydrocarbon receptor 
(AhR), to which PAHs bind (Takano, Yanagisawa et al. 2002).  Following binding, the 
PAH/AhR complex is transported to the nucleus, where enzyme induction occurs via the 
xenobiotic response element (Hankinson 1995). 
 PAH metabolism produces ROS and reactive metabolites like PAH-O-quinones.  
These, and the quinones desorbed from the DEP, can produce ROS by redox cycling.  
Quinoid redox cycling has been proposed as a mechanism for continued free radical 
production in response to particulate air pollution (Squadrito, Cueto et al. 2001).  Quinones 
can generate ROS by redox cycles as well generating free radicals indirectly through the 
activity of enzymes such as NADPH-cytochrome P-450 reductase.  Quinones are detoxified 
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by two-electron reduction performed by the phase II metabolizing enzyme NADPH-quinone 
oxireductase 1 (NQO-1), which also shows increase on DEP exposure (Baulig, Garlatti et al. 
2003). 
 Reduced glutathione (GSH) and oxidized glutathione (GSSG) are the primary redox 
pair involved in the homeostasis of cellular oxidative state.  Because of this, the GSH/GSSG 
ratio is often used to describe the oxidative stress level of an organ or tissue, or of cultured 
cells.  The presence of ROS causes a dose dependant decrease in the GSH/GSSG ratio in the 
cells as the glutathione reacts with the ROS and is oxidized (Li, Kim et al. 2002).  The 
decrease in GSG/GSSG ratio is accompanied by a hierarchical oxidative stress that begins 
with a cytoprotective response and concludes with cell death. 
 Exposure to low levels of DEP and, thus, low levels of oxidative stress are marked by 
an induction of antioxidant stress proteins and detoxification enzyme production.  NF-E2 
related factor 2 (Nrf2) is a transcription factor that is activated by DEP-OE and PM exposure 
in airway epithelial cells and macrophages (Baulig, Garlatti et al. 2003; Li, Alam et al. 2004).  
Nrf2 is a regulator of antioxidant stress proteins including heme oxygenase-1 (HO-1) and 
detoxification enzymes including the phase II metabolizing enzymes glutathione S-
transferase (GST), and NQO-1 (Ishii, Itoh et al. 2000).  Nrf2 activation is thought to occur by 
ROS interference with the proteasomal degradation of Nrf2 and a resultant accumulation of 
Nrf2 in the nucleus.  Inside the nucleus, Nrf2 is able to activate the antibody response 
element (ARE) in conjunction with small Maf proteins and perhaps the activator protein-1 
(AP-1) transcription factor (Li, Alam et al. 2004).  If the antioxidant and detoxification 
measures taken by the cell, as outlined above, are not successful in eliminating ROS from the 
cell, a proinflammatory response will be elicited. 
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 A number of cytokines have been induced following DEP or DEP-OE exposure of 
both epithelial cells and macrophages.  Interleukins 1β, 6, and 8, as well as granulocyte 
macrophage-colony stimulating factor (GM-CSF) and eotaxin all showed an increase in 
expression and/or transcription following exposure to DEP or one of its components (Table 
1.3).  The activation of proinflammatory genes is known to be regulated by nuclear factor-κB 
(NF-κB).  Activation of NF-κB occurs by the proteolytic degradation of NF-κB inhibitor 
(IκB) followed by translocation to the nucleus and DNA binding.  This activation process has 
been observed in response to DEP exposure in human bronchial epithelial cells (Takizawa, 
Ohtoshi et al. 1999; Marano, Boland et al. 2002).  At sufficiently high concentrations, DEP 
or DEP-OE cause a partial or complete loss of viability in cultured cells (Li, Kim et al. 2002).  
This loss of viability can be due to apoptosis or necrosis depending on the concentration of 
DEP and type of cell exposed.  The level of ROS required to elicit these responses are 
different in the different cell types.  Macrophages are a protective scavenger cell with a 
relatively high capacity to neutralize or inactivate oxygen radicals.  For this reason they 
experience a slower decline in the GSH/GSSG ratio following exposure to the same amount 
of DEP than epithelial cells.  Macrophages also require higher exposure levels to elicit 
apoptosis and mitochondrial perturbation (Li, Hao et al. 2003). 
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Cytokine Cell Source 
IL-1β HNE (Boland, Baeza-Squiban et al. 1999) 
IL-6 BET-1A, BEAS-2B 
(Steerenberg, Zonnenberg et 
al. 1998; Abe, Takizawa et al. 
2000) 
IL-8 BET-1A, NHBE, 16HBE14o-, HNE, A549, THP-1 
(Bayram, Devalia et al. 1998; 
Boland, Baeza-Squiban et al. 
1999; Takizawa, Ohtoshi et al. 
1999; Abe, Takizawa et al. 
2000; Li, Wang et al. 2002; 
Bommel, Haake et al. 2003; 
Cheng, Malone et al. 2003) 
GM-CSF 16HBE14o-, NHBE, HNE, BEAS-2B 
(Bayram, Devalia et al. 1998; 
Boland, Baeza-Squiban et al. 
1999; Takizawa, Ohtoshi et al. 
1999; Baulig, Sourdeval et al. 
2003) 
Eotaxin BET-1A, NHBE (Abe, Takizawa et al. 2000) 
Table 1.3. Examples of cytokines that have been induced in vitro in response to 
exposure to diesel exhaust particles (DEP) or the organic extract of DEP and the cell 
types where the induction was recorded.  HNE = Human nasal epithelial cells (primary 
culture); NHBE = Normal human bronchial epithelial cells (primary culture). 
 
1.8 Pathogenesis of Disease in Diesel Exhaust Particle Exposure 
 The cellular basis for the toxicity of DEP is rooted in the direct effects of ROS and 
the consequent inflammatory response.  ROS can be directly toxic by damaging lipids, 
proteins, and DNA.  This damage can lead to the destruction of lung tissue and mutagenesis.   
The cytokines and growth factors released from macrophages and epithelial cells can lead to 
inflammation, cell injury, cell proliferation, and hyperplasia in the lung.  Some of the 
cytokines released cause infiltration of additional local alveolar macrophages and neutrophils 
via chemotaxis.  Once in systemic circulation, cytokines and chemokines cause further 
neutrophil migration.  This has been seen in animals in response to DE exposure (Table 1.2).  
The large number of neutrophils in the area can cause tissue damage in the short term via the 
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epidermal-growth-factor receptor (Brunekreef and Holgate 2002).  The inflammation in the 
region can also lead to epithelial apoptosis and shedding from the bronchial mucosa, 
bronchial hyperactivity, and exacerbation of asthma (Nel, Diaz-Sanchez et al. 2001).  DEP 
have also shown to decrease the ability of bronchial epithelial cells to attach to the 
extracellular matrix which would decrease wound healing and facilitate cell detachment 
(Doornaert, Leblond et al. 2003).  The direct cell damage and chronic inflammation caused 
by oxidative stress in the lung is thought to play a role in chronic obstructive pulmonary 
disorder (COPD) pathogenesis (MacNee and Rahman 2001).  Circulating inflammatory 
mediators of lung origin may induce cardiovascular events through increased blood 
coagulability (Sydbom, Blomberg et al. 2001).  Induction of thrombosis by ultrafine (< 100 
nm) particles that have translocated from the lung to the blood has also been proposed as a 
mechanism for induction of cardiovascular effects (Nemmar, Hoylaerts et al. 2004).  
Increased susceptibility to infection may be caused by a depressed antimicrobial potential of 
alveolar macrophages and/or decreased lung clearance of microbes (Castranova, Ma et al. 
2001). 
1.9 Current In Vitro Diesel Exhaust Particle Exposure Techniques 
 There are many questions and concerns when attempting to draw conclusions about 
human toxicology from studies conducted in vitro.  These concerns are amplified for an 
insoluble inhaled toxicant, such as DEP, because of the complicated interaction between 
deposition, particle properties, and toxicity.  Any data gathered from cells in culture must be 
considered carefully and may only be relevant to the particular cells, growth conditions, 
materials, and exposure conditions used.  For these reasons, creating realistic exposure 
conditions with respect to both toxicant and cell is vital to a suitable test system.  The 
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particles being tested must resemble the particles that deposit on the surface of the lung and 
they must be presented to the cell in a manner relevant to in vivo deposition. 
 The current prevalent methodology for in vitro DEP toxicity testing involves placing 
an aqueous suspension of DEP onto the apical surface of cells.  This method is broadly 
acceptable to identify potential mechanisms for DEP toxicity in the lung, but does not 
address issues specific to atmospheric DEP, such as particle size and the interaction between 
insoluble and soluble compounds.  The limitations of testing apical DEP suspensions have 
been identified and methods of depositing freshly generated DEP onto the surface of cells 
have been developed (Massey, Aufderheide et al. 1998; Wolz, Krause et al. 2002).  These 
methods represent the most realistic deposition scenario, but are difficult and expensive to 
perform because they require a diesel engine to be operated on site.  Due to the complexity of 
the combustion process, engine-based exposure systems also inevitably lead to inter-
laboratory variability in the particles produced.  The work described in this dissertation 
presents an option for depositing DEP as an aerosol onto the apical surface of cells grown in 
culture without the need to employ expensive and site-specific engines. 
 
1.10 Hypotheses 
1. Diesel exhaust particles from a bulk source can be presented to cells in culture in a 
physiologically relevant manner, i.e. delivered as an aerosol to cells cultured at the air-liquid 
interface, to facilitate study of a realistic biological response. 
2. Cellular response, measured by formation of reactive oxygen species, production of 
proinflammatory mediators, and cell viability, to exposure to aerosols will be measurable and 
will differ from response to exposure to liquid suspensions. 
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 1.11 Specific Aims 
1. Aerosol Generation: Generate and characterize diesel exhaust particle (DEP) aerosols in an 
aerodynamic size range that allows deposition onto cultured cells. 
 
2. Aerosol Deposition: Deliver DEP aerosols to cells in culture in a reproducible manner over 
a range of doses without affecting those cells. 
 
3. Evaluation of Cellular Response: Examine the formation of reactive oxygen species, the 
production of proinflammatory mediators, and the rates of apoptosis/necrosis in cultured lung 
epithelial and monocyte/macrophage cells following the deposition of DEP aerosols and DEP 
suspensions. 
 
1.12 Summary 
 DEP are an important element of atmospheric pollution associated with toxicity 
mediated by their impact on local inflammatory responses and their ability to act as vehicles 
for toxicants and substances that are known to be metabolized to toxicants.  The prevalent 
methodology for conducting in vitro DEP toxicology studies does not accurately model in 
vivo DEP toxicology.  For data from cultured cells to be applied to the understanding of lung 
inflammation and damage, more relevant DEP delivery methods must be developed.  Several 
labs have adopted this philosophy and developed elaborate systems of delivering freshly 
generated diesel exhaust or parts of that exhaust to cells in culture (Abe, Takizawa et al. 
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2000; Knebel, Ritter et al. 2002; Aufderheide, Knebel et al. 2003).  The systems described in 
these studies are elaborate, large, and presumably expensive.  The development of a method 
to generate DEP as an aerosol and deliver it to cultured cells quickly and easily in a typical 
laboratory environment would be novel and of importance to inhalation toxicology.  This 
approach would allow almost any researcher to conduct in vitro toxicology studies with a 
physiologically relevant DEP aerosol and would allow small quantities of the same DEP to 
be distributed to different geographic location, allowing laboratories to employ the same 
materials and thereby reproduce experiments.  A more relevant model should lead to a better 
understanding of cardiopulmonary disease pathogenesis following DEP exposure.  The 
following chapter (2) describes the generation and characterization of DEP required to 
address specific aim 1. 
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Figure 1.1. Diagram representing of the 5 mechanisms of particle deposition in the 
lungs.  Solid arrows represent air streams and dotted arrows represent particle paths. 
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Figure 1.2. Approximate fractional deposition of aerosols in the human respiratory 
system as a function of particle aerodynamic diameter following nasal inhalation, 
showing the range of particulate matter ≤ 2.5 µm (PM2.5) and particulate matter ≤ 10 
µm (PM10).  Adapted from (ICRP 1994). 
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Figure 1.3. Diagram of clearance mechanisms for insoluble particles in the lungs. 
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Figure 1.4. Sources and fates of particulate matter in the atmosphere as a function of 
particle aerodynamic diameter.  Adapted from (Hinds 1999). 
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Figure 1.5. Diagram of a typical accumulation mode diesel exhaust particle. 
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Figure 1.6. Size distribution of diesel exhaust particles in the atmosphere.  Adapted 
from (Kittelson 1998). 
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2 AEROSOL GENERATION AND CHARACTERIZATION 
2.1 Introduction and Background 
 Regeneration of diesel exhaust particle (DEP) aerosols from small quantities of bulk 
powder in particle sizes relevant to atmospheric pollution for laboratory testing is a desirable 
technique to develop.  As indicated in Chapter 1 (Section 1.2), particles larger than 10 µm do 
not deposit to any significant extent in the lungs, with 5 µm often being considered the cutoff 
particle size for lung deposition (ICRP 1994; Gonda 2004).  Beyond relevance to pulmonary 
exposure, a regenerated DEP aerosol would ideally be similar in size distribution that in the 
atmosphere.  DEP exist in the atmosphere as spherical primary particles as small as 10 nm 
and as aggregates of those spherical particles that range in diameter from 50 nm to larger 
than 1 µm (U.S.EPA 2002).  When collected by filtration and stored in a sealed vessel, DEP 
are forced into close contact with each other and aggregate further.  Scanning electron 
micrographs of DEP collected by filtration are shown in Figure 2.1, and a high level of 
aggregation can be seen.  The production of aerosols with a small average particle diameter 
from an aggregated powder is not easily accomplished and requires a method to de-aggregate 
the powder. 
 Pharmaceutical scientists have specialized in the generation of remarkably small 
quantities of airborne particles (~10µg - 1mg) for more than 50 years.  The potential 
application of methods employed in pharmaceutical aerosol products to particles of 
environmental interest is the objective of these studies.  Several methods of DEP aerosol 
generation were explored that employ different particle de-aggregation strategies.  A method 
was tested that de-aggregates particles by blending them with lactose prior to subjecting to 
shear in a low velocity airflow.  A second method that used compressed air as a source of 
energy to create high shear, turbulence, and collision forces, to de-aggregate the DEP was 
tested and characterized.  A final method that de-aggregated the particles by suspending them 
in a liquid followed by sonication was also developed and characterized.  Each method 
offered advantages and disadvantages and the last two were used in subsequent experiments 
to deliver DEP to cells in culture. 
2.1.1 Dispersion of Aggregated/Agglomerated Particles 
 Aerosol dispersion from a powder source requires fluidization followed by de-
aggregation (Figure 2.2).  Fluidization is the movement of the bulk powder from its source 
by interaction with air.  This is usually accomplished by flowing air over or around the 
powder, imparting the energy for fluidization.  De-aggregation can occur from the time of 
fluidization until deposition.  The forces required for de-aggregation are derived from the 
airflow or from collision with a surface or other particles.  The dispersibility of a powder is a 
measure of the ability of the powder to fluidize and de-aggregate and is governed by the 
physicochemical properties of that powder (Concessio and Hickey 1997; Dunbar, Hickey et 
al. 1998; Hinds 1999; Atkins and Crowder 2004).  The properties having the largest impact 
on dispersibility are size, crystallinity, morphology, moisture content, and hygroscopicity. 
 The cohesive force between two spherical particles is influenced by van der Waals 
force (Fvdw), capillary force, and electrostatic force.  Fvdw force of attraction between two 
spherical particles is given by: 
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where A is the Hamaker constant, D is the diameter of the particle, and h is a characteristic 
length scale representing the shortest distance between particles.  Electrostatic attraction is 
proportional to the charge of the individual particles, and is usually small in comparison to 
Fvdw (Dunbar, Hickey et al. 1998).  Capillary forces may be present in DEP to some extent, 
but are likely only a fraction of Fvdw because of the hydrophobic nature of most of the 
adsorbed hydrocarbons.  Although the attractive Fvdw between particles is proportional to the 
particle diameter (Equation 2.1), the aerodynamic force that is necessary to break the 
particles apart is proportional to the cross-sectional area, or the diameter squared.  The 
smaller the particle, therefore, the higher the attractive force when compared to the forces 
that can overcome the attraction.  These attractive forces are multiplied when more than two 
particles are interacting, as is the case for highly aggregated particles.  The high state of 
aggregation also shields the innermost particles from interaction with air and the forces of de-
aggregation.  This makes it very difficult to disperse very small, highly aggregated, particles 
such as filter-captured DEP into their primary particle sizes. 
 Some devices, including the Wright dust feeder and fluidized bed generators, 
generate aerosols from a bulk source of powder (Hinds 1999).  These devices are not 
designed to create concentrated aerosols and use large masses of powders.  The creation of 
aerosols from small quantities of powder has been an aim of the pharmaceutical industry for 
years.  De-aggregation of small particles may be assisted by blending with larger particles.  
Lactose (in the U.S.) and other excipients (in other countries) with particle sizes of ~30-100 
µm are often blended with micronized drugs in dry powder inhaler (DPI) formulations for 
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therapeutic applications.  These carrier particles provide a large surface area for interaction 
with drug particles, ideally allowing all drug-drug particle interactions to be replaced by 
single drug-carrier interactions during blending.  The combined forces leading to single drug-
carrier interactions are more easily overcome during dispersion than multiple drug-drug 
interactions because the aerodynamic forces on carrier particle are large compared to drug 
particles and because every drug particle is bound at the surface of an aggregate at only a 
single location. 
 Dispersion from a DPI is a function of powder formulation and device.  The simplest 
DPIs are passive inhalers which use the inspiratory air flow of the user as the energy source 
for fluidization and de-aggregation (Dunbar, Hickey et al. 1998).  Fluidization of the powder 
occurs by shear force over a punctured blister or bulk powder reservoir or capillary or 
mechanical force through a punctured capsule.  Following fluidization, the DPIs are designed 
to generate either high shear force, high turbulence, or both to de-aggregate the particles.  
The Inhalator Ingelheim (Boehringer Ingelheim, Germany) is a DPI designed for inhalation 
from a gelatin capsule containing a carrier-blended formulation.  During inhalation, the 
capsule is pierced on both ends and the pressure drop across the capsule creates a capillary 
force that fluidizes the powder.  De-aggregation in this inhaler occurs by shear and collision 
forces. 
2.1.2 Formulation Using Propellant 
 Metered dose inhalers (MDIs) are used in the pharmaceutical industry to deliver 
aerosols by inhalation (Atkins and Crowder 2004).  MDIs consist of a container able to 
withstand internal pressure, a metering valve, and an actuator (Figure 2.3).  Drug and 
potentially an/several excipient(s) are added to an empty container.  The container is capped 
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with a valve that is then sealed and the container is filled with pressurized liquid propellant.  
The drug dissolves in or is suspended in the propellant.  A mixture of both dissolution and 
suspension is possible, although is not ideal because recrystalization can occur that affects 
that particle size distribution and dispersion properties of the suspended particles.  Solution 
MDI formulations often require the use of a co-solvent such as ethanol because of the limited 
solubility of many drugs in propellants.  Suspension MDI formulations require the drug to be 
a microparticulate because the resultant aerosol particles cannot be smaller than the 
suspended particles.  Surfactant is also commonly added to MDI formulations to increase 
drug solubility (solutions) or to control aggregation or physical stability (suspensions) 
(Vervaet and Byron 1999). 
 The aerosol is formed by the ejection of a metered volume of propellant formulation 
from the canister.  A small amount of the formulation is stored in the metering chamber prior 
to each actuation.  When the valve is depressed during actuation, the valve stem is pushed 
into the metering chamber.  This movement closes the metering chamber to the canister 
contents and opens it to the atmosphere.  The vapor pressures of the propellants used are 
much higher than atmospheric pressure (approximately 6 times), causing rapid expulsion 
from the metering chamber and evaporation of the propellant.  The propellant is forced 
through the spray jet orifice of the actuator before entering the air flow.   The spray jet orifice 
is small (0.1 – 0.5 mm) and is designed to create uniform droplets and plume shape as the 
propellant passes through.  The final particle size of the aerosol created is a function of drug 
and excipient concentration as well as spray jet design. 
 Until relatively recently, chlorofluorocarbons (CFCs) were used as the propellant in 
almost all MDI formulations.  The discovery that CFCs have a detrimental effect on the 
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Earth’s ozone layer has led to use of non-ozone depleting propellants (Rowland 1991).  The 
most common new generation propellants are the hydrofluoroalkanes (HFAs), particularly 
HFAs 134a and 227 (Atkins and Crowder 2004).  HFA 134a (1,1,1,2-Tetrafluoroethane) is 
used in currently marketed formulations for several drugs and is considered safe for 
inhalation.  HFA 134a has a vapor pressure of 91 PSI at 25°C and has a density of 1.21 g/ml. 
2.1.3 Suspension Stability 
 The stability of a suspension can be predicted by the aggregation and sedimentation 
of the suspended particles.  The aggregation of solid particles suspended in liquid occurs 
under one of two regimes: diffusion-limited colloid aggregation (DLCA) or reaction-limited 
colloid aggregation (RLCA) (Weitz, Huang et al. 1985; Lin, Lindsay et al. 1989).  DLCA 
occurs when there are no repulsive forces between the particles and is controlled exclusively 
by the rate at which particles interact by diffusion.  RLCA occurs when there is some 
repulsive force between particles.  The two regimes have different kinetics and yield 
aggregates with different particle size distributions and fractal dimensions (an indication of 
how completely the aggregates fill a space), with DLCA occurring much faster and resulting 
in aggregates of a lower fractal dimension. 
 The settling of particles in suspension is dependant on the primary particle size and 
the volume fraction of the particles (Allain, Cloitre et al. 1995).  As with sedimentation of 
particles suspended in air, the larger the particle or aggregate, the faster the particle will 
settle.  Very small particle (like DEP) will never settle as primary particles because the 
diffusional forces are dominant over the gravitational forces.  For small particles at low 
volume fractions, particles aggregate over time until they reach a size where gravitational 
forces begin to dominate and sedimentation occurs (cluster settling).  The time it takes an 
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aggregate to reach sedimentation size decreases as the volume fraction increases due to 
increased chance for inter-particulate interactions leading to aggregation  At higher volume 
fractions, aggregation occurs fast enough that a loose gel filling the entire volume of the 
container is formed before individual particles can settle.  The gel then sediments as a whole 
(collective settling).  The rate at which the gel sediments is dependant on the volume 
fraction.  The gels formed from higher fractions sediment slower than the gels formed from 
lower fractions because of the increased forces necessary to compact gels of higher density.  
If the volume fraction is high enough, the gel will not settle at all (no settling). 
2.1.4 Particle Size and Morphological Characterization 
 Particles may be characterized by size, morphology, or chemistry.  As described in 
Chapter 1 (Section 1.1), particle size is the most important factor in predicting location and 
amount of lung deposition of an aerosol.  Aerosols generally contain populations of particles 
that are distributed over a range of sizes.  The size of particles can be measured by inertial 
impaction (aerosols), light-scattering (aerosols or liquid suspensions), or microscopic 
(deposited particles) methods (Hickey 2004).  These different sizing methods take advantage 
of different particle properties and result in different measures of average particle size and 
distribution width that are often only comparable to values generated by the same sizing 
method.  The size range of particles in these populations can usually be approximated by a 
normal distribution if particle frequency or mass is plotted against the log of particle diameter 
(Hickey 2004).  This log-normal distribution can be described with a median size based on 
number frequency or mass and a geometric standard deviation (GSD).  GSD a measure of the 
distribution width and is calculated as described in Section 2.1.4.1. 
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2.1.4.1 Inertial Impaction Sizing 
 Inertial impaction sizing devices are designed on the principles of particle flow in a 
gas stream, which is described in more detail in Chapter 3 (Section 3.1).  Cascade impactors 
are a common type of inertial sampling device which function by drawing air at a constant 
flow rate through a series of plates that have orifices of decreasing diameter.  Beneath each 
orifice plate is an impaction plate, which the air must pass around before entering the 
subsequent stages (Figure 2.4).  When an aerosol is introduced into the airflow, the particles 
will either follow the airflow around the impaction plate or impact on the plate.  Impaction 
occurs only if the momentum of the particle is large enough to overcome the aerodynamic 
forces that keep it in the air stream.  Momentum is the product of the velocity and size 
(mass); therefore, each stage (orifice plate plus impaction plate) has a specific cutoff size for 
a given airflow.  Particles larger than the cutoff size will impact and the smaller ones will 
continue to the next stage.  The orifices decrease in size from the top stages to the bottom 
stages of the impactor, making the linear velocity (volumetric airflow divided by cross-
sectional area of orifices) of the air through the top stages lower than that at the bottom.  This 
allows each stage to collect particles in a specific, narrow range of sizes.  The collection 
efficiency of particles larger than the cutoff size is not 100% in practice, nor is the passing 
efficiency 0% for particles smaller than the cutoff.  The cutoff size used in any calculations is 
the particle size with 50% collection efficiency for that stage (Figure 2.5).  This cutoff 
diameter (D50) is related to the Stokes’ number, which relates the stopping distance of a 
particle to a characteristic dimension, as discussed in Chapter 3 (Section 3.1). 
 The Andersen Non-Viable Cascade Impactor (NVCI, Graseby-Andersen, Smyrna, 
GA) is an 8 stage cascade impactor that is calibrated at airflows of 28.3, 60, and 90 L/min.  A 
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pre-separator may be added above the impactor to remove particle larger than 10 µm from 
the airflow into the impactor.  The cutoff diameters of each stage for several airflows are 
listed in Table 2.1. 
 
NVCI ELPI 
Stage 28.3 l/min 60 l/min 30 l/min Stage 
-1 -- 8.6 3.863 11 
0 8.7 6.5 2.313 10 
1 6.1 4.5 1.547 9 
2 5 3.2 0.918 8 
3 2.8 1.9 0.594 7 
4 1.8 1.1 0.327 6 
5 1 0.5 0.219 5 
6 0.5 0.2 0.101 4 
7 0.3 -- 0.051 3 
-- -- -- 0.032 2 
-- -- -- 0.025 1 
-- -- -- 0.007 Filter 
Table 2.1. Cut-off diameters for each stage of the Non-viable Cascade Impactor (NVCI) 
operated at 28.3 and 60 l/min (Dunbar, Hickey et al. 1998) and the Electronic Low-
Pressure Impactor (ELPI). 
 
 The Electrical Low-Pressure Impactor (ELPI, Dekati Ltd., Finland)) is a cascade 
impactor which has additional features in comparison with the NVCI.  The ELPI has 12 
impaction stages and has several electronic components that allow real time monitoring of 
deposition on each stage.  A unipolar diode charger (coronal charger) imparts a positive 
charge on each particle upstream of the impactor stages.  The charge imparted on each 
particle is well defined and related to the electrical mobility diameter of the particle.  The 
particles then flow through a trap that collects ions and particles smaller than can be 
measured by the ELPI, and then to the impactor.  An electrometer is connected to each stage 
to measure the total charge deposited.  The number concentration of particles in each size 
range is calculated from the charge detected on each stage, using the relation of charge to 
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electrical mobility diameter (Baltensperger, Weingartner et al. 2001).  Each ELPI is 
calibrated after manufacture and those calibration values are employed in an algorithm that 
calculates number and volume concentrations from charge.  The ELPI can take 
measurements once per second and the cut-off diameters of the stages are listed in Table 2.1.  
Low pressure impactors are able to separate particles with smaller diameters than standard 
impactors by decreasing the pressure in the lower stages below atmospheric pressure, 
lessening the force of air on the particles. 
 The data from a cascade impactor can be used to estimate the median diameter and 
GSD of an aerosol if the aerosol has a log-normal size distribution.  The cumulative fraction 
of particle number or mass below each stage is converted to a z-score (number of standard 
deviations away from the mean, based on a normal cumulative distribution) for each stage.  
The log of the particle size cutoff for each stage is then plotted as a function of those z-
scores.  The resulting graph will be linear if the distribution is log-normal and all of the 
particles deposited in the impactor.  The y-intercept of the fitted line corresponds to peak of 
the distribution (where z-score = 0) and the median diameter found by finding the inverse log 
of that intercept.  Because the particle diameter relevant to inertial impaction is the 
aerodynamic diameter (Da), the median diameter is referred to as the mass median 
aerodynamic diameter (MMAD) if mass is being measured, as in the NVCI, or the count 
median aerodynamic diameter (CMAD) if particle number is being measure, as in the ELPI.  
The GSD is found by dividing the particle size associated with the 16th or 84th percentile (z-
score = 1) with the median particle size.  CMAD is related to MMAD by the following 
equation (Cooper 2001): 
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])(ln3exp[ 2GSDCMADMMAD =                                         (2.1) 
 
 Liquid impingement is another particle sizing technique based on inertial impaction.  
The size separation concept is the same as cascade impaction, except a liquid serves as the 
impaction surface.  The twin-stage liquid impinger (TSLI) operates at a flow rate of 60 l/min 
and separates particles into two size ranges (Figure 2.6).  The cut-off diameter of the upper 
stage of the TSLI is 6.4 µm, with the remainder of particles depositing in the lower stage.  
The deposition in the lower stage is often considered a measure of the mass of fine particles, 
but the collection efficiency curve of the TSLI is very broad, meaning that the size selectivity 
of this method is inefficient (Dunbar, Hickey et al. 1998). 
2.1.4.2 Light Scattering Sizing 
 Light-scattering particle sizing methods rely on analyzing the pattern of light on a 
detector following particle exposure.  Laser diffraction (LD) is a particle sizing technique 
that analyzes the angles of diffraction of laser light shone on particles suspended in liquid or 
gas.  LD sizers have a laser light source and a number of concentric ring detectors that 
measure diffracted light at varying angles from the particles being sized.  The angle of 
diffracted light is inversely proportional to the particle volume, so each ring corresponds to a 
certain particle size range (Hickey 2004).  The predictions of light scattering behavior are 
based on Mie theory or the Fraunhofer approximation of the Mie theory (Jones 2003).  The 
calculations based on these theories require the estimation of refractive index for accurate 
determination of particle size.  The intensity data from the detectors can be plotted as a 
particle size distribution and typical LD instruments report the particle diameter for which 
50% of the volume of particles is contained below and above (D50) and the span, a 
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measurement of the width of the distribution.  The D50 can only be compared to the MMAD 
if the particles are spherical with unit density.  The size range of particles that can be 
measured by LD is approximately one hundred nm to several mm, with lower accuracy at the 
edges of the size range. 
2.1.4.3 Microscopic Sizing 
 Particles may also be examined by light microscopy or scanning electron microscopy 
(SEM).  Microscopy can yield information on the shape and size of particles and can be used 
to examine individual particles.  The resolution limit of light microscopy is approximately 
200 nm under the best possible circumstances, limiting its usefulness for small particles.  The 
resolution of SEM is approximately 1000 times smaller than that of light microscopy (Hickey 
2004), allowing magnification of up to 100,000 times (Fletcher, Small et al. 2001).  SEM 
works by focusing an electron beam on the surface of an object and detecting the electrons 
that scatter back.  As the electron beam scans across the object, a two dimension image is 
formed with areas of light and dark corresponding to areas of high or low electron scatter.  
The resultant image is a representation of the surface of the object.  The sample is placed in 
low-pressure during SEM imaging, prohibiting the study of most liquids, low vapor pressure 
materials, or structurally delicate objects.  The sample must also have a conductive surface to 
avoid charging by the electron beam.  Samples with an insulating surface may be coated with 
a conductive film prior to imaging. 
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2.2 Characterization of Bulk Diesel Exhaust Particles 
2.2.1 Sources of Diesel Exhaust Particles 
 The DEP used in this project were obtained from Dr. Daniel Costa and Dr. Ian 
Gilmour from the United States Environmental Protection Agency (EPA).  The DEP was 
received in 2 batches, referred to as DEP1 and DEP2.  DEP1 was from a 1.61 Volkswagen 
Diesel Engine (40kW), standard city driving cycle according to U.S. test protocol FTP 72 
(Stinn, Chnell et al. 1999).  DEP1 was stored in a plastic vial at room temperature.  DEP2 
was generated at the EPA main campus in Research Triangle Park, North Carolina using a 30 
kW (40 hp) 4-cylinder Deutz BF4M1008 diesel engine connected to a 22.3 kW Saylor Bell 
air compressor to provide a load.  The engine and compressor were operated at steady-state 
to produce 0.8 m3/min of compressed air at 400 kPa.  This translates to approximately 20% 
of the engine’s full-load rating.  Emissions from the engine were diluted with filtered air 
(3:1) to near ambient temperatures (~35°C) and directed to a small baghouse (Dustex Model 
T6-3.5-9 150 ACFM pyramidal baghouse using nine polyester felt bags).  Gram quantities of 
DEP2 were collected using reverse air pulsing.  Once collected, the DEP2 samples were 
stored in sealed glass containers in a refrigerator (~4°C).  DEP2 was used in all of the cell 
exposure studies, but DEP1 was used in many of the preliminary studies. 
2.2.2 Quantification of Diesel Exhaust Particles 
 Gravimetric measurement of the mass of DEP was difficult because of the small 
amounts involved in analysis, so an alternative quantification method was developed.  Mass 
of DEP suspended in ethanol was directly proportional to the light extinction, also known as 
turbidity, of that suspension, with peak extinction at 700 nm. 
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2.2.2.1 Materials and Methods 
 A turbidity concentration curve was prepared by reading the light extinction at 700 
nm (EXT700) of serial dilutions of DEP1 suspensions in ethanol (UV160U 
spectrophotometer, Shimadzu).  It was observed that turbidity increased following sonication 
(FS21H sonication water bath, Fisher Scientific).  All subsequent suspensions were sonicated 
prior to measurement.  To create concentration curves, DEP1 or DEP2 were suspended in 
ethanol, sonicated, serially diluted, and sonicated again briefly before reading EXT700.   
 To determine the effect of sonication time on EXT700, 7.95 µg/ml of DEP2 was 
suspended in ethanol.  The suspensions were placed in a sonication water bath (Branson 
2510) for 30, 60, or 180 seconds with swirling every 15 seconds.  The suspensions were 
removed from the bath, swirled, and EXT700 was measured (Libra S22, Biochrom). 
2.2.2.2 Results and Discussion 
 The turbidity concentration curves were linear, with values of the square of 
correlation coefficient for linear regression (R2) > 0.99.  The following equation relates 
DEP1 concentration to EXT700 in non-sonicated ethanol suspensions: 
 
7001 137)( EXTgionconcentrat DEP ×=μ                                      (2.2) 
 
 
This relationship is significantly different from that of sonicated DEP1 suspensions: 
 
       7001 8.08.38)( EXTgionconcentrat DEP ×±=μ                             (2.3) 
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This change is corroborated by the observation that the suspensions became visually darker 
following sonication.  According to Lambert-Beer law, turbidity of a suspension is directly 
proportional to the number concentration if the size distribution and refractive index of the 
particles do not change (Gebhart 2001).  The linearity of the both the sonicated and non-
sonicated concentration curves indicates that the size distribution of particles in suspension 
stays constant with concentration for both.  The difference in slope indicates a change in the 
size distribution following sonication, which is expected, as sonication is used to decrease the 
size of particles in suspension (thus, also increasing the number significantly).  The 
relationship of sonicated DEP2 suspensions to light extinction is slightly different from that 
of DEP1: 
 
                                    7002 5.16.56)( EXTgionconcentrat DEP ×±=μ                                (2.4) 
 
This difference may indicate a difference in size distribution, refractive index, density, or 
chemical makeup between the two sources. 
  The EXT700 values of the 7.95 µg/ml DEP2 suspension following sonication for 30, 
60 and 180 seconds were 0.141±0.001, 0.141±0.001, and 0.144±0.004, respectively.  These 
values were not dependant on time after sonication when monitored up to 15 minutes (results 
not shown).  This indicated that it was acceptable to sonicate for as little as 30 seconds and to 
wait up to 15 minutes following sonication to measure light extinction. 
2.2.3 Morphological Characterization of Bulk Diesel Exhaust Particles 
 Small amounts of DEP1 and DEP2 were placed on 13mm diameter round glass cover 
slips and were examined by SEM (JEOL JSM-6300, JEOL America, Peabody, MA).  Cover 
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slips were coated with gold-palladium by sputter-coating for 60 seconds prior to imaging to 
improve conductivity (model E-5200, Electron Beam Services, Agawan, MA). 
 SEM images of DEP2 can be seen in Figure 2.1.  The highly aggregated state of the 
particles can be seen.  The primary particles are not distinct, but give the powders a fluffy 
appearance. 
2.3 Lactose Blend Aerosol Formulation 
 The feasibility of blending DEP with lactose carrier particles in order to an aerosol in 
the respiratory size range was tested.  Prior to blending, lactose particles are separated by size 
(by sieving, for example) so that small particles can be excluded from the blend.  This 
prohibits the presence of lactose from the respirable fraction (< 5 µm) of the generated 
aerosol. 
2.3.1 Preparation and Aerosolization 
   DEP1 powder was ground in a mortar and pestle and then blended with lactose (45-
75 µm sieved fraction) in a Turbula mixer (Glen Mills, Inc, Clifton, NJ) for 10 minutes (1% 
DEP in lactose, %w/w).  For aerosolization, approximately 50 mg of the 1% blend was added 
to #4 a capsule and the capsule was loaded into an Inhalator Ingelheim® (Boehringer 
Ingelheim) dry powder inhaler. 
2.3.2 Morphological and Size Characterization 
 The Lactose/DEP blend was delivered to the NVCI operated at 60 l/min with glass 
cover slips placed on the stages.  These cover slips were sputter coated and imaged by SEM 
as described in 2.2.3.  Powder deposition was seen on all 8 stages.  SEM images of the glass 
cover slips revealed that the majority of the deposition was lactose, although DEP deposition 
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could be seen (Figure 2.7).  The fluffy (highly porous/space filled) appearance of the DEP 
can be differentiated from the more flat and crystalline appearance of the lactose.  The 
presence of the lactose in the NVCI indicated that the lactose used contained some particles 
that smaller than expected (45-75 µm).  Concurrent DEP/lactose deposition on the cell 
surface would require lactose only controls to be performed with any cell experiments and 
may not allow some of the effects of DEP deposition to be differentiated.  It might be 
possible to produce a DEP aerosol by this method by using a different sample of lactose that 
was free of small particles, but it was determined that deposition of DEP without lactose 
would be a better option. 
2.4 Pressurized Gas Expulsion Aerosol Generation 
 Several methods were tested to disperse DEP using pressurized gas.  A similar 
approach was used by Gerde, et al. to generate small quantities of DEP aerosol for short-term 
exposure of isolated perfused rat lungs (Gerde, Ewing et al. 2004).  The method development 
process described in this section includes the use of DEP1 and DEP2 and resulted in a single, 
optimized, aerosolization method.  This method was used in all subsequent studies and the 
aerosol produced was characterized more completely.  The optimized method takes 
advantage of high shear, turbulent, and collision forces to de-aggregate the DEP. 
2.4.1 Propellant Expulsion  
 The first pressurized gas that was used was a liquefied propellant, HFA134a.  This 
propellant was used to blow treated or non-treated DEP out of a capillary tube into an air 
stream in various configurations.  The propellant source provided the de-aggregation forces 
and the DEP was added to the small diameter tube by tapping the tube into a bed of powder.  
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The pressure that expelled the DEP from the tube was dependant on the speed at which the 
propellant could flow from the metering valve and evaporate to create a pressure above 
atmospheric pressure.  In a closed system the propellant would develop a pressure equal to its 
vapor pressure of 91 PSI, however the DEP was likely expelled long before maximum 
pressure was reached. 
2.4.1.1 Materials and Methods  
 An MDI canister was fitted with a 25 µl metering valve (Bespak, Apex, NC) and 
sealed by crimping (Aerotech Crimper, Maryland, NY).  The canister was then filled with 20 
g of HFA134a through the valve using a pressure burette (Aerotech, Maryland, NY) at 175 
PSI.  The canister was attached to a hematocrit tube (75 mm length, 1.4 mm OD, 1.0 mm ID) 
by a 1000 ml micropipette tip.  The hematocrit tube was lightly tapped into DEP until the 
height of the DEP in the tube reached 6 mm.  This created a DEP plug of set height in the end 
of the tube.  It was assumed that the bulk density of the DEP was uniform throughout the vial 
so that would yield a consistent dose.  When the valve was depressed, the propellant pushed 
the DEP out of end of the tube, creating an aerosol (Figure 2.8). 
 A number of configurations based on this apparatus, described in Table 2.2, were 
used to create DEP aerosols and introduce them into a 60 L/min air stream leading into a 
TSLI.  DEP1 was used in bulk state or following grinding in a mortar and pestle to increase 
the uniformity of the powder.  The amount of DEP in 6 mm of capillary tube for bulk and 
ground DEP was determined by measuring EXT700 for each (n=3).  A spacer (AeroChamber 
Plus, Monaghan Medical Corporation, Plattsburgh, NY) was used in some configurations to 
increase the distance from tip to TSLI and, therefore, increase de-aggregation time.  A 
configuration was used where the hematocrit tube was reversed on the pipette tip, placing the 
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DEP plug in the proximal end to the MDI canister.  A Y-tube configuration (Figure 2.9) was 
tested to determine if a converging airflow at the point of aerosolization would create more 
de-aggregation because of increased turbulence at the site of aerosolization.  Each branch of 
the Y-tube was 31 mm long and had an ID of 7.5 mm, with the two branches having an 
internal angle of 60°.  The branch of the Y-tube containing the hematocrit tube was left open, 
or was restricted with a glass (1.7 mm ID) or plastic (2.8 mm ID) tube to restrict flow around 
the hematocrit tube. 
 
Configuration 
Number 
Spacer DEP Plug End Y-Tube Y-Tube 
Restrictor 
1 No Bulk Far No N/A 
2 Yes Bulk Far No N/A 
3 No Ground Far No N/A 
4 No Ground Near No N/A 
5 No Ground Far Yes No 
6 No Ground Far Yes Plastic 
7 No Ground Far Yes Glass 
Table 2.2. Configurations of the HFA134a expulsion methods tested.  Plug end indicates 
whether the DEP was loaded into the end of the hematocrit tube proximal to the MDI 
canister (near) or proximal to the twin-stage liquid impinger (far). 
  
 Following deposition in the TSLI, the inlet, and both stages of the TSLI were washed 
with ethanol, but were not sonicated, and the EXT700 was read (n ≥ 3 for each configuration). 
Statistical Analysis 
 The statistical significance of the differences in means between groups was 
determined using the one-way analysis of variance (ANOVA) functions in Microsoft® Excel 
2003.  The one-way ANOVA function tests the hypothesis that data from two groups come 
from populations with equal means and variations.  The resultant p value is the probability 
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that the hypothesis is true.  A one-way ANOVA comparing data from only two groups is 
equivalent to the Student’s t-test. 
2.4.1.2 Results and Discussion 
 The EXT700 values for the same mass of DEP in different regions of the TSLI may be 
different because the particle sizes are different and light extinction is dependant on particle 
size.  The mass values, therefore, may not be accurate and were only compared within, but 
not between, the same TSLI stages.  The 6 mm DEP plug contained greater mass in the 
ground (1347±56 µg, n=5) than in the bulk (561±63 µg, n=5) state.  Figure 2.10 shows the 
mass of DEP from stage 2 of the TSLI, reflecting the mass of particles with diameter less 
than 6.4 µm (fine particles mass, FPM), for each configuration.  The two configurations 
using bulk DEP (1 and 2) had the lowest FPM, which may be explained by the smaller mass 
of particles contained in the tube.  Of the two configurations, the one with the spacer (2) had 
the lowest FPM.  This may be explained by the large amount (334±70 µg) of DEP was 
deposited on the walls of the spacer.  The spacer was not used in any other configurations.  
The location of the DEP plug (near or far) did not have a significant effect on FPM, although 
near (4) showed a slight increase in FPM over far (3).  The use of a Y-tube (5) increased 
FPM by a small amount over no Y-tube (3).  The restriction of that Y-tube increased the 
FPM further, in a significant (6, p < 0.05) or non-significant (7) manner.  The highest FPM 
was produced with configuration 6: ground DEP with the plug at the far end, using the Y-
tube constricted by a glass tube.  The calculated FPM for setup 6 was 107±22 µg, although 
this value may not reflect the actual mass because of the lack of sonication in the 
measurement and construction of the concentration curve. 
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2.4.2 Compressed Air Expulsion 
 Compressed air was used as a second pressurized gas source.  A solenoid valve (1/4” 
orifice, KIP Inc., Farmington, CT) was attached to a compressed air tank so that the air 
pressure could be delivered rapidly.  A micropipette tip containing DEP was attached to the 
outlet of the solenoid valve and the valve was opened to expel the DEP (Figure 2.11).  
Preliminary experiments showed that when DEP was delivered to the TSLI using this 
method, more than half of the DEP was not recovered.  Powder could be seen outside the 
TSLI upon opening the valve, so it was postulated that a significant portion of the DEP did 
not enter the TSLI, but was blown out into the room.  The volumetric flow rate of the 
expelled air was calculated from Bernoulli’s theorem: 
  
PaCQ odis Δ= 2                                               (2.5) 
 
where Q is the volumetric flow rate, Cdis is discharge coefficient, ao is the area of the orifice, 
and ΔP is the change in pressure.  Cdis represents the loss of energy due to friction, with a 
value of 1 representing no loss (Hickey and Ganderton 2001).  The air flow was also 
measured directly using a flow meter.  The measured air flow rate as a function of pressure is 
shown in Figure 2.12.  Figure 2.12 also shows the calculated air flow using values for Cdis of 
1.0 and 0.6.  The measured flow was between the calculated flows, indicating that there was 
some energy loss at the tip due to friction, and that the discharge coefficient was between 0.6 
and 1.0 over this pressure range.  The measured volumetric flow rate was less than the intake 
of the TSLI (60 l/min) at pressures up to 70 PSI, but the linear velocity was greater than the 
intake velocity.  Assuming equal flow over the entire mouth of the throat, the linear velocity 
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of the intake of the TSLI was approximately 200 cm/sec.  If the same assumptions are made 
for the pipette tip, the linear velocity was 100 to 500 times higher than at the TSLI intake, 
depending on the pressure.  This mismatch in linear velocities would lead to turbulence in the 
inlet, including the possibility that some air and particles were dispersed into the room air.  In 
order to prevent this, an adapter was added to the throat of the TSLI (Figure 2.13).  The 
adapter was designed to limit the amount of DEP that escaped by providing a chamber where 
particles blown backward can re-enter the air stream.  The effectiveness of this adapter was 
tested, as was the impact of the type of DEP used and the expulsion pressure.  
2.4.2.1 Materials and Methods 
 A micropipette tip (100-1000 µl Universal Fit, Corning Inc.) was secured to the 
output end of the closed solenoid valve with the input attached to a tank of compressed air set 
to a designated pressure.  The micropipette tip was tapped into a vial containing 10 cm of 
tap-compressed DEP2 3 times.  The level of DEP in the vial was kept at 10 cm to maximize 
the dose repeatability.  To produce the DEP aerosol, the solenoid valve was opened and the 
powder blown out of the tip. 
 The effects of grinding the DEP with mortar and pestle and the addition of the adapter 
on total dose, emitted dose and FPM were tested.  The total dose was determined by loading 
the pipette tip and suspending the un-aerosolized DEP in ethanol, then reading EXT700 
following sonication (n=5 for bulk and crushed DEP2).  Emitted dose was determined by 
loading the tip as described above with bulk or ground DEP and expelling the dose at 50 PSI 
into a United States Pharmacopeia (USP) emitted dose device (EDD, MSP Corporation, 
Shoreview, MN)) fitted with a 0.1 µm polycarbonate filter (Millipore) operated at 60 l/min 
with and without the adapter (n≥5).  The filter and device were washed in ethanol and the 
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EXT700 was read following sonication.  FPM was measured by expelling the DEP in the 
same manner into the TSLI. 
 The effect of expulsion pressure on FPM was also tested using the TSLI.  Ground 
DEP2 was loaded into a micropipette tip as described above and delivered to the TSLI at 
pressures of 10 to 60 PSI.  The pipette tip, TSLI inlet, and both TSLI stages were rinsed in 
ethanol and EXT700 was read. 
 Aerosol size distribution was characterized using an ELPI.  DEP2 was delivered to 
the ELPI with an expulsion air pressure of 50 PSI.  The ELPI was operated at 30 l/min, but a 
second vacuum pump was added in parallel with a 45 degree angle split to increase the total 
air flow to 60 l/min to match the flow into the TSLI (n=6). 
2.4.2.2 Results and Discussion 
 The total and emitted doses for bulk and ground DEP with and without the adapter 
are shown in Figure 2.14.  The mass of DEP delivered to the EDD without the adapter were 
less than 1/3 of the total dose for the bulk and ground DEP.  The pipette tip contained less 
than 1% of the mass in each case, meaning that the remaining DEP was not collected.  The 
DEP lost was almost certainly blown back into the ambient air.  The addition of the adapter 
allowed the collection of an emitted dose equal to or greater than (not statistically different 
from) that of the calculated total dose for both the bulk and crushed DEP.  This data shows 
that the adapter was effective in preventing the DEP from escaping into the room air.  The 
total and emitted doses were larger for the ground DEP than for the bulk DEP, indicating a 
greater potential mass of small particles.   
 The deposition of the DEP in the TSLI is shown in Figure 2.15.  The results reflect 
the increase in DEP reaching the device with the addition of the adapter as well as the larger 
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dose of the crushed over bulk DEP.  An anticipated large increase in throat deposition 
occurred when the adapter was used because the deposition in the adapter was added to the 
throat deposition in those cases.  More DEP also reached both stages with the adapter, 
indicating that a portion of the DEP that entered the ambient air without the adapter was in 
all size ranges.  The increase in dose following grinding of the DEP was also reflected in an 
increase in deposition in all parts of the TSLI, with the ground DEP delivered with the 
adapter having the largest FPM (84 ± 6 µg). 
 Deposition of DEP expelled at various pressures in the TSLI is shown in Figure 
2.16a.  Increased expulsion pressure led to increased deposition in the throat and stage 2 
(FPM, Figure 2.16b) and decreased deposition in stage 1.  The increase in pressure caused an 
increase in throat deposition presumably because a larger number of particles impacted on 
the back of the throat due to the increase in exit velocity.  These impacted particles were not 
introduced into the air stream that continued to the stages.  It is likely that the increased 
pressure also produced higher and more turbulent flow from the device, providing more 
energy to break apart aggregates and increase FPM.  The pipette tip was blown off of the 
solenoid valve several times when the pressure was set to 60 PSI.  Consequently, an upper 
pressure limit of 50 PSI was used in subsequent experiments. 
 The total number of particles detected by the ELPI on each stage is shown in Figure 
2.17a.   The peak of deposition was on stages 5-7 (0.2 – 0.6 µm), but the deposition on each 
stage was quite variable.  When plotted as a percentage of total number per aerosolization, 
there was much less deviation (Figure 2.17b).  Much of the variation came from total dose 
delivered to the ELPI and not the size distribution of the aerosol.  The total number 
deposition in the ELPI had a 36% standard deviation (22.4 ± 8.1 x 107 particles per 
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aerosolization), while FPM delivered to the TSLI had only a 7% standard deviation (84 ± 6 
µg).  This may be explained the difference in inlet deposition between the two devices.  The 
inlet of the TSLI is glass, so centering of the pipette tip was easier than it was in the opaque 
metal inlet of the ELPI.  Off-center alignment could have led to the expulsion of the aerosol 
into the inlet wall, increasing wall deposition of those runs. 
 The z-scores were plotted against log of particle size, as described 2.1.4.1, and the 
resulting relationship was linear (R2 > 0.99), indicating a log-normal particle size 
distribution.  The CMAD (0.46 µm) and GSD (2.3) were calculated from the equation of the 
line and the MMAD (3.7 µm) was calculated from Equation 2.1.  This data indicates that 
reproducible aerosols in the size range of both accumulation and coarse mode atmospheric 
DEP can be produced by compressed air expulsion (CAE).  These aerosols have a FPM of up 
to 84 µg, with higher masses possible with higher initial doses and/or expulsion pressures 
above 50 PSI. 
2.5 Propellant Suspension Aerosol Formulation 
 Propellant suspensions in a range of concentrations were made by adding DEP to 
empty metered dose inhaler bottles that were fitted with a valve and filled with the propellant 
HFA134a.  The suspension concentrations were chosen based on typical MDI suspension 
concentrations.  The stability of the suspensions was tested and the emitted dose and particle 
size of the generated aerosol were characterized.  The aerosols from three concentrations of 
DEP in propellant using a 25 µl metered valve and one concentration using a continuous 
valve were characterized.  The aerosol generated using the continuous valve was tested 
because it offered an opportunity to release a larger quantity of propellant and therefore 
deliver a larger quantity of DEP in a short period than the metered valves. 
 57
2.5.1 Materials and Methods 
2.5.1.1 Preparation and Aerosolization of Propellant Suspension 
 DEP was added to plastic-coated clear glass bottles (Wheaton Glass) fitted with a 25 
µl metering valves (Bespak) that were sealed by crimping (Aerotech).  Prior to fitting, holes 
were drilled in some of the metering valves that connected the valve stem to the bottle when 
actuated, creating non-metered, continuous valves.  The bottles were then filled with 20 g of 
HFA134a through the valve using a pressure burette (Aerotech) at 175 PSI.  The resultant 
suspensions (0.2 to 5.0 mg DEP/g HFA134a) were placed in an ultrasonic bath for 10 
minutes to disperse the particles.  All aerosols were generated using an actuator with 300 µm 
round orifice. 
2.5.1.2 Suspension Stability 
 Stability of 0.2, 1.0, and 5.0 mg/g suspensions was estimated by observing 
aggregation and settling of the suspended particles as a function of time following 10 seconds 
of vigorous vortex mixing (Fisher Vortex Genie 2).  Aggregation and settling in the first 5 
minutes following mixing was monitored visually and the opacity and sedimentation height 
over that time were recorded (n=3 for each of 3 bottles for each concentration).  Relative 
concentration of suspended DEP was measured by EXT700 (Shimadzu) from 5 to 80 minutes 
following mixing (n=3 for each of 3 bottles for each concentration).  For EXT700 
measurements, the bottles were centered between the light source and detector of the 
spectrophotometer.  The statistical significance of the differences in means between groups 
was determined using the two-way analysis of variance (ANOVA) functions in Microsoft® 
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Excel 2003, which tests the hypothesis that data from groups came from populations with 
equal means and variations when there are two factors (independent variables). 
2.5.1.3 Emitted Dose 
 The emitted doses for 0.2, 1.0, and 5.0 mg/g suspensions in bottles fitted with 25 µl 
metered valves and for a 1.0 mg/g suspension fitted with a continuous valve were determined 
by actuation into an EDD with a 0.1 µm polycarbonate filter (Millipore).  The suspensions 
were vortexed for 10 seconds prior to testing and a separate actuator was used to prime the 
suspensions 3 times.  Because of the limit of detection of the EXT700 method, 10, 5, and 5 
actuations were used for each run for 0.2, 1.0, and 5.0 mg/g suspensions, respectively (n=6 
per concentration).  One actuation of approximately 1 second was used for the 1.0 mg/g 
suspension with the continuous valve (n=5).  A pause of at least 5 seconds between 
actuations allowed the bottles to be swirled vigorously by hand to minimize aggregation and 
settling.  DEP were recovered by washing the device, filter, and actuator in ethanol in an 
ultrasonic bath and were quantified by measuring EXT700.  The mass of each bottle was 
recorded before and after each experiment to facilitate calculation of the amount of 
propellant used.  Expected DEP deposition was calculated by multiplying the amount of 
propellant used by the DEP concentration. 
2.5.1.4 Size Characterization 
 Deposition of DEP aerosols as a function of aerodynamic diameter was measured 
using a NVCI and an ELPI.  The NVCI was operated at a flow of 28.3 l/min with a USP 
sampling inlet.  Deposition was quantified by washing the actuator, inlet, and stages in 
ethanol followed by sonication and determination of EXT700.  20, 10, and 5 actuations (0.2, 
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1.0, and 5.0 mg/g) were used for each run with metered valves and 5 actuations were used for 
each run with a continuous valve due to the limit of detection of the turbidity (EXT700) 
method (n=3 per concentration).  The suspensions were primed 3 times with a separate 
actuator prior to testing, allowing at least 5 seconds between actuations, during which time 
the bottles were swirled vigorously by hand.  To examine the effect of evaporation time on 
deposition, the same experiments were repeated for bottles with metered valves with a 78 cm 
long, 5 cm diameter tube serving as a spacer.  The volume of the spacer was approximately 
1.5 L, which allowed approximately 3 seconds of added travel time for the aerosol from 
actuator to inlet (for 30 l/min). 
 The ELPI was operated with sintered metal collection stages and the filter stage in 
place.  The aerosol was introduced to the inlet with and without the spacer described above 
and data was gathered by averaging deposition from 5 sequential actuations with swirling in 
between (n=3 per concentration). 
 The statistical significance of the differences in means between groups was 
determined using the one-way ANOVA, as described in Section 2.4.1.1. 
2.5.1.5 Morphological Characterization 
 For morphological analysis, aerosols from a 1.0 mg/g DEP suspension were deposited 
on glass cover slips placed on all stages of the NVCI operated at 60 l/min.  Aerosols from 
0.2, 1.0, and 5.0 mg/g DEP suspensions were deposited on glass cover slips placed on Stages 
1, 2, and 3 of the ELPI.  These cover slips were sputter coated and imaged by SEM as 
described in Section 2.2.3. 
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2.5.1.6 Chemical Composition 
 A method for determining the concentration of benzo[a]pyrene (B[a]P) and 
benzo[k]fluoranthene (B[k]F) was used to determine the effect of suspension in HFA134a on 
the compounds adsorbed to the surface of the DEP.  The method was adapted from a dual 
wavelength fluorometric detection method (Masaki, Susaki et al. 2005).  Fluorescence 
concentration curves for B[a]P and B[k]F dissolved in DCM (0-500 ng/ml) were made by 
serial dilution (n=2 per compound).  The fluorescence of each concentration of each 
compound was read at an emission wavelength of 429 nm with excitation wavelengths of 370 
and 395 nm with 5 nm slits (LS50B luminescence spectrometer, PerkinElmer)). 
 Bulk DEP2 was suspended in dichloromethane (DCM) in glass vials at concentrations 
of 0.25 to 2.5 mg/ml to determine the concentration of the compounds adsorbed onto DEP 
(n=6).  DEP2 suspended in HFA134a (1.0 mg/g) aged 6 months at room temperature or less 
than 1 week at 4°C (fresh) was aerosolized and deposited onto the filter of an EDD (n=3 per 
condition).  The filter was added to a glass vial and suspended in DCM (0.1-0.5 mg/ml DEP).  
All bulk DEP and DEP aerosol suspensions were placed in an ultrasonic bath for 30 minutes 
to dissolve surface adsorbed compounds.  The suspensions were then centrifuged at 10000 g 
for 15 minutes to pellet the suspended particles.  Five ml of the supernatant were added to a 
new glass vial and allowed to evaporate at room temperature.  In order to determine the 
collection efficiency of the evaporation and extraction methods, solutions of B[a]P and B[k]F 
in DCM (0-500 ng/ml) were made by serial dilution.  Five ml of each concentration of each 
compound were added to glass vials and allowed to evaporate. 
 The remaining solids from the bulk and aerosol DEP and known PAH concentrations 
were dissolved in 5 ml of methanol.  The methanol solutions were cleaned with a solid phase 
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extraction column (1cc HLB, Waters).  For extraction, the columns were conditioned with 1 
ml DCM and rinsed with 1 ml methanol then 1 ml water.  After 3 ml of sample was added, 
columns were rinsed with 1 ml of water and the compounds were eluted with DCM.  The 
fluorescence was read at an emission wavelength of 429 nm with excitation wavelengths of 
370 and 395 nm, as above. 
2.5.2 Results and Discussion 
2.5.2.1 Suspension Stability 
 The range of suspension concentrations displayed very different aggregation and 
sedimentation rates.  Both the 0.2 and 1.0 mg/g suspension underwent cluster deposition, but 
at different rates.  The lowest concentration (0.2 mg/g) showed the lowest degree of visual 
aggregation.  Mixing produced uniform, slightly translucent, suspensions.  The suspensions 
remained uniform, without individually distinguishable aggregates, for the first 5 minutes.  In 
the 1.0 mg/g suspensions, some large flocculates were seen by 10 seconds after mixing.  The 
majority of large flocculates settled to the bottom of the bottle by 1 minute after mixing, 
leaving the remaining suspension more translucent than the 0.2 mg/g suspensions.  The 5.0 
mg/g suspensions underwent collective settling.  A loose gelled mass formed in the entire 
volume of the bottle within seconds after mixing.  The height of the gel dropped linearly 
from the top of the propellant level for approximately 1 minute, after which the height 
dropped very slowly (Figure 2.18).  The velocity of sedimentation was calculated as 0.71 
mm/sec by fitting a line to the first 4 data points (R2=0.94).  The propellant above the gelled 
mass in the 5.0 mg/g suspension appeared transparent with few if any suspended particles. 
 The average EXT700 values for the 0.2 and 1.0 mg/g suspensions as a function of the 
log of time from 5 to 80 minutes are shown in Figure 2.19.  The EXT700 values for the 5.0 
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mg/g suspension did not change much over this time period because almost all particles had 
sedimented with the gel previously.  Lines were fitted to this data with R2 values of 0.997 
and 0.994 for 0.2 and 1.0 mg/g suspensions, respectively.  A concentration curve for DEP in 
HFA134a could not be produced, but light extinction of particles in suspension is directly 
proportional to concentration, provided the particles are of the same size (Gebhart 2001).  
Figure 2.19 shows that the concentration of particles in suspension decreased linearly as a 
function of the log of time following an initial lag time.  The rate of decrease was greater for 
the 0.2 mg/g suspension because the volume concentration after 5 minutes, thus the 
aggregation rate and sedimentation rate, was greater.  The rates of aggregation and 
sedimentation was much greater in the first few minutes for the 1.0 mg/g suspension, but 
once the large flocs that formed had sedimented, the volume of remaining suspended 
particles was less than 0.2 mg/g.  The slopes and intercepts of linear regressions were 
recorded for each run of each bottle and there were no statistically significant differences 
between bottles or runs (all p> 0.05). 
 Twenty four hours after mixing, DEP were not detected in suspension.  The 
propellant was transparent, but did vary slightly in color with DEP concentration.  The 
propellant from 0.2 mg/g suspension did not appear different in color to propellant without 
DEP.  The propellant from the 1.0 mg/g had a slight yellowish tint and that tint was darker in 
the propellant from the 5.0 mg/g suspension, indicating dissolution of adsorbed compounds 
in the propellant. 
 It was clear that when left unstirred, DEP aggregate in suspension in HFA134a in 
concentrations of 0.2 to 5.0 mg/g.  The rate of this aggregation and the sedimentation of 
those aggregates was dependant on initial concentration.  It was also clear that the particles 
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de-aggregate to the same extent every time when the same energy was added to the 
suspension in the form of mixing.  The aggregation, settling, and concentration as a function 
of time are reproducible and occur every time each canister was mixed and caking did not 
occur in suspensions left undisturbed up to 6 months.  The degree of particle aggregation in 
the first seconds after mixing the suspensions is unknown and the use of these suspensions to 
create reproducible aerosols requires actuation very soon after mixing, but should by 
reproducible if that time is kept short and constant.  It was also clear from the color of the 
liquid following complete settling that there are compounds present on the DEP that 
dissolved in the propellant to some extent.  The exact compounds that dissolve and to what 
extent they dissolve are unknown, but it should be noted that some dissolution of the 
adsorbed compounds does occur in HFA134a. 
2.5.2.2 Emitted Dose 
 The volume of suspension emitted per actuation and the expected DEP deposition 
calculated from that volume are shown in Table 2.3.  The metering valves are reported to 
emit 25 µl per actuation, but the three valves used in these experiments delivered an average 
of 27.9 to 28.9 µl per actuation.  Approximately 10 times (293±19 µl) the suspension volume 
was delivered from each actuation of the continuous valve. 
 
 
 
 
 
 
 64
25 µl Metered Valve Continuous Valve 
 
Product Information 
0.2 mg/g 1.0 mg/g 5.0 mg/g 1.0 mg/g 
Actuations per run 10 5 5 1 
Suspension/actuation (µl) 27.9±0.2 28.9±0.2 28.2±0.1 293±19 
Expected DEP Dose (µg) 67.5 175 853 354±23 
Actuator deposition (µg) 18±1 43±2 186±1 102±11 
Device deposition (µg) 47±1 125±5 648±7 239±18 
Total deposition (µg) 65±1 168±6 834±6 341±23 
Deposition per actuation 6.5±0.1 33.6±1.2 166.8±1.2 341±23 
Percent recovery 96.3±1.5 96.0±3.4 97.8±0.7 96.4±1.3 
Table 2.3. Data and calculations from the Emitted Dose Device (mean ± SD, n=6). 
 
 The mass of DEP recovered from the actuator, the EDD, the addition of those (total 
deposition), and the percent recovery (total/expected deposition x 100) are also shown in 
Table 2.3.  Recovery ranged from 96.0 to 97.8 % and there are several possible reasons for 
recovery under 100%.  DEP may have been incompletely washed from the emitted dose 
device, filter, or actuator because of the small volumes of ethanol used.  It was also expected 
that a portion of the DEP mass flowed through the filter and was not captured because the 
filters used are designed to capture only particles larger than 100 nm.  The data gathered 
from the ELPI (reported in Section 2.5.2.3) shows that there was a significant fraction of 
particles in the aerosols that was smaller than 100 nm.  However, the fraction of particles 
smaller than 100 nm was not likely to contain 2-4 % of the total mass.  It is possible that a 
portion of the DEP mass was aggregated in the bottle to a size that was unable to pass into 
the metering chamber, but this was also unlikely because the 5.0 mg/g suspension, in which 
aggregation occurred the fastest, had the highest recovery. 
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2.5.2.3 Size Characterization 
NVCI Results  
 The total mass of DEP collected (actuator, inlet and NVCI) per actuation and the 
mass of DEP collected on the stages of the NVCI per actuation are shown in Table 2.4.  The 
recoveries of the aerosols from the 0.2, 1.0, and 5.0 mg/g suspensions fitted with metered 
valves were 85.1±1.1%, 84.6±5.3%, 93.7±2.6%, respectively.  The recovery of the aerosol 
from the 1.0 mg/g suspension fitted with a continuous valve and was 89.7±2.1%.  The same 
explanations are valid for recovery below 100% of nominal mass as with the emitted dose.  
The last stage of the NVCI has a cutoff diameter of 300 nm, allowing a fraction of small 
particles to pass though without depositing. 
 DEP deposition on each stage of the NVCI, the sampling inlet, and the actuator, as 
percentages of total expected dose for each suspension concentration is shown in Figure 
2.20a.  The deposition patterns in the NVCI were similar among the concentrations, with a 
slight increase in the deposited fraction in the middle size range (stages 3 and 4, 1.8-5.0 µm) 
and a decrease in deposited fraction in the smaller size range (stages 6 and 7, 0.3-1.0 µm) as 
suspension concentration increased.  The proportion of particle mass deposited in the inlet 
was much greater for the 5.0 mg/g suspension than for the 0.2 or 1.0 mg/g suspensions.  This 
may have been due to a larger fraction of large particles impacting in the back of the inlet for 
the 5.0 mg/g suspension. 
 Similar DEP deposition patterns in the NVCI were seen when the spacer was used 
(Figure 2.20b).  There was a slight decrease in the mass deposited in the smaller stages for 
the 0.2 mg/g suspension and an increase in the deposition on most stages for the 5.0 mg/g 
suspension.  These differences can be seen more easily when the deposition on each stage is 
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normalized for the width of the particle size range (in logarithms) collected on each stage, 
creating histograms similar to particle size distributions (Figure 2.21).  The particle size 
distributions for each concentration were multimodal with primary maxima < 2 µm and 
secondary maxima in the 5-6 µm range.  There were slight variations in the location of the 
maxima, which are discussed in conjunction with the ELPI data below.  The location of these 
maxima better describe the distributions than estimation of MMAD.  Calculations of GSD 
could only be performed if the distributions were log-normal with a single mode.  Since this 
was not the case, this calculation was not performed. 
 The particle size distribution of the aerosol from the 1.0 mg/g suspension with the 
continuous valve (Figure 2.21d) was similar to the distribution of the aerosol from the 1.0 
mg/g suspension with the metered valve (Figure 2.21b).  There was an increase (18.4±3.4% 
compared to 5.6±2.4%) in fractional inlet deposition for the continuous valve that may have 
been due to a change in plume shape resulting from a change in actuation duration. 
 
DEP Concentration (mg/g) Measured Particle 
Property 
Spacer 
0 0.2 1.0 5.0 
Total Mass/Actuation (µg) No NA 5.7±0.1 29.6±1.9 159.7±4.4 
NVCI Mass/Actuation (µg) No NA 3.7±0.1 19.2±0.7 76.2±3.7 
NVCI Mass/Actuation (µg) Yes NA 3.1±0.1 20.4±1.2 90.1±3.5 
Number/Actuation (x 108) No 19.3±3.7 44.7±8.6 58.4±2.9 53.8±7.6 
Number/Actuation (x 108) Yes 3.7±0.4 20.9±0.7 31.3±0.8 30.3±1.3 
Table 2.4. Total mass recovered, mass recovered from the stages of the non viable 
cascade impactor (NVCI, n=3), and number deposition on the stages of the electronic 
low pressure impactor (ELPI, n=5) per actuation (mean ± SD). 
 
ELPI Results 
 The total numbers of particles detected by the ELPI for each DEP suspension fitted 
with a metered valve are shown in Table 2.4.  A statistically lower number of particles 
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deposited from the aerosol of the 0.2 mg/g suspension than from the other DEP aerosols with 
and without a spacer (p < 0.05).  This decrease may be explained by a decrease in average 
particle size, as is discussed below, and an associated increase in number of particles small 
enough to pass through the filter and remain uncounted.  The presence of empty (containing 
no DEP) droplets, also discussed below, may have also contributed to the decrease. 
 The total particle numbers for the aerosol from the propellant alone was much lower 
than the other formulations, but were greater than zero.  This indicates that the propellant had 
not completely evaporated by the time the aerosol reached the ELPI or that there was a 
contaminant, such as dissolved water, remaining.  Water is somewhat soluble in HFA134a 
(Atkins and Crowder 2004) and could have remained after the propellant had evaporated. 
 The number of particles that deposited per actuation on each stage of the ELPI for 
each formulation with and without use of the spacer is shown in Figure 2.22.  The pattern of 
deposition, like for mass deposition in the NVCI, is similar for all the formulations.  For each 
formulation, the largest number of particles deposited on the filter stage (7 - 25 nm), with a 
general trend of decreasing particle deposition in the higher stages.  The use of the spacer 
decreased the average number and standard deviation of particles counted per actuation on 
each stage for all formulations.  Figure 2.23 shows the percentage decrease in deposition on 
the stages with the use of the spacer.  These decreases in deposition may have been due to 
collection of particles in the spacer, although if this was the case it was either limited to 
smaller particles that did not constitute much of the particle mass or was confounded with the 
change in deposition in the inlet.  The mass deposited in the NVCI was lower for 0.2 mg/g, 
approximately the same for 1.0 mg/g, and higher for 5.0 mg/g with the addition of the spacer.  
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It was not easy to discern if the decreases in deposition in the ELPI were dependant on 
particle size from Figure 2.23 because of the large standard deviations in the upper stages. 
 The decrease in number may also have been due to evaporation of propellant and/or 
other molecules.  There was roughly a 50% decrease in deposition for the suspension 
formulations on each stage and an 80% decrease for the propellant only formulation.  This 
difference can not be explained with deposition in the spacer.  If the aerosol from the 
propellant only formulation contained particles of water, some may have evaporated to a size 
smaller than was detectable by the ELPI. 
 The number deposition on each stage was normalized for the width of the particle size 
range (in logarithms) collected on each stage, creating histograms similar to particle size 
distributions (Figure 2.24).  The number distributions of the suspension formulation are 
similar and appear to be multimodal with primary maxima < 100 nm and secondary maxima 
at approximately 300 nm.  These primary maxima would not be seen in the data from the 
NVCI because the majority of particles in this size range are too small to deposit in that 
device and contain very little mass.  The secondary maxima likely represent the same particle 
mode that is represented by the primary mass maxima seen at ~1 µm.  The relation between 
the CMAD and MMAD of log-normally distributed particles is shown in Equation 2.1.  The 
second mode seen in the NVCI (~5 µm) likely contained too few particles to be seen in the 
ELPI data. 
Discussion 
 The size distributions of suspension MDI aerosols are functions of the initial droplet 
sizes and the number of suspended particles that each droplet contains.  The number of 
suspended particles in each droplet is dependant on the size of the primary particles, the 
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concentration of those particles in suspension, and the degree of aggregation at the time of 
aerosolization.  For the PS DEP aerosols, these parameters can only be estimated from the 
final aerosol size distribution.  If no aggregation is assumed, each droplet would contain a 
number of particles dependant on DEP concentration.  The diameter of an aerosol particle is 
proportional to the cubed root of its volume and, therefore, it is proportional to the cubed root 
of initial DEP concentration.  If the initial droplet size distribution was the same for each 
DEP concentration, each particle in the aerosol from the 5.0 mg/g aerosol would have a 
diameter ~1.7 (cube root of 5) times larger than from the 1.0 mg/g suspension ~2.9 (cubed 
root of 25) times larger than from the 0.2 mg/g suspension.  This would yield particle size 
distributions with the same shape, but with a shift on the x-axis (particle diameter). 
 This phenomenon is evident in the 0.5-1.5 µm mass mode for the PS aerosols (Figure 
2.21).  As the concentration increases, the peak of that mode appears to shift to the right on 
the order of 1.7 times.  This is not as clear for the larger mass mode peak (~5µm) and the 
very small particle number mode (<100 µm), but may be present.  If the peak seen ~ 1 µm in 
the mass distribution does represent the same particles size mode as the peak seen ~300 nm 
in the number distributions, the initial droplet distribution was likely trimodal.  It has been 
shown previously that some HFA134a pressurized metered dose inhaler aerosols have multi-
modal droplet size distributions (Smyth and Hickey 2003). 
 Aggregation of particles does occur in these suspensions, as described in Section 
2.5.2.1.  If aggregation did occur to any significant extent in the propellant prior to droplet 
formation, an initial droplet size distribution with only one or two modes could have yielded 
three or more final aerosol particle size modes.  In this scenario, droplets of a particular size 
might or might not contain an aggregate.  Those containing aggregates would have a final 
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particle size different than those that did not, yielding two different particle size modes from 
one initial droplet size.  This seems unlikely, however, because aggregation rates are 
dependant on particle concentration and differences in aggregation rates would be evident in 
the number particle distributions.  
2.5.2.4 Morphological Characterization 
 SEM images of DEP deposited on stages 3-6 of the NVCI (60 l/min) are shown in 
Figure 2.25.  The particles appear to be roughly spherical aggregates with diameters 
dependant on the stage on which they deposited.  As with the bulk and CAE particles, the 
primary particles cannot be distinguished, but give the aggregates a fluffy appearance.  
Images of DEP deposited on stage 2 of the ELPI are shown in Figure 2.26.  The particles on 
stage 2 of the ELPI (0.032-0.051 µm cutoffs) are generally smaller and with a wider range of 
sizes and shapes, than those seen in the lowest stage of the NVCI (200 nm cutoff for stage 6).  
The physical diameter of the DEP deposited on stage 2 of the ELPI varies from < 50 nm to 
~1 µm.  A higher magnification SEM image of DEP deposited on stage 2 of the ELPI is 
shown in Figure 2.27.  It is impossible to determine whether the larger particles in Figures 
2.26 and 2.27 represent individual aggregates that deposited or particles that aggregated 
following deposition. 
2.5.2.5 Chemical Composition 
 The concentration curves for B[a]P and B[k]F were linear for both wavelengths over 
the concentration range of 0-125 ng/ml (R2 > 0.999 for all lines).  The equations for these 
lines and average values are shown in Table 2.5. 
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Run 1 Run 2 Average Compound Excitation 
Wavelength m b m b m b 
B[a]P 370 0.69 -0.8 0.76 -1.1 0.74 -1.0 
B[a]P 395 2.09 -3.9 2.24 -2.6 2.17 -3.3 
B[k]F 370 1.84 -2.8 1.74 -2.4 1.79 -2.6 
B[k]F 395 1.46 -2.9 1.39 -2.2 1.43 -2.6 
Table 2.5. Slopes (m) and intercepts (b) of concentration curves for benzo[a]pyrene 
(B[a]P) and benzo[k]fluoranthene (B[k]F) fluorescence at emission wavelength of 429 
nm and excitation wavelengths of 370 and 395 nm. [Concentration (ng/ml) = m x 
Fluorescence + b]. 
 
 The ratio of fluorescence at the two wavelengths is different, which means that 
equations can be formed to allow the concentration of both compounds to be determined 
from a set of fluorescence measurements at both wavelengths: 
708.0
46.038.1 390395
][
FlFlConc FkB
⋅−⋅=                       (Equation 2.6) 
38.1
56.0 ][370
][
FkB
PaB
ConcFl
Conc
⋅−=                        (Equation 2.7) 
These equations were used to calculate the amount of both B[a]P and B[k]F that dissolved in 
the DCM in the sonicated DEP suspensions.  The calculated PAH concentrations appeared to 
be functions of the log of DEP concentration (Figure 2.28).  The recovery for the known 
PAH concentrations from the solid phase extraction columns was 92-98% for B[a]P and 84-
92% for B[k]F over the range of concentrations and was not dependant on concentration.  
This indicates that the PAHs likely dissolved in the DCM as a function of the log of DEP 
concentration.  Figure 2.28 also shows there were no obvious differences in the amount of 
PAH in the DEP of bulk or aged or fresh aerosol, all data points appeared to lie on the same 
line.  In order to estimate the fraction of DEP mass made up of B[a]P or B[k]F, PAH particle 
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was plotted against DEP suspension concentration for all samples (Figure 2.29).  It was 
assumed that as the DEP concentration approached zero, the actual PAH concentration was 
approached.  This appears to be 30-50 ng/mg for B[a]P and 50-70 ng/mg for B[k]F.  The 
Diesel Particulate Matter Standard Reference Material (SRM 1605a) from the National 
Institute of Standards and Technology is certified to contain 1.33±0.3 and 2.64±0.31 ng/mg 
B[a]P and B[k]F  PAH levels have been reported as high as 558 and 289 ng/mg extract for 
B[a]P and B[k]F, respectively and extract is usually 10-50% of the total mass (Tong and 
Karasek 1984). 
2.6 Conclusions 
 The specific aim of the work addressed in this chapter was to generate DEP aerosols 
relevant to atmospheric DEP for subsequent deposition on the surface of cells grown in 
culture.  As stated in the introduction (Section 2.1), DEP exist in the atmosphere in three 
overlapping particle size modes.  The nuclei mode (5-50 nm) consists of condensed organic 
or sulfuric compounds and spherical carbon particles and constitutes most of the total DEP 
numbers, but only 1-20% of the mass (U.S.EPA 2002).  The accumulation mode (50 nm - 1 
µm) consists of aggregates of the spherical particles and constitutes a small fraction of the 
total number, but the majority of the mass (80-95 %) of atmospheric DEP.  A coarse mode 
(>1 µm) also exists, but contains few particles or mass.  DEP aerosols were generated using 
several different methods that had particle size distributions close to one or more of the 
atmospheric modes. 
 DEP aerosols with a log-normal particle size distribution with a CMAD of 0.46 µm 
and a GSD of 2.3 were created by the CAE method.  This particle size distribution is quite 
broad, but contains particles over a range of sizes that includes both the accumulation and 
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coarse modes of atmospheric DEP.  The DEP aerosols generated by a similar method for the 
exposure of isolated perfused rat lungs had a slightly smaller, but overlapping, size 
distribution (CMAD = 0.55, GSD = 2.17) (Gerde, Ewing et al. 2004).  The CAE-generated 
DEP aerosols are composed of aggregates of individual primary DEP, as in the atmosphere.  
The shapes of these aggregates in the CAE aerosols, however, were not the same as the 
aggregates in the accumulation mode of atmospheric DEP.  DEP aggregates are formed in 
the atmosphere by DLCA and are dendritic in shape, while CAE aerosols were formed from 
de-aggregation of more tightly aggregated particles and resulted in irregularly shaped 
aggregates. 
 The FPM of the CAE aerosols was 84 ± 6 µg.  It would be possible to increase this 
dose by further method optimization.  Following the trend seen in Figure 2.16, FPM would 
likely be increase by increasing the solenoid valve inlet pressure beyond 60 PSI.  This could 
be done if a better system to fasten the pipette tip to the solenoid outlet were developed and 
further safety precautions were put into place.  Increased inlet pressure might also decrease 
the average size of the particles contained in the FPM.  A larger total dose would also likely 
increase FPM, as would implementing a more complex air flow configuration, similar to 
those tested in the propellant expulsion configurations described in Section 2.4.1. 
 DEP aerosols were created by the PS method that had particle size distributions 
similar to atmospheric DEP.  Particles were generated with aerodynamic diameters over the 
entire measurable range of the ELPI and NVCI (0.007 – 8.7 µm).  There was a mass mode at 
5-6 µm in each PS aerosol that corresponds to the coarse mode of atmospheric DEP, 
although the peak particle diameter or the mode was larger in the PS aerosol than in the 
atmosphere.  There was a mode of particles containing significant mass and numbers that 
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was roughly log-normal distributed and corresponded to the accumulation mode (CMAD ~ 
0.3 µm, MMAD ~ 0.5-1.5 µm) of atmospheric DEP.  In addition, there was a fraction of 
particles, large by number and small by mass, of particles present that were < 100 nm, which 
is the size range of nuclei mode of atmospheric DEP. 
 It was difficult to determine the exact composition of the very small mode of DEP, 
but because they have such a small aerodynamic diameter, they were composed either of 
aggregates of a small number of primary DEP or of compounds that dissolved from the DEP 
surface and remained following propellant evaporation.  The SEM of the particles deposited 
on Stage 2 of the ELPI (Figure 2.27) shows aggregates of a range of sizes, potentially down 
to one or several primary particles.  The particles from the filter stage could not be imaged, 
however, because they could not be deposited on a removable surface.  The color change of 
the propellant with the addition of DEP indicated that there was some dissolution of adsorbed 
compounds in the propellant.  This opens up the possibility that some of the very small 
particles that were counted by the ELPI contained solely dissolved material, without any 
elemental carbon.  This would have occurred if the initial droplet contained no primary 
particles.  This was likely the case for at least a fraction of the very small particles because of 
the number particle size distributions seen for the propellant only formulation.  The 
propellant only aerosol contained a significant number of particles in the very small sizes 
even in the absence of DEP, showing that the creation of an aerosol composed of dissolved 
compounds is possible.  A diagram of the potential size distribution of droplets and final 
aerosol particles that includes both types of small particles is shown in Figure 2.30. 
 The PS DEP aerosolization method could be further optimized in terms of particle 
shape and size distribution.  Altering the suspension concentration, actuator design, or 
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potentially adding additional chemicals to the suspension could produce aerosols with 
different size and shape characteristics. 
 The suspension of DEP in HFA134a had the potential to affect the compounds 
adsorbed on the particle surface in several ways.  It is clear from the color change of the 
propellant that some of the compounds were at least somewhat soluble.  Because of this, 
there was the possibility of redistribution of chemicals, along with chemical reactions in 
solution and loss of compounds during the aerosolization/evaporation process.  This was not 
of great concern because it was assumed that any compounds that dissolved in the propellant 
would re-adsorb to the particle surface as the propellant evaporated.  It was not possible to 
fully analyze the pre- and post-aerosolization DEP chemical makeup, but several medium-
sized (5-ring) aromatic molecules, B[a]P and B[k]F, were analyzed and showed no changes 
upon suspension in HFA134a and aerosolization. 
 The aerosolization methods discussed above were developed in order to deposit DEP 
onto the surface of cells grown in culture.  Notably, the aerosolization methods are also 
applicable to in vivo exposure.  There are a number of factors that influence the size and 
chemical concentration of DEP aerosols generated from engines in the laboratory 
environment including engine type, operating conditions, fuel type, and post-combustion 
conditions.  It is difficult to tightly control all of these parameters and, thus, to ensure that a 
reproducible DEP aerosol is produced for inter-laboratory comparison of data.  DEP aerosols 
generated from a standardized bulk source would be much easier to be made reproducible.  
Aerosols were prepared and characterized, meeting the objectives of specific aim 1, allowing 
the subsequent specific aims to be addressed.  In vitro deposition is discussed in Chapter 3.   
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 (b) (a) 
 
Figure 2.1. Scanning electron micrographs of diesel exhaust particles in bulk at 
(a)1000X and (b)10000X. 
 
 77
  
Fluidization De-aggregation 
Airflow 
Figure 2.2. Diagram of aerosol dispersion from a bulk powder source.  Adapted from 
(Dunbar, et al. 1998). 
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Figure 2.3. Diagram of the components of a typical metered dose inhaler. 
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Figure 2.4. Diagram of a trans-section of the flow of air through a single stage of a 
cascade impactor. 
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Figure 2.5. Typical particle collection efficiency curve for an inertial impactor. 
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Figure 2.6. Diagram of a trans-section of the flow of air through a twin-stage liquid 
impinger. 
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 (a) (b)  
Figure 2.7. Scanning electron micrographs of deposition of a 1% DEP/lactose blend on 
a cover slip placed on stage 4 (1.1-1.9 µm) of the non viable cascade impactor operated 
at 60 l/min.  (a) 1000 X, scale bar = 10 µm and (b) 7500 X, scale bar = 1 µm. 
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Figure 2.8. Diagram of propellant (HFA134a) driven expulsion of DEP from a packed 
hematocrit tube. 
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Figure 2.9. Y-tube configuration for the generation of DEP aerosols by propellant 
(HFA134a) expulsion into an air flow of 60 l/min.  Arrows indicate direction of air flow. 
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Figure 2.10. Deposition of DEP on stage 2 (< 6.4 µm) of the twin stage liquid impinger 
from the various configurations of propellant (HFA134a) expelled aerosols (mean ± SD, 
n=3). 
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Figure 2.11. Diagram of compressed air expulsion DEP aerosolization method. 
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Figure 2.12. Measured and calculated (using discharge coefficients, CD, of 1.0 and 0.6) 
volumetric flow rates from a pipette tip attached to the outlet of the solenoid valve with 
a range of inlet air pressures. 
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Figure 2.13. Throat extension for the compressed air expulsion DEP aerosolization 
method, consisting of a 22 mm inner diameter (ID) to 13 mm ID brass pipe adapter 
inserted in a 82 mm, 25 mm ID tube. 
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Figure 2.14. Total dose of bulk and mortar and pestle crushed DEP in the compressed 
air expulsion device and collected dose (CD) from the emitted dose device with and 
without the adapter following aerosolization (mean ± SD, n=5). 
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Figure 2.15. Deposition of compressed air expulsion aerosols of bulk and crushed DEP 
in the twin-stage liquid impinger with and without addition of the adapter (mean ± SD, 
n=6). 
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Figure 2.16. DEP deposition of compressed air expulsion aerosols in (a) the pipette tip 
and each stage of the twin-stage liquid impinger (TSLI) and (b) stage 2 of the TSLI only 
for expulsion pressures of 10-60 PSI (mean ± SD, n=3). 
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Figure 2.17. Deposition of compressed air expulsion DEP aerosol on each stage of the 
electronic low pressure impactor as (a) number of particles per actuation and (b) 
percentage of total particles per actuation (mean ± SD, n=3). 
 
 93
 0
5
10
15
20
25
30
35
0 50 100 150 200 250 300 350
Time (sec)
G
el
 H
ei
gh
t (
m
m
)
 
Figure 2.18. Height of the gel formed in the 5.0 mg/g DEP suspension over time after 
mixing.  Each point represents one bottle at one time point and the dotted line was used 
to determine the settling velocity (mean ± SD, n=3). 
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Figure 2.19. Light extinction at 700 nm (EXT700) over time (5-80 minutes post mixing) 
with linear regressions for 0.2 and 1.0 mg/g DEP in HFA134a suspensions (mean ± SD, 
n=9). 
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Figure 2.20. Percentage of expected total DEP dose deposited per actuation in actuator, 
sampling inlet, and nonviable cascade impactor (a) with and (b) without the spacer 
(mean ± SD, n = 3). *Actuator and inlet deposition not calculated when the spacer was 
used. 
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Figure 2.21. Particle size distributions by mass of DEP aerosols deposited in the non-
viable cascade impactor (NVCI) with and without the spacer (mean, n=3). 
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Figure 2.22. Number of particles deposited per actuation on each stage of the electronic 
low pressure impactor (a) with and (b) without the spacer (mean ± SD, n = 5). 
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Figure 2.23. Proportional decrease in particle number with the addition of the spacer 
on each stage of the electronic low pressure impactor (mean ± SD, n=5). 
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Figure 2.24. Particle number distributions of aerosols deposited in the electronic low 
pressure impactor with and without the spacer (mean, n=5). 
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Figure 2.25. Scanning electron micrographs of 1.0 mg/g propellant suspension DEP 
aerosols deposited on stage 3-6 of the non viable cascade impactor operated at 60 l/min.  
Scale bar = 100 µm (100X) and 1 µm (5000X). 
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Figure 2.26. Scanning electron micrographs of DEP deposited on a glass cover slip 
placed on (a) stage 1 (25-32 nm) and stage 2 (32-51 nm cutoffs) of the electronic low 
pressure impactor following 15 actuations of a 1.0 mg/g DEP in HFA134a suspension. 
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Figure 2.27. Scanning electron micrograph of DEP deposited on a glass cover slip 
placed on stage 2 (32-51 nm cutoffs) of the electronic low pressure impactor following 
15 actuations of a 1.0 mg/g DEP in HFA134a suspension. 
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Figure 2.28. Concentrations of (a) benzo[a]pyrene (B[a]P) and (b) benzo[k]fluoranthene 
(B[k]F) as functions of the log of DEP concentration calculated for bulk DEP and 
aerosols from 1.0 mg/g DEP suspensions that were freshly made or aged 6 months. 
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Figure 2.29. Concentration of two polyaromatic hydrocarbons (PAHs), benzo[a]pyrene 
(B[a]P) and benzo[k]fluoranthene (B[k]F), as functions of the DEP concentration. 
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Figure 2.30. Diagram of potential droplet formation followed by evaporation yielding 
three different aerosol size modes. 
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3 DEVELOPMENT AND CHARACTERIZATION OF AEROSOL DEPOSITION 
METHODOLOGY 
  
 Methods were developed to deposit the DEP aerosols described in Chapter 2 onto the 
surface of lung epithelial cells grown at the air/liquid interface.  The outcomes to be studied 
were the effects of exposure to these deposited particles so it was important that the methods 
were reproducible and that the integrity of the cells was not challenged by aerosol deposition. 
3.1 Introduction and Background 
 Several laboratories have developed methods of exposing cells grown at the air/liquid 
interface to particles present in cigarette smoke (Abe, Takizawa et al. 2000; Knebel, Ritter et 
al. 2002) and diesel engine exhaust (Massey, Aufderheide et al. 1998; Wolz, Krause et al. 
2002).  These methods were designed to expose the cells to an atmosphere containing a low 
concentration of particles over long (> 30 minute) periods.  The DEP aerosols in the present 
studies were much more concentrated than typical atmospheric concentrations, so they could 
be deposited in less than 30 minutes.  It is important to limit the time that the cells are 
exposed to the atmosphere outside of the incubator to reduce the chances of contamination, 
infection, or deposition of non-DEP atmospheric components.  None of the exposure systems 
cited above make an attempt to characterize the particle size or even the concentration of 
particles deposited.  A more reproducible deposition method with specific, known deposition 
as a function of particle size is needed.  Each of the lung deposition mechanisms (diffusion, 
gravimetric sedimentation, electrostatic precipitation, and inertial impaction), as described in 
Chapter 1 (Section 1.2), are potential mechanisms for in vitro deposition.  Deposition by each 
of these mechanisms occurs to different extents and at different rates dependant on the 
characteristics of the particles to be deposited and the flow of air around the particles.  These 
differences lead to advantages and disadvantages of using each of the mechanisms as well as 
limit some of their usefulness. 
3.1.1 Particle Movement in Air 
 In order for a particle to deposit on a surface, it must move from site of generation to 
that surface.  The movement of particles in air has been studied extensively and is well 
defined (Hinds 1999; Baron and Willeke 2001).  The majority of movement of aerosol 
particles occurs with the bulk movement, or flow, of air molecules.  The pattern of this bulk 
flow greatly affects particle movement and may be turbulent, laminar, or transitional, 
depending on a number of variables included in the calculation of Reynolds’ number, Re 
(Hinds 1999).  The flow of a gas may be described with density, ρg, and dynamic viscosity, 
η, moving with a velocity, V, relative to an object and can be predicted by calculating Re: 
 
η
ρ Vdg=Re                                                          (3.1) 
 
where d is a characteristic dimension of the object.  Re is a dimensionless ratio of inertial 
forces of the gas to frictional forces between the gas and the object surface.  The 
characteristic dimension of flow in a tube is its diameter, with laminar flow defined as 
occurring for Re > 2000 and turbulent flow for Re > 4000 (Hinds 1999). 
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 Particles can also move relative to the air molecules.  This relative movement is very 
important to aerosol deposition because bulk flow only brings a particle close to a surface.  
The distance traveled to approach the surface is always relative to bulk flow (with the 
exception of interception) due to the undisturbed nature of air at the surface.  Relative 
movement is resisted by air molecules and so the local airflow at the surface of the particle 
becomes important.  Reynolds’ number is also used to estimate flow around a particle 
surface, with the particle diameter being the characteristic dimension.  That flow is laminar 
for particles with Re < 1, but becomes less smooth at higher values (Hinds 1999). Reynolds’ 
number can be used to describe the type of bulk or local air flow, but does not describe the 
movement of a particle in airflow. 
 The main force counteracting the movement of a spherical particle with diameter, D,  
relative to air molecules moving with velocity, V,  is the drag force, Fdrag. 
 
8
22 DVC
F gdragdrag
πρ=                                                (3.2) 
 
where Cdrag is the coefficient of drag (Hinds 1999).  This drag coefficient is roughly constant 
(~0.44) for particles with Re > 1000, but is not constant for aerosol particles, which have a 
Reynolds’ number much lower.  To find the relationship between drag coefficient and 
particle size, Stokes’ law can be used.  Stokes’ law states that when certain assumptions are 
made, the Navier-Stokes equations, a comprehensive set of equations describing fluid 
motion, can be simplified to describe total resistive force on a spherical particle in a fluid: 
 
     VDFdrag πη3=                                                     (3.3) 
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 Cdrag can be solved for by equating equations 3.2 and 3.3 and substituting for Re (equation 
3.1): 
 
        
Re
24=dragC                                                        (3.4) 
 
The assumptions made by Stokes’ limit the use of his law to particles with low Reynolds 
number.  The error in Fdrag is less than 1% for Re < 0.1 and less than 10% for Re < 1.0 
(Hinds 1999).  When equation 3.4 can be used, a particle is said to be in the Stokes’ region.   
 Equations 3.3 and 3.4 also make the assumption that the forces from air molecules on 
a particle are constant and uniformly distributed at the surface, forming a continuum.  This is 
not true for particles smaller than 1 µm, as they may “slip” by molecules and move with less 
resistance than expected by Stokes’ law.  The Cunningham slip correction factor, Cc, is used 
to correct for this decrease in drag force in very small particles: 
 
  
c
drag C
VDF πη3=                                                      (3.5) 
 
where 
 
   
D
Cc
λ52.21+=                                                        (3.6) 
 
for particles > 0.1 µm, and 
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for particles > 0.01 µm (Hinds 1999).  The mean free path of the gas, λ, is the mean distance 
a gas molecule will travel before colliding with another molecule and is 66.4 nm for air at 
20°C and 1 atm (Hinds 1999).  Equations 3.1 to 3.7 can be used to determine the extent of 
deposition by the various mechanisms. 
3.1.2 Diffusion 
 Movement of a particle by diffusion is controlled by the diffusion coefficient, Cdiff.  
Cdiff is inversely dependant on the size of the particle and air viscosity:  
 
D
kTCC cdiff πη3=                                                      (3.9) 
 
where k is the Boltzman constant (1.38 x 10-23 Nm/K) and T is temperature.  The forces that 
increase the drag on a particle decrease its ability to move by Brownian motion.  Cdiff can be 
used to determine the average (root mean square, xrms) distance that a particle will travel in a 
specified time, t: 
 
tCx diffrms 2=                                                      (3.10) 
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This displacement is varies from 1000 to 7 µm in 10 seconds for particles from 0.01 to 10 
µm.  These distances would require a particle to be brought into very close proximity to the 
deposition surface, or be in proximity for a long time for deposition by diffusion to occur.  
The direction of diffusion forces is random, and therefore equally probable in every 
direction.  This means that guided deposition towards a surface is not possible.  The rate and 
proficiency of deposition by diffusion are dependant on particle size and limited by 
proximity to the deposition surface making diffusion alone not a likely candidate for targeted 
deposition of particles >1 µm.  Diffusion could be combined with another mechanism such as 
sedimentation in order to increase deposition, especially of large particles. 
3.1.3 Sedimentation 
 Movement of a particle by sedimentation is the result of action of gravity.  The force 
exerted by gravity (Fg) on a spherical particle is the product of particle volume, particle 
density, ρp, and acceleration due to gravity (g): 
 
 
6
3 gD
F pg
πρ=                                                     (3.11) 
 
This gravitational force accelerates the particle until the drag force becomes equal in the 
opposite direction, at which point the particle reaches terminal settling velocity, Vts.  Vts can, 
therefore, be calculated by setting Fg equal to Fdrag (eq. 3.5) and solving for velocity: 
 
η
ρ
18
2
cp
ts
gCD
V =                                                     (3.12) 
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 Equation 3.12 is only valid for spherical particles, as the drag will change if the particle has a 
non-spherical shape.   To account for this, a dynamic shape factor, χ, is applied to Stokes’ 
law: 
 
χπη edrag VDF 3=                                                    (3.13) 
 
and terminal settling velocity: 
 
ηχ
ρ
18
2
cep
ts
gCD
V =                                                    (3.14) 
 
with De representing the diameter of a spherical particle having the same volume as the 
particle of interest, or the equivalent volume diameter.  The dynamic shape factor is 
determined experimentally by measuring actual terminal settling velocities (Hinds 1999).  
Terminal settling velocity varies by size for aerosol particles, with average distances of 0.7 to 
30000 µm traveled 10 seconds for 0.01 to 10 µm particles (Baron and Willeke 2001). 
 There are several measures of particle diameter, other than actual and equivalent 
volume, that are commonly used in aerosol science and based on Vts.  Stokes’ diameter, Dp, 
is the diameter of the sphere that has the same density and settling velocity as the particle.  
Aerodynamic diameter, Da, as explained in Chapter 1 (Section 1.2), is the diameter of a 
sphere with unit density (1 g/cm3) that has the same settling velocity as the particle: 
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where ρ0 is unit density.   
 For deposition to occur by sedimentation, a particle would need to have a residence 
time above a surface sufficient for the particle to travel the intervening distance.  This places 
residence time, proximity, and particle size restrictions on the use of sedimentation as an in 
vitro deposition method.  There are several potential ways to approach sedimentation as a 
deposition method.  Sedimentation time could be long, i.e. cells could be placed at the 
bottom of a holding chamber into which an aerosol is introduced allowed to settle to the 
bottom over a period of time.  This would require a fairly concentrated aerosol in order to get 
substantial deposition on the cell surface because the entire dose must be present in the 
volume of the deposition chamber.  A second approach could involve bringing the aerosol in 
close proximity to the cell surface with bulk airflow and allowing sedimentation to occur 
over a final small distance.  Because this distance is small, this approach would combine 
sedimentation with diffusion.  This approach has been taken Vitrocell® Systems and their 
CULTEX® cell exposure system.  This system slowly draws gas (8.3 ml/min) through a 
trumpet shaped module that outputs very close to the surface of a 24 mm diameter Transwell 
(Aufderheide, Knebel et al. 2003).  The CULTEX® system has been used to expose human 
bronchial epithelial cells grown at the air interface to native diesel engine exhaust (Knebel, 
Ritter et al. 2002) and to side stream cigarette smoke (Wolz, Krause et al. 2002).  There is no 
published data, however, on the deposition of aerosols by this method as a function of size. 
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3.1.4 Electrostatic precipitation 
 Deposition by electrostatic precipitation only occurs when a charged particle enters 
an electrical field in the lung which creates a force directing the particle to the lung surface.  
The electrostatic force, Felec, on a particle is dependant on the electric field, E: 
 
neEFelec =                                                       (3.16) 
 
where n is the number of units of elementary charge, e, on the particle.  Deposition by 
electrostatic precipitation occurs similarly to sedimentation, except the gravitational force is 
replaced by electrostatic force.  Felec results in a terminal velocity when set equal to Fdrag and 
deposition occurs in the time necessary for the particle to travel to the deposition surface at 
that velocity. 
 Electrostatic precipitation is not thought to be common in the lungs because the 
electrical fields in the lungs are quite small (Gonda 2004).  Deposition by electrostatic 
precipitation can be greatly enhanced in vitro by creating a large electrical field and 
imparting charge on the surface of the particles.  An electrical field can easily be created 
between two parallel plates with potential difference, ΔVolt and separation distance, x: 
 
x
VoltE Δ=                                                   (3.17) 
 
This approach is used in electrostatic precipitators to create forces much larger than 
gravitational forces.  Electrostatic precipitators can remove virtually all aerosol particles from 
a gas, and can do so size selectively (Flagan 2001).  The gas carrying the aerosol in an 
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electrostatic precipitator flows through a corona charger that imparts charge on the surface of 
all particles.  The magnitude of charge imparted on a specific particle surface by a corona 
charger is a known function of corona voltage and particle size (Hinds 1999).  The airflow is 
then delivered at a constant rate through an inlet into a chamber with an electrical field.  The 
particles are attracted to, and deposit on, the chamber surface that is oppositely charged to the 
particles.  Because there is a constant gas flow through the chamber parallel to the deposition 
surface, the particles will travel a certain distance before they deposit.  This distance is a 
function of the air velocity and terminal velocity, dictated by the electrical and drag forces.  
Therefore, particles of a desired size could be directed to deposit at a particular distance from 
the inlet by altering flow and the charge on the deposition surface.  This would allow for 
deposition of a desired particle size on a cell layer placed at that distance.  This method has 
several restrictions, however.  There must be time for the particles to move to the deposition 
surface, so there is a maximum rate at which the gas can be passed through the deposition 
chamber, and thus a maximum rate of deposition.  This maximum is approximately 5 l/min 
for commercially available electrostatic precipitators (Hinds 1999).  Another potential 
disadvantage of this system is that the cell layer must be placed in an electrical field.  A549 
cells were placed in an electrical field generated by an electrostatic precipitator over 30 
minutes and remained viable by MTT assay, but non-lethal effects were not examined (de 
Brunijne, Lake et al. 2006).  It is likely that a strong electric field would have some affect on 
the polar and charged molecules in and around the cells. 
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3.1.5 Inertial  Impaction 
 Inertial impaction occurs when an air stream changes direction and a particle does not 
follow the stream, but instead continues on its original path and impacts on a surface.  The 
equations governing impaction are derived form particle relaxation time, τ: 
 
η
ρτ
18
2
cpp CD=                                                    (3.18) 
 
Relaxation time is the time needed for a particle to adjust its velocity to a new set of forces, 
such as in a turn of the air stream (Hinds 1999).  Particle relaxation time is used to calculate 
Stokes’ number, Stk: 
 
d
VStk oτ=                                                       (3.19) 
 
Where Vo is the original velocity of the particle and d is a characteristic dimension.  Stokes’ 
number is used to predict whether a particle will deposit in an impactor.  In an ideal impactor 
all particles with a Stokes number larger than a specific value would deposit and all particles 
smaller would pass.  In practice, some oversize particles pass through and some undersize 
particles deposit on the impaction surface, as shown by a collection efficiency curve (Figure 
2.5).  To develop the collection efficiency curve, cumulative particle deposition is plotted 
against the square root of Stokes’ number.  The value for which 50% are deposited and 50% 
pass through the stage, the Stk50, can be used to determine the size cutoff for that impactor. 
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 A diagram of a typical round jet impactor is shown in Figure 3.1.  The characteristic 
dimension for an inertial impactor with a round jet is the jet radius (Dj/2): 
 
j
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D
VCd
Stk η
ρ
9
2
=                                                     (3.20) 
 
The particle diameter for which 50% of the particle pass, called the cutoff diameter, Dcut, can 
be calculated by solving equation 3.20 for particle diameter, with Stk50 as the Stokes’ 
number: 
 
cp
j
cut VC
StkD
D ρ
η 509=                                                   (3.21) 
 
This Stk50 for circular nozzle impactors that meet certain geometric and flow criteria is 0.24.  
The Reynolds’ number in the jet should be between 500 and 3000 to ensure laminar flow 
(Hinds 1999).  The ratio of the distance from nozzle to impaction surface to nozzle diameter 
should exceed 1.0 to allow for development of perpendicular flow (Hinds 1999).   
 Deposition by inertial impaction can occur much faster than sedimentation, diffusion, 
or electrostatic precipitation because the flow through an impactor is higher than through the 
other devices.  Volumetric flow rates up to 90 l/min are commonly used in commercially 
available inertial impactors, allowing deposition of large masses of particles in a short time.  
There are size restrictions with impaction by definition, however, because particles smaller 
than the cutoff size will not deposit.  Deposition by inertial impaction onto a cell surface also 
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may have an effect on the cells via the pressure from the air streams or the force from the 
impacting particles themselves. 
3.1.6 Summary of Deposition Mechanisms 
 Each of the deposition mechanisms has advantages and disadvantages that are 
outlined in Table 3.1.  Inertial impaction provides an opportunity to deposit a large 
concentration of DEP particles in the shortest period of time in a predictable and reproducible 
manner. 
 
Deposition 
Mechanism 
Deposition 
Rate 
Particle Size 
Range (µm) Other Advantages or Disadvantages 
Diffusion Low < 1 +Surface is not affected -Particles must be very close to surface 
Sedimentation Low > 0.3 +Surface is not affected 
Electrostatic 
Precipitation Medium All 
+Deposition can be dependant on size 
-Surface is under electrical field 
Impaction High > 1 -Surface is subject to high gas flows and particle impaction 
Table 3.1. Properties of deposition of aerosols by various means. 
 
3.1.7 Cell Culture at the Air/Liquid Interface 
 Any method used to deposit aerosols onto cells must do so onto cells grown at the air 
interface.  Cells are grown at the air interface by using permeable membranes.  Corning-
Costar produces a commonly used cell culture insert called the Transwell® (Figure 3.2a).  
Transwells®-clear inserts consist of a permeable polycarbonate membrane at the bottom of a 
media cup, which is attached to a plastic ring that holds the insert suspended in a well of a 
standard multiwell culture dish.  Cells are grown on Transwells by seeding the membrane 
with cells and filling the standard culture dish and media cup with growth media.  After the 
cells have adhered to the membrane, the cells may be grown as is, under liquid cover culture 
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(LCC) conditions, or with the apical media removed, under air interface culture (AIC) 
conditions.  AIC cells are exposed to media only from the basolateral side through the pores 
in the membrane.  AIC is used for lung epithelial cells to produce a phenotype that closer 
mimics cells in vivo, as discussed in Chapter 4 (Section 4.1).  After the start of this project, 
Corning-Costar began marketing another culture insert, the Snapwell™, which has the same 
permeable membrane for growing cells, but has a removable lower cup that is shorter (Figure 
3.2b). 
3.2 Viable Cascade Impactor 
 The feasibility of using a commercial inertial impaction particle sizing device to 
deposit the DEP aerosols onto the surface of cells grown on permeable membranes was 
tested.  Cascade impactors, described in Chapter 2 (Section 2.1.4.1), are made up of a 
number of sequential stages on which particles of decreasing size deposit.  Using a cell layer 
as the impaction surface in a cascade impactor would allow for the deposition of particles in 
a selected size range, dependant on the stage below which the cell layer was placed.  The 
NVCI was considered, however, there was insufficient room between the orifice plates to 
place a Transwell.  Andersen manufactures another impactor that is designed to sample 
biological aerosols onto agar surfaces in a size-dependant manner.  The 6-Stage Viable 
Cascade Impactor (VCI, Thermo-Andersen, Smyrna, GA)  functions like the NVCI with 6, 
instead of 8, stages and agar-filled petri dishes acting as the impaction surface instead of 
metal plates.  There is enough room between orifice plates in the VCI to place the Transwells 
(Figure 3.3a and b).  Substituting a Transwell in place of the petri dish allows the cells to 
serve as the impaction surface for particles that would have deposited on the dish below that 
orifice plate.  Snapwells are short enough (5 mm) to be placed in petri dishes for deposition 
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(Figure 3.3c).  Several Transwell or Snapwell membranes can be placed on any stage of the 
VCI for simultaneous delivery an aerosol to multiple cell layers.  The fraction deposited on 
each membrane was small, however, because the surface area of a single membrane was 
small in comparison to the entire deposition surface area of the impactor stage.  The cutoff 
diameters of the stages of the VCI were calibrated by the manufacturer for use at 28.3 l/min, 
but the impactor needed to be operated at 60 l/min to allow for deposition of the compressed 
air expulsion (CAE) DEP aerosols as tested in Chapter 2 (Section 2.4.2).  The cutoffs of the 
VCI operated at 60 l/min were estimated using impaction theory and experimentation.  The 
pattern of particle deposition over the surface of the cell layer is important, as it may 
influence the response of the cells to the particles.  The quantity and pattern of deposition of 
DEP aerosols using the VCI was examined by light and scanning electron microscopy. 
3.2.1 Materials and Methods 
3.2.1.1 60 l/min Calibration 
 The cutoff diameters for each stage of the VCI operating at 60 l/min were calculated 
theoretically by two methods.  Equation 3.21 was solved for each stage, using the values for 
orifice diameter and number of orifices given by the manufacturer to calculate air velocity.  
Also, the proportionality between cutoff diameter and air velocity ( VDcut /1∝ ) was used 
to calculate cutoff diameter from manufacturer’s cutoff values for operation at 28.3 l/min, 
listed in Table 3.2: 
 
)(687.0)(1 min/3.28min/3.28
3.28
60min/60 lll
cutoffcutoffcutoff ==                  (3.22) 
 121
  The estimation of cutoff diameter was also evaluated experimentally by comparing 
the deposition of a fluorescent marker compound in the NVCI at 60 l/min, for which there 
are calibrated cutoff diameters, to deposition in the VCI at 60 l/min.  A 1% blend of 
micronized (Glen Mills Inc., Clifton, NJ) disodium fluorescein (DF, Sigma) and sieved 
(Sieve shaker, Gilson Company, Inc.) lactose (45-75µm fraction, Sigma) were prepared 
(Turbula mixer, Switzerland). Dry powder aerosols of the blend were generated using the 
Inhalator (Boehringer Ingelheim, Ridgefield, CT) and characterized using the NVCI at 60 
l/min.  Impactor plates were coated with 1% silicon oil/hexane to reduce bounce re-
entrainment and washed with 5 mL of phosphate buffer (pH 7.4) to recover powder.  DF 
solutions were analyzed using a spectrophotometer (UV/VIS, Shimadzu, Columbia MD) at 
490 nm or by spectrofluorimetry (Perkin Elmer) with excitation and emission wavelengths of 
480 and 525 nm, respectively.  MMAD and GSD were calculated as described in Chapter 2 
(Section 2.1.4.1).  The DF/lactose blend was also delivered to the VCI operated at 60 l/min.  
Petri dishes on each stage were filled with 15 mL of phosphate buffer (pH 7.4).  The stage 
cutoff diameters for the VCI were determined by using the distribution obtained from the 
NVCI and establishing the particle size values that corresponded to the cumulative amounts 
of aerosol deposited on each stage of the VCI.  
3.2.1.2 Diesel Exhaust Particle Deposition 
 DEP suspended in HFA134a (5.0 mg/g, 25 µl valve, 5 actuations) were delivered to 
the VCI with empty petri dishes under each orifice plate to determine total deposition per 
stage (n=3).  The same aerosol was delivered to the VCI with the petri dishes of stage 3, 4 or 
5 replaced with three 1.2 cm diameter Transwells (n=3) and to the VCI with three Snapwells 
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placed in the stage 5 petri dish.  The actuator, inlet, petri dishes, and/or Transwells or 
Snapwells were washed in ethanol and DEP deposition was quantified by EXT700 following 
sonication.  The deposition pattern beneath each stage of the VCI and on Transwell and 
Snapwell membranes was monitored by eye and by light microscopy.  The fraction collected 
was calculated by dividing the deposition per membrane by the deposition on the entire stage 
with petri dishes in place.  The collection fraction was calculated theoretically by dividing 
the area of the membrane by total area of the petri dish. 
3.2.2 Results and Discussion 
3.2.2.1 60 l/min Calibration 
 A 1% DF/lactose powder blend delivered aerosol with an MMAD of 5.1 µm and a 
GSD of 2.0.  This size was sufficient to deposit in all of the upper stages of the NVCI and 
VCI to allow calculation of cutoff diameters for stages 1-4.  These values, and the theoretical 
values, are listed in Table 3.2.  There was insufficient deposition in stages 5 and 6 for 
comparison.  The experimentally estimated cutoff diameter was between the two 
theoretically calculated values for stage 1 and lower than theoretical values for stages 2-4.  
Further experimentation using aerosols with MMADs lower than 5.1 µm might be performed 
to more accurately determine the cutoff values. 
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Cutoff Diameter (µm) at Specified Flow Rate (l/min) 
Stage 28.3 60 (From Experimental) 
60 (From Eq. 
3.21) 
60 (From 28.3 
Values) 
1 7.0 5.4 8.6 4.8 
2 4.7 2.8 3.1 3.2 
3 3.3 1.3 2.1 2.3 
4 2.1 0.9 1.4 1.4 
5 1.1 Na 0.70 0.75 
6 0.65 Na 0.44 0.45 
Table 3.2. Manufacturers calibrated (28.3 l/min) and estimated (60 l/min) cutoff 
diameters for the viable cascade impactor. 
 
3.2.2.2 Diesel Exhaust Particle Deposition 
 The DEP deposited on the petri dishes of the VCI in discrete piles under the 
individual orifices with spaces of little to no deposition between piles.  The diameter and 
placement of these piles was dependant on the diameter and placement of the orifices.  The 
piles under stage 5 and 6 were approximately 0.5 and 0.3 mm in diameter, respectively, with 
orifices of 0.34 and 0.25 mm (Figure 3.4).  The pile diameters were slightly larger than the 
orifice diameters, due to lateral movement of particles before impaction.  The actuator and 
throat deposition were comparable to deposition of the same DEP aerosol in the NVCI 
Chapter 2 (Section 2.5.2.3, Figure 2.20b).  This was expected, as they are the same throat and 
actuator.  Deposition on the petri dishes of the VCI (256.0 ± 11.6 µg) was less than the 
deposition on the stages of the NVCI (380.9 ± 18.3 µg).  This decrease in deposition may be 
due to empty petri dishes having lower collection efficiencies than NVCI impaction plates.  
The VCI was designed to collect particles on petri dishes filled with 15 ml of agar and in 
these experiments the petri dishes were empty.  This increased the distance between the 
orifices and deposition surface, which is known to decrease collection efficiency (Marple, 
Olson et al. 2001). 
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  DEP deposition on the Transwells that replaced the petri dishes was very low and 
could not be observed with the naked eye or under the microscope.  The average deposition 
was lower than the limit of detection plus instrument error for each stage, although most 
membranes recorded some minimal EXT700.    When fluorescent aerosols were deposited by 
this method (Chapter 4, Section 4.3.2.1), distinct piles similar to the DEP on the petri dishes 
could be seen, but the DEP did not stand out so clearly.  Although this method could likely 
be used to deposit small amounts of aerosol, the deposition fraction on each membrane was 
<< 1%.  
 Deposition on the Snapwells was visually the same as on the petri dishes, with 
obvious piles (Figure 3.5).  Deposition was 2.1±0.2 µg per membrane with no statistical 
difference between runs (all p>0.1).  The 10% standard deviation is likely due to the 
positioning of the individual Snapwells in the petri dish.  Figure 3.5a shows a Snapwell with 
12 or 13 DEP piles on the membrane and another 19 on the rim.  Changing the position of the 
Snapwell can lead to a small change in the number of piles deposited on the membrane and 
rim. 
 The total deposition area for each stage is approximately 44.2 cm2, while the area of a 
single 1.2 cm diameter Transwell is 1.1 cm2.  This yields a theoretical fractional deposition of 
2.6 % of stage deposition for each membrane.  The actual deposition was 3.1 % (2.1 µg / 
67.2 µg).  This fraction is also reflected in the fraction of the 400 total orifices whose clumps 
were deposited on the membrane (3% for 12 and 3.25 % for 13).  Both the mass and pile 
number fractions are larger than the theoretical deposition.  This may be explained by the fact 
that the orifices are not distributed evenly over the entire surface of the petri dish.  The center 
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and edges of the dish do not have orifices over them, so the actual deposition area is less than 
the 44.2 cm2 area of the entire petri dish. 
 Deposition by VCI onto Snapwell membranes is not ideal because it results in piles of 
particles.  This would not provide equal exposure to all cells in the cell layer grown on the 
membrane.  The width of the piles, and thus evenness of deposition, is dependant on the 
stage in which the Snapwells are placed.  The upper stages of the VCI yield a more even 
distribution, but less deposition of small particles.  If the aerosols generated in Chapter 2 are 
to be deposited to a significant extent, the lower stages must be used. 
3.3 Twin-Stage Liquid Impinger 
 The twin-stage liquid impinger (TSLI), described in Chapter 2 (Section 2.1.4.1), was 
also used to deposit DEP aerosols onto cells grown on Transwells.  The TSLI has a single 5 
mm diameter orifice at the outlet on the bottom stage and offers the opportunity to deposit a 
much higher fraction of DEP to a single membrane.  With slight modification of the TSLI, a 
membrane can be placed below that orifice that then serves as an impaction surface (Figure 
3.5).  The lower stage was replaced by a 50 ml culture tube that holds the membrane at a 
desired distance from the orifice.  DEP deposition on Transwells was quantified and 
compared to deposition in the lower stage of TSLI operated under standard conditions. 
3.3.1 Materials and Methods 
 DEP suspended in HFA134a (5.0 mg/g, 25 µl valve, 5 actuations) were delivered to 
the TSLI with a 1.2 cm diameter Transwell 1 or 2 cm below the orifice (n=3).  Deposition 
was quantified by suspension in ethanol followed by sonication for 30 seconds and 
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determination of EXT700.  The theoretical cutoff diameter of an impactor with a single orifice 
of 5 mm and a volumetric flow rate of 60 l/min was determined using equation 3.21. 
3.3.2 Results and Discussion 
 Actuator deposition of DEP in the TSLI runs (193.5 ± 8.1 µg) was virtually the same 
as deposition in the NVCI runs of the same aerosol (186.4 ± 3.3) from Chapter 2 (Section 
2.5.2.3).  No difference was expected, as they are the same actuator in both cases.  
Deposition in the throat and upper stage (> 6 µm) of the TSLI was combined (109.1 ± 6.9 
µg) and was lower than deposition in the throat and first two stages (> 6.1 µm) of the NVCI 
(305.6 ± 10.3 µg).  This may be explained by the TSLI throat being shorter, with a smaller 
area for deposition than the NVCI throat and the collection efficiency of the upper stage of 
the TSLI is lower than the stages of the NVCI.  Deposition in the lower stage of the TSLI 
(470.3 ± 19.2 µg) was higher than the deposition in the remaining stages, 2-7, of the NVCI 
(306 ± 16.1 µg), because less aerosol deposited in the upper region.  Deposition on the 
Transwells was 26.2 ± 2.0 µg for membranes placed 1 cm from the orifice and 20.8 ± 1.7 µg 
for membranes placed 2 cm away.  This corresponds to 5.5 and 4.4 % of lower stage 
deposition.  Greater deposition on the membranes placed 1 cm from the orifice than 2 cm 
was expected because collection efficiency decreases as distance from the orifice increases 
(Marple, Olson et al. 2001).  Both deposition fractions were far lower than what would be 
expected from an impactor with these dimensions. 
 The theoretical cutoff diameter for this impactor, calculated using equation 3.21, is 
1.8 µm.  Excluding the mass of particles smaller than 1.8 µg (180 ± 5 µg, from NVCI data in 
Chapter 2 (Section 2.5.2.3), expected deposition would still be approximately 290 µg, which 
is more than ten times the amount that was deposited.  There are several explanations for this 
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low deposition fraction.  Firstly, the calculated Reynolds’ number of this orifice from 
equation 3.1 is over 17,000.  A Reynolds’ number this high (> 4000) indicates turbulent flow, 
which is not desired in inertial impaction.  In order for the impactor calculations to be 
correct, laminar flow is assumed.  Turbulent flow and a Reynolds’ number of 17000 can 
significantly decrease the efficiency of an impactor (Marple, Olson et al. 2001).  A second 
problem is that the impaction surface is at the bottom of a cup.  The orifice diameter (4.7 
mm) is close to the diameter of the Transwell (12 mm), so the sides of the cup may interfere 
with flow toward the membrane surface.  Even though the deposition fraction was much 
lower than expected, it was higher than the per membrane deposit fraction in the VCI. 
 The pattern of particle deposition could not be determined visually.  There appeared 
to be a general darkening of the entire membrane, but no individual particles or areas of 
heavy areas of deposition could be seen using the naked eye or light microscopy.  It was, 
therefore, assumed that an even distribution had been achieved.  Deposition by TSLI appears, 
therefore to have an advantage over VCI in terms of evenness of distribution and a slightly 
higher deposition fraction per membrane, but only allows deposition onto a single membrane 
at a time. 
3.4 Custom Deposition Chamber 
 The methods described in Chapter 3.2 and 3.3 employed commercially available 
particle sizing devices with slight modifications to deposit particles.  Neither method yielded 
ideal deposition of DEP aerosols.  Ideal deposition would meet three criteria: 1)Simultaneous 
deposition to multiple membranes; 2)Even distribution over entire membrane surface; 
3)Allow deposition of particles in a defined size range, with all particle sizes possible.  A 
custom deposition chamber (CDC) was built to accommodate these criteria. 
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 Delivery to multiple membranes simultaneously is an advantage in that it increases 
the speed at which multiple exposures can be done and ensures the membranes are exposed 
to the same aerosol at the same time.  The VCI samples particles onto multiple membranes 
concurrently, but much of the aerosol is deposited on other portions of the petri dish surface.  
Much more efficient delivery can be accomplished by limiting the jets to the area above the 
membranes.  For deposition on multiple membranes, this requires evenly splitting the aerosol 
and directing it to jets placed above the individual membranes.  Certain considerations are 
required in designing a system conduit to split an aerosol evenly.  Firstly, any division in the 
aerosol must yield equal mass and quality aerosols downstream of the division.  Even splits 
are ensured by making junctions symmetric and having a sufficient length of straight conduit 
prior to the split.  Sufficient length is necessary to form a symmetric distribution of particles 
in the conduit.  Secondly, deposition in the conduit should be minimized.  Deposition is 
limited by making the walls as smooth as possible and minimizing the number and angles of 
direction changes to the air flow.  Conduit composition may also have an effect on deposition 
by changing the likelihood that a particle that touches the material will stick and by affecting 
electrostatic precipitation.  If the aerosol has a surface charge, a grounded metal conduit can 
be used to eliminate any electric fields that could force charged particles to the surface. 
 The conduit for the CDC splits the parent air stream into 4 equal air streams.  It is 
constructed from 2 sequential polypropylene 60° bifurcations.  The outlets of the bifurcations 
are 4 equal lengths of polyethylene tubing.  A diagram with specifications and photograph 
are shown Figure 3.6. 
 Even deposition across a surface using inertial impaction is not possible because the 
distance traveled parallel to the surface, away from the center of the jet, is a function of 
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particle size.  The motion of larger particles will not be as impacted by drag forces as the 
motion of small particles, therefore the larger particles will not move as far in the parallel 
direction and tend to impact closer to the center of the jet.  This does not, however, produce a 
strict gradient of particle sizes over the deposition surface because not all particles start in the 
same location in the air stream.  The most even distribution possible would occur with a 
single jet with a diameter about equal to the membrane diameter above each membrane. 
 The evenness of distribution is not the only feature dependant on the dimensions of 
the impactor jets.  If 4 single jets of the diameter of a typical Transwell (12 mm) are used to 
deposit aerosol on 4 Transwells simultaneously, the cutoff diameter would be very large.  
Using equation 3.21, an inertial impactor with 4 jets of 12 mm diameter operated at 60 l/min 
has a theoretical cutoff diameter of 14.6 µm.  This impactor would not collect a significant 
portion of the DEP aerosols.  The cutoff diameter of an impactor is controlled by jet diameter 
and air velocity.  Decreasing jet diameter decreases both Dj in equation 3.21, but also is a 
mathematically squared factor in estimating the area of the jet, which is used to calculate the 
velocity of air if volumetric flow rate is kept constant.  Therefore, for a constant volumetric 
flow rate: 
 
5.1
jcut DD ∝                                                      (3.24) 
 
The most commonly used Transwells have 12 or 24 mm diameters, but Transwells with a 
diameter of 6.5 mm are available.  Lowering the diameter of the 4 jets to 6.5 mm would 
lower the theoretical cutoff diameter to 5.8 µm for a flow of 60 l/min, which is still too high 
for DEP aerosol deposition.  Volumetric air flow, and thus air velocity, can also be increased 
 130
to decrease cutoff diameter.  Increasing volumetric flow to 90 l/min would yield a cutoff of 
4.8 µm.  Increasing the flow much further is not possible because of the limits of the vacuum 
pump. 
 A configuration other than 4 single jets was necessary to lower the cutoff diameter to 
a size that would lead to DEP deposition.  An array of closely situated jets that covers the 
membrane surface would provide fairly even distribution.  The closest packing configuration 
for same-sized circles is rhombohedral (Hickey and Ganderton 2001).  Seven circles can be 
packed in a hexagonal pattern that covers the majority of the area of a circle.  The area 
covered by the 7 circles decreases, however, when the circles have any spaces between them. 
 Other considerations in impactor design are the distance from jet to impaction surface 
and jet Reynolds’ number (Marple, Olson et al. 2001).  The distance from the jets to the 
deposition surface should be at least as large as the jet diameter in order for equation 3.21 to 
be valid.  It is also recommended that the Reynolds’ number be between 500 and 3000 to 
retain sharpness of the collection efficiency curve (Hinds 1999).  These considerations led to 
the construction of the CDC (Figure 3.7). 
 The CDC jets are made from bundles of 7 hematocrit tubes that were secured inside 
¼” ID glass tubes with epoxy (Figure 3.8).  A configuration of 7 tubes with inner diameter 
(ID) of 1 mm and outer diameter (OD) of 1.5 mm has a total jet area of 5.5 mm2 spread 
evenly over a Transwell surface of 33.2 mm2.  This coverage is far from complete, but much 
larger than present in the VCI.  The glass tubes containing the hematocrit tubes are secured in 
a 1/3” (8.6 mm) thick clear acrylic plate that serves as the lid of the deposition chamber.  The 
tubes are arranged so that the center of the jet bundles is directly above the center of the 4 
corner wells of a standard 24-well culture plate, into which 6.5 mm Transwells fit.  The 
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upper side of the lid has 4 inlet ports that lead to the deposition tubes to allow for attachment 
of the air stream splitting conduit.  Four acrylic upper support arms with magnets are 
attached to the chamber lid.  A culture dish support is fitted with magnets with opposite poles 
to allow firm attachment to the arms.  The dimensions and placement of the support arms and 
culture dish support are such that when a 24-well culture plate containing Transwells in the 
corner wells is placed on the support and the support is attached to the arms, the Transwells 
are centered under the jet bundles at a distance of 4 mm from the jets (Figure 3.9).  The 
remainder of the chamber is constructed of 1/3” (8.6 mm) clear acrylic sealed with epoxy.  
The bottom of the chamber has an outlet to which a vacuum can be attached.  There is foam 
rubber insulation glued around the edge of the chamber and lid where they meet to provide 
an airtight seal when the lid is attached.  There are clasps attached to both the lid and 
chamber on two sides that close the lid tightly on the chamber.  
 A model aerosol was used to characterize the deposition of particles onto Transwells 
placed in the deposition box as a function of size.  The model aerosol was size characterized 
by cascade impaction directly and after it was passed through the deposition box with and 
without the Transwells present to serve as a deposition surface.  The differences in size 
distribution were used to estimate deposition box and Transwell deposition for particles in 
several discrete size ranges.  DEP aerosols were also delivered to the Transwells and that 
deposition was quantified. 
 An important aspect of aerosol delivery not addressed in this chapter is the effect of 
air flow and particle deposition on the cells grown on the membranes.  The forces on the cell 
layer are dependant on the dimensions of the impactor and flow of air.  Each jet produces a 
stream of air that will have a force on the cell surface.  This force is dependant on the 
 132
diameter of the jet and the velocity of air moving through it and was measured and calculated 
for the CDC. 
3.4.1 Materials and Methods 
3.4.1.1 Model Aerosol Deposition 
 An Acorn II nebulizer (Marquest Medical Products, Inc., Englewood, Co) containing 
3 ml of 100 µg/ml disodium fluorescein (DF, Sigma) in 5% saline solution was used to create 
a model aerosol.  The aerosol particle size was characterized by cascade impaction (NVCI), 
laser diffraction (Malvern), and emitted dose device (EDD).  For cascade impaction and 
emitted dose determination, the nebulizer was operated at 50 PSI for 30 seconds.  The 
nebulizer was weighed before and after adding the DF solution and after nebulization to 
determine the mass of solution nebulized.  For laser diffraction, the nebulizer was operated at 
50 PSI and a reading was taken 5 to 10 seconds after initiation of nebulization, when the 
aerosol had stabilized.  The aerosol was passed i) directly through the EDD with a 0.1 µm 
filter, ii) through the throat of the TSLI to the NVCI or Malvern as controls, iii) through the 
CDC with and without Transwells to the NVCI or Malvern.  The aerosol was also sized by 
laser diffraction directly from the nebulizer (control, no flow).  For direct LD sizing, the 
center of the nebulizer outlet was placed 3 cm away from the center of the detector lens in the 
vertical direction and 2 cm away from the detector lens in the horizontal direction.  A 
vacuum was placed 3 cm vertically and 5 cm horizontally from the detector lens to direct the 
aerosol across the path of the laser.  The flow through the EDD, NVCI, and Malvern was 
maintained at 60 l/min.  For emitted dose and cascade impaction runs, all surfaces and filters 
were washed with phosphate buffer (pH 7.4) to recover deposited DF.  The DF concentration 
was measured by fluorescence spectroscopy (Perkin Elmer) with excitation/emission 
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wavelengths of 480/525 nm and filter slits of 5/5 nm.  MMAD and GSD were calculated as 
described in Chapter 2 (Section 2.1.4.1).  The amount of DF that was emitted in each run was 
determined by multiplying the theoretical amount emitted (mass lost by nebulizer multiplied 
by DF concentration) by a fraction representing actual emitted dose.  This fraction was 
determined by taking the amount delivered to the EDD as calculated from fluorescence and 
dividing that by the theoretical amount.  The amount delivered to each portion of the system 
was then represented as a percentage of this real amount emitted.  This method takes into 
account the mass lost to evaporation and to particles that flow out of the back of the nebulizer 
in 30 seconds. 
3.4.1.2 Diesel Exhaust Particle Deposition 
 DEP suspended in HFA134a (1.0 mg/g, continuous valve, 1 or 10 actuations) were 
delivered to Transwells using the CDC (n=5).  Deposition was quantified by suspension in 
ethanol followed by sonication for 30 seconds and determination of EXT700.  Mass of DEP 
emitted in each run (dose) was determined by multiplying the mass of the suspension lost 
during actuation by the concentration of DEP in the suspension.  Deposition per membrane 
as a fraction of emitted dose was determined, as was the mass deposited per unit area of each 
membrane.  Deposition pattern was monitored visually by eye and light microscopy.  The 
statistical significance of the differences in means between groups was determined using the 
one-way ANOVA, as described in Chapter 2 (Section 2.4.1.1), when there was a single 
variable (dose), and using two-way ANOVA, as described in Chapter 2 (Section 2.5.1.2), 
when there were two variables (well location and run). 
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3.4.1.3 Force Calculations 
 The force exerted on the membrane by the flowing air was calculated from theory and 
was measured.  The force generated (F) was calculated from the change in momentum (p) in 
the perpendicular dimension at the surface of the cells over time (t): 
dt
dpF =                                                           (3.25) 
The rate of change in momentum (dp/dt) was determined by the multiplying the mass flow 
(dm/dt) by the linear velocity (V) of the air flow: 
V
dt
dm
dt
dp =                                                          (3.26) 
 The volumetric flow through each jet (U=15 l/min=2.5x10-4 m3/s) was used to calculate V: 
sm
A
UV /5.45==                                                     (3.27) 
where A is the total area of the jets (5.5x10-6 m2).  The rate of change in momentum was 
determined from U and the density of air (ρair =1.29 kg/m3): 
skgU
dt
dm
air /102.3
4−×== ρ                                            (3.28) 
The velocity calculated from Equation 3.27 and the rate of change in mass calculated from 
Equation 3.28 were used to solve for F in Equation 3.25.  . 
 The force was measured experimentally by placing an empty Transwell on a balance 
and reading the mass equivalent of the force produced by an air flow of 15 l/min through the 
jets onto the Transwell surface.  The mass equivalent was then multiplied by the acceleration 
due to gravity (9.8 m/s2) to determine the force. 
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3.4.2 Results and Discussion 
3.4.2.1 Model Aerosol Deposition 
 The deposition in the EDD was 69.2 ± 1.3 % of the dose calculated by weight lost in 
the nebulizer.  This percentage was used to calculate the dose delivered to the throat of the 
impactor (emitted dose) in all other studies.  Figure 3.10 shows the aerosol deposition as a 
percentage of emitted doses for all configurations.  The same of deposition was seen 
upstream of the impactor (throat, conduit, and lid) with and without Transwells present.  
Impactor deposition was decreased when Transwells were present, as there was significant 
deposition on them.  These differences in deposition in the impactor were used to calculate 
the deposition on the Transwells as a function of size.  Deposition on each stage of the NVCI 
is shown in Figure 3.11.  The size distribution of particles that reached the NVCI appeared to 
be log-normal in all conditions except the control.  The control distribution appeared 
multimodal with one or two peaks from 0.5 µm to 3.2 µm (stages 3-5) and another > 10 µm 
(pre-separator).  The MMAD and GSD calculated from these distributions are shown in 
Table 3.3.  The deposition on the Transwells as a function of size were calculated as 
percentage of emitted dose (deposition mass difference / mass on stage for control) and as a 
percentage of delivered dose (deposition mass difference/mass on stage without Transwells).  
These percentages are shown in Figure 3.12.  As expected, deposition of delivered dose 
increased with increasing particle size.  The theoretical Dcut for the CDC, 1.0 µm, falls in 
between stages 4 (Dcut = 0.5 µm) and 5 (Dcut = 1.1 µm).  There was 8.6 and 56 % deposition 
of delivered dose for stages 4 and 5, respectively, indicating that the experimental Dcut 
diameter is just under 1.1 µm.  The deposition as a percentage of emitted dose is quite a bit 
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lower due to the high deposition of particles, especially larger ones, in the upper portions of 
the CDC. 
 The size distributions of the aerosol as determined from laser diffraction are shown in 
Figure 3.13 and the D50 and span of are shown in Table 3.3.  The aerosol directly from the 
nebulizer (control, no flow) had a multimodal distribution, while the aerosol passed through 
the throat and the aerosols passed through the throat and CDC with and without Transwells 
had single peaks.  There was a decrease in the cutoff diameter of particles from the control to 
those passed through the CDC, which is consistent with the NVCI data and the idea that 
larger particles deposit in the CDC, with or with Transwells present, to a higher degree than 
smaller particles.  There was no significant difference in cutoff diameter between aerosols 
passed through the CDC with and without Transwells.  This is not consistent with the NVCI 
data that indicated size-selective deposition on the Transwells.  A possible reason for the 
similarity between the data is the deposition of the Transwells was only a small percentage 
(17%) of the total aerosol mass and the LD device was operating below the recommended 
obscurity level.  
 
Configuration MMAD GSD D50 Span 
Control aerosol, no flow   3.39±0.10 0.32±0.01 
Control aerosol, 60 l/min 1.28±0.13 3.07±0.14 3.52±0.01 0.29±0.01 
W/out Transwells 0.82±0.01 2.18±0.05 2.29±0.05 0.28±0.02 Through 
the CDC W/ Transwells 0.60±0.01 1.83±0.02 2.37±0.06 0.32±0.01 
Table 3.3. Particle size distribution properties of the model aerosol in various 
configurations (mean ± SD, n=3). 
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3.4.2.2 Diesel Exhaust Particle Deposition 
 DEP deposited in seven overlapping clumps as shown in Figure 3.14.  The average 
mass of DEP deposited per membrane was 32.6 ± 4.3 µg for 1 actuation and 293.0 ± 9.7 µg 
for 10 actuations.  The average deposition percentages were 2.5 ± 0.3 % and 2.4 ± 0.3 % of 
the emitted dose per membrane for 1 and 10 actuations, respectively.  These percentages 
were not statistically different (p>0.05), showing that deposited fraction did not change by 
varying the number of actuations.  There were, however, differences in deposition fraction 
per membrane between runs.  The between run differences were significant (p<0.01) while 
the between membrane location differences were not (p>0.05) for both 1 and 10 actuations.  
This indicates that while the total deposition may vary between runs, the splitting of the 
aerosol to the four locations was not skewed towards any well. 
 The standard deviations in deposition between well locations (4.5-5.8 % for 1 
actuation and 1.9-3.1 % for 10 actuations) were considerable less than the standard deviation 
in the total mass deposited per run (10.6 % for 1 actuation and 15.2 % for 10 actuations).  
This indicates that using one well as a test well to determine the mass deposited in the other 
wells is a more accurate method than using the total mass of suspension lost during actuation. 
 The proportion of deposition per well (2.4-2.5 %) was close to that expected from the 
model aerosol.  Expected deposition was determined from the particle size distribution of the 
DEP aerosol (Chapter 2, Section 2.5.2.3) and the deposition percentages as a function of 
particle size (Figure 3.12).  This expected value for 1.0 mg/g suspension with a continuous 
valve was 2.3%. 
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3.4.2.3 Force Calculations 
 The theoretical force on each membrane placed in the CDC from the flowing air was 
calculated to be 0.0146 N.  The mass equivalent measured from the balance was 1.5 g, which 
is equal to a force of 0.0147 N.  The theoretical and measured forces are almost equivalent.  
This force cannot easily be converted to a pressure (compressive stress) that would be present 
on a cell layer because the force is not distributed over the surface of the membrane evenly.  
If the force were applied evenly over the entire surface of the membrane (area = 3.3x10-7 m3), 
the resultant pressure would be 442 Pa.  The pressure is actually higher directly below the 7 
jets than between them because that is where the change in flow direction occurs.  If the force 
is applied only to the area below the jets, the pressure would be 2636 Pa in those areas.  The 
real compressive stress on any cells placed in the CDC will likely be an uneven distribution 
of values in between 442 and 2636 Pa.  The distribution of those pressures will be dependant 
on the properties of the apical cell layer. 
 The particles that deposit by inertial impaction would also create forces on the surface 
of the deposition site.  When the average force over time was calculated in the same manner 
as the force from the air, the force from particle deposition was significantly lower (the air is 
flowing at rate of roughly 320 mg/s while the particles are flowing at 3.3 µg/s, so there is a 
10000 fold decrease in force).  This does not mean that particle deposition will have no effect 
on the cells.  The change in energy absorbed by the membrane for each deposited particle 
would be equivalent to the kinetic energy of the particle immediately prior to deposition and 
that energy is absorbed over a small area for each particle.  This is similar to the observation 
that the force from a strong wind is unlikely to hurt someone, but a BB (with significantly 
less force) can break the skin. 
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 Aside from the compressive stress from the air and the impacting particles, there is a 
sheer stress from the flow of air across the surface.  This shear stress is dependant on the 
exact flow at the surface and the air-membrane interface.  The forces from the flow of air to 
and across the surface and from the deposition of particles by inertial impaction may affect 
cells in different ways that are dependant on cell type and culture conditions.  There is 
undoubtedly a limit to the flow that can be used without affecting the cells for each cell type 
and these cellular effects is addressed in Chapter 4. 
3.5 Conclusions 
 Three devices were used to deposit DEP aerosols onto the surface of permeable 
membranes.  Two devices were modified versions of commercially available particle sizing 
instruments and one device was constructed to specific design specifications.  Each device 
has advantages and disadvantages with respect to the size of particles deposited, ease of 
exposure, deposition fraction, and deposition pattern.  The general features of each device are 
outlined in Table 3.4. 
Feature VCI TSLI CDC 
Cutoff diameter (µm) Down to 0.3 (dependant on stage) > 1.8 ~1 
# of membranes exposed 6 1 4 
Deposition Fraction (% of 
particles ≥ cutoff) 1.2 3.4 to 4.2 2.5 
Deposition pattern 12-13 piles (size dependant on stage) Fairly even 
7 overlapping 
piles 
Table 3.4. Deposition features of the viable cascade impactor (VCI), twin-stage liquid 
impinger (TSLI), and custom deposition chamber (CDC). 
 
 The VCI offers the opportunity to deposit the smallest particles of the three devices 
by placing the membranes on the stage 6 (0.3 µm cutoff).  On the lower stages, however, the 
VCI yields a deposition pattern that is punctuate and the distribution of particles is very 
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uneven over the surface area of the membrane.  The distribution of particles over the surface 
of membranes deposited in the TSLI is fairly even, but this impactor has a jet with a very 
high Reynolds number that leads to turbulent flow and unpredictable deposition with respect 
to particle size.  The TSLI also only allows deposition on a single membrane at a time, 
making exposure experiments with replicates difficult.  The CDC allows deposition of 
particles as small as 1 µm on 4 membranes simultaneously.  The deposition in the CDC is not 
completely even over the membrane surface, but is more so than deposition in the VCI. 
 While some limitations to the sampling techniques, they were considered sufficiently 
effective and reproducible to allow the remaining objectives of specific aim 2 (cellular effect 
of deposition devices) and the objectives of specific aim 4 to be undertaken, as described in 
Chapter 4.   
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Figure 3.1. Diagram of a typical round-jet impactor with jet diameter, dj, distance from 
jet to impaction surface, Xji, and air velocity, V. 
 
dj
Xji
V
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12 mm 12 mm 
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Figure 3.2. Diagrams of (a) Transwell® and (b) Snapwell™ culture inserts with 12 mm 
diameter permeable membranes. 
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Vacuum Out (a) 
Air/Aerosol In 
Figure 3.3. Diagrams of (a) Viable cascade impactor and two stages showing (b) 
Snapwell™ membranes in a petri dish or (c) Transwell® membranes on the subsequent 
orifice plate. 
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Figure 3.4. Photographs of deposition of DEP from a 1.0 mg/g HFA 134a suspension at 
7X on (a) stage 5 and (b) stage 6 of the viable cascade impactor and on a Snapwell™ 
placed on stage 5 at (c) 7X and (d) 30X. 
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Figure 3.5. Diagram of the twin-stage liquid impinger with modifications made for 
deposition onto the surface of a Transwell®. 
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32 mm Length 
7.5 mm ID 
60 degree angle 
38 mm Length 
10 mm ID 
60 degree angles 
120 mm Length 
10 mm ID 
(b) 
Figure 3.6. (a) Diagram and (b) photograph of the 4-prong inlet tubing for the custom 
deposition chamber. 
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76.0 8.6 33.6 Upper support arms (4) 
9.4 6.5 6.5 Transwell® Inserts (4) 
20 85 127 24-Well culture dish 
101.0 8.6 178.5 Lower support legs (4) 
187.1 235.3 161.3 Chamber (inside) 
178.5 252.5 178.5 Chamber (outside) 
2.4 154.5 106.0 Culture dish support 
145.0 9.7 9.7 Deposition tubes (4) 
8.6 155.0 105.0 Upper support block 
8.6 252.5 178.5 Lid 
Height 
(mm) 
Width 
(mm) 
Length 
(mm) 
Component 
Figure 3.7. Diagram of the custom deposition chamber, separated to show individual
components, and table of dimensions of those components. 
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Outer Tube: 
9.5 mm OD 
5.5 mm ID 
105 mm Length 
Inner Tubes (7): 
1.5 mm OD 
1.0 mm ID 
75 mm Length 
Epoxy 
(b(a) 
Figure 3.8. (a) Lateral and (b) cross-sectional diagrams of an individual deposition tube 
from the custom deposition chamber. 
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Air stream 
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Deposition tube tips (1 mm ID) 
4 mm 
 
Figure 3.9. Diagram of the tip of an individual deposition tube positioned near the 
surface of a Transwell® for deposition using the custom deposition chamber. 
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Figure 3.10. Fractional deposition of model aerosols (1% disodium fluorescein in saline) 
in the custom deposition chamber (CDC) and nonviable cascade impactor (NVCI).  
Aerosols were passed through the CDC at 60 l/min with and without Transwells® to 
serve as a deposition surface (mean ± SD, n=3). 
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Figure 3.11. Fractional deposition of model aerosols (1% DF in saline) in the nonviable 
cascade impactor (NVCI).  Aerosols were passed through the custom deposition 
chamber at 60 l/min with and without Transwells® to serve as a deposition surface 
(mean ± SD, n=3). 
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Figure 3.12. Proportional deposition of emitted dose (deposition on impactor stage 
when Transwells were present / deposition on stage from control) and delivered dose 
(deposition on impactor stage when Transwells® were present / deposition on impactor 
stage when Transwells® were not present) of model aerosols (1% disodium fluorescein 
in saline) that deposited on Transwells® in the custom deposition chamber in several 
size ranges (mean ± SD, n=3). 
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Figure 3.13. Particle size distribution by volume of model aerosols (1% disodium 
fluorescein in saline) at the nebulizer output (control), flowing through a sampling tube 
at 60 l/min (control, 60 l/min), and flowing through a sampling tube at 60 l/min after 
passing through the custom deposition chamber with and without Transwells in place 
(mean ± SD, n=3). 
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b) a)  
Figure 3.14. Scanning electron micrographs of DEP deposition on glass cover slips 
placed beneath the jets of the custom deposition chamber. (a) Magnification of 20X, 
with the upper left corner wiped clean to show that there was deposition over the entire 
surface and (b) 5000X, showing individual particles. 
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4 CELLULAR EFFECTS OF DIESEL EXHAUST PARTICLE EXPOSURE 
4.1 Introduction 
 Novel methods of generating diesel exhaust particle (DEP) aerosols and depositing 
them onto the surface of permeable membranes were described in Chapters 2 and 3.  These 
methods were developed in order to compare the effects of exposure to DEP deposited as an 
aerosol, the physiologically relevant situation, to the effects of exposure to DEP as a 
suspension in media on cells in culture.  As described in Chapter 1 (Section 1.7), the in vitro 
cellular response to DEP exposure has been evaluated in a number of epithelial and 
macrophage cell types and related cell lines.  The goal of in vitro cell system assessment is to 
gain insight into the pathogenesis of disease resulting from in vivo DEP exposure.  Therefore, 
it is important that the cells being used respond to the DEP in a similar manner to cells in 
vivo. 
 As discussed in Chapter 1 (Section 1.1), the epithelium of the lungs varies in 
morphology and function along its length.  The cells of the airways epithelium are a mix of 
progenitor, ciliated, and secretory cells that create and maintain a blanket of mucus that is 
constantly being moved toward the pharynx.  The alveolar epithelium consists of secretory 
Type II cells and broad, thin, Type I cells, which constitute a majority of surface area and 
allow gas to transport to occur.  It is important to consider the characteristics of these cells 
and any cells grown in culture when drawing conclusions about in vivo response from in 
vitro toxicology studies.  The characteristics to take into account when evaluating the 
usefulness of a respiratory epithelial cell type or line include the ability to form continuous 
layer connected by tight junctions, the production and secretion of mucus and/or surfactant, 
the development of apical microvilli or cilia, the expression of transport and efflux pumps, 
and the expression of metabolic systems.  These characteristics can affect the toxicant and/or 
the toxicant-cell interactions and, therefore, the cellular response to exposure. 
 The formation of tight junctions is important if the studied response is dependant on 
the presence of a tight barrier to paracellular transport or requires apical to basolateral cell 
polarization.  The presence of apical secretions and protrusions can substantially affect the 
properties of deposited particles and the interaction of those particles with the cells.  The 
metabolic potential of the cells is particularly important when evaluating the toxicity of DEP 
exposure.  As indicated in Chapter 1 (Section 1.7), the cellular response to DEP exposure is 
due in large part to ROS generated by the metabolism of compounds adsorbed to the particle 
surface.  It is vital that the metabolic processes that occur in any cell or cell line chosen for in 
vitro assessment are present in the cell that is being represented by that assessment.  It is 
known that there is differential distribution of metabolizing enzymes in the respiratory 
system and that certain cell types in the different regions express more of those enzymes.  In 
the bronchial region, Clara cells appear to be the most significant contributor to the 
metabolism of xenobiotics, while in the alveolar region it is the Type II cells (Baron, Burke 
et al. 1988; Dahl and Lewis 1993). 
 Certain cell lines are considered similar to specific types of lung epithelial cells. 
Cultured primary lung cells are a logical choice for testing response to DEP because they 
have morphologic and physiologic similarity to cells in vivo (Gruenert, Finkbeiner et al. 
1995).  The use of primary lung cell cultures is restricted by the lack of supply, difficulty in 
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culture, and finite life span of the cells.  Individual variation in primary cell cultures can also 
complicate comparison of data between laboratories.  Immortalized cell lines offer the 
advantages of convenience and reproducibility and are used in almost all fields of biology 
and medicine.  A number of different cell lines with varied characteristics have been 
employed to in studies evaluating the transport and cellular response to xenobiotics and 
drugs.  Three of the more commonly used cell lines are the Calu-3 and 16HBE14o-, and 
A549 lines. 
4.1.1 Calu-3 Cell Line 
 The Calu-3 cell line was derived from an adenocarcinoma in the bronchial region of a 
25-year old Caucasian individual and was established by Fogh in 1975 (Fogh, Fogh et al. 
1977).  Calu-3 cells grown in culture have shown many morphological and functional 
similarities to bronchial epithelial cells in vivo.  The apical surface of bronchial epithelial 
cells is a specialized membrane where cilia can be formed and mucus is secreted.  The apical 
surface of Calu-3 cells is covered in small protrusions that have been reported as cilia 
(Florea, Cassara et al. 2003), but are much more representative of microvilli (Shen, 
Finkbeiner et al. 1994; Grainger, Greenwell et al. 2006).  Much longer protrusions, likely to 
be cilia, have been seen in a small fraction of Calu-3 cells in culture (Grainger, Greenwell et 
al. 2006).  Approximately 20% of Calu-3 cells in one study contained secretory granules 
resembling those of goblet or mucosal gland cells of the airway epithelium (Shen, Finkbeiner 
et al. 1994).  Mucin is the principal protein component of mucus and is used as a marker of 
mucus production.  The transcription of 4 mucin genes (MUC1, MUC4, MUC5, and 
MUC5B) in Calu-3 cells has been shown by mRNA northern blot and polarized mucin 
secretion has been observed (Berger, Voynow et al. 1999). 
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 Perhaps the most important aspect of all epithelial cells is there ability to serve as a 
barrier.  The formation of a barrier is dependant on the formation of intercellular adhesions.  
The most important adhesions between cells, with respect to barrier formation, are tight 
junctions (TJs).  TJs separate the apical from the basolateral fluid compartments, allowing 
the polarization of those regions.  TJs are formed from complexes of proteins that extend 
through the cell membrane and attach the cytoskeleton of adjoining cells.  These complexes 
are distributed around the apical perimeter of the cells (Matter and Balda 2003).  There are a 
number of proteins involved in the formation of TJs, including those only on the interior of 
the cell and transmembrane proteins such as occludins and claudins that interact with each 
other to join neighboring cells.  Calu-3 cells form layers that are joined by TJs and 
desmosomes that can be seen by electron microscopy (Shen, Finkbeiner et al. 1994).  Tight 
junction formation allows Calu-3 cells to form a tight barrier to paracellular transport.  Solute 
permeability across Calu-3 layers grown on permeable membranes was shown to be 
dependant on lipophilicity and inversely related to molecular size, indicating a barrier is 
formed in culture (Mathias, Timoszyk et al. 2002).  Functional tight junctions (co-localized 
ZO-1 and occludin staining), desmosomes (desmoplakin staining) and zonulai adherents (E-
cadherin staining) have all been identified in Calu-3 cells by histochemistry (Winton, Wan et 
al. 1998; Wan, Winton et al. 2000). 
 Calu-3 cells have also been shown to transport compounds in a polarized manner and 
express a number of membrane transporters and receptors that are present in vivo.  Calu-3 
cells actively transport amino acids, nucleosides, and dipeptide analogs (Mathias, Timoszyk 
et al. 2002) and show polarized transport of drugs including the macromolecule, insulin 
(Pezron, Mitra et al. 2002) and the small molecular weight molecule, flunisolide (Florea, van 
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der Sandt et al. 2001).  There is evidence of Na+-glucose transporter (Finkbeiner, Carrier et 
al. 1993), working cystic fibrosis transmembrane conductance regulator (Shen, Finkbeiner et 
al. 1994), P-glycoprotein (P-gp) (Florea, van der Sandt et al. 2001; Hamilton, Yazdanian et 
al. 2001), and multidrug resistance-associated protein 1 (MRP1) expression in Calu-3 cells 
(Hamilton, Topp et al. 2001).  The cells also express secretory IgA receptors (Loman, Radl et 
al. 1997) and β-adrenergic receptors that can be stimulated (Abraham, Kneuer et al. 2004).   
 The metabolic capacity of Calu-3 cells has also been studied.  Western Blots of Calu-
3 microsomes have revealed that the cells express the phase I metabolizing enymes CYP1A1, 
CYP2B6, CYP3A4, and CYP2E1, although they could not be induced by the researchers 
(Foster, Avery et al. 2000).  There is evidence for increased retention time of budesonide, a 
glucocorticosteroid, by a metabolic pathway that converts it to a fatty acid ester in Calu-3 
cells (Borchard, Cassara et al. 2002).  There is also evidence for the intracellular oxidation of 
estradiol to estrone in Calu-3 cells (Florea, Cassara et al. 2003). 
 Calu-3 cells have been used to a limited extent to evaluate toxicity in vitro.  The 
toxicity of cereulide was monitored by loss of mitochondrial membrane potential, and 
showed similar results to HeLa, Caco-2 and PaJu cells (Jaaskelainen, Teplova et al. 2003).  
The cytotoxicity of thermosensitive polymers was investigated using standard assays in Calu-
3 cell cultures (Vihola, Laukkanen et al. 2005).  A method to study respiratory toxicity 
involving the co-culture of Calu-3 cells and a human fetal lung fibroblast line (Wi-38) has 
also been proposed (Hermanns, Kehe et al. 2006).  Cellular signaling of Calu-3 (basolateral 
release of IL-6 and IL-8) in response to stimuli has been measured in response to exposure to 
starch or chitosan microparticles (Witschi and Mrsny 1999). 
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 The properties of Calu-3 cells, like other lung epithelial cells, depend on the growth 
conditions of those cells.  Calu-3 cells can be grown on a solid surface, such as standard 
polystyrene tissue culture plastic, or on a permeable membrane (polyester or polycarbonate).  
When grown on a permeable membrane the cells can be grown with no apical culture media, 
referred to as air interface culture (AIC), or with apical media, referred to as liquid-covered 
culture (LCC).  The culture conditions, along with seeding density, time after seeding that the 
apical media is removed for AIC, and total growth time before experimentation, affect the 
growth and differentiation of the cells.  Typically, cells grown under LCC conditions develop 
a tighter barrier to transport than AIC-grown cells.  The tightness of a cell monolayer grown 
on a permeable membrane may be monitored by measuring the transepithelial electrical 
resistance (TEER).  Table 4.1 lists the TEER values of Calu-3 cells grown on Transwells by 
different laboratories under various seeding and growth conditions.  It has also been reported 
that the apical microvilli are shorter and thicker when the cells are grown under LCC 
conditions than under AIC conditions (Florea, Cassara et al. 2003; Grainger, Greenwell et al. 
2006) and that AIC-grown cells have a mucous coating while LCC-grown cells do not 
(Fiegel, Ehrhardt et al. 2003). 
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Condition If AIC, 
Time After 
Seeding 
(hours) 
Coating Peak TEER 
(Ω cm2) 
Citation 
LCC - Matrigel 300 (Winton, Wan et al. 1998) 
LCC - none 2500 (Loman, Radl et al. 1997) 
LCC - collagen 1000 (Pezron, Mitra et al. 2002) 
LCC - none 1000 (Grainger, Greenwell et al. 2006) 
AIC 0? collagen 115 (Shen, Finkbeiner et al. 1994) 
AIC 12 collagen 600 (Foster, Avery et al. 2000) 
AIC 48 collagen >800 (Mathias, Timoszyk et al. 2002) 
AIC 24 collagen 400 (Borchard, Cassara et al. 2002) 
AIC 48 none 300 (Grainger, Greenwell et al. 2006) 
Table 4.1. Transepithelial electrical resistance (TEER) values of Calu-3 cells grown on 
permeable inserts under air interface culture (AIC) and liquid covered culture (LCC) 
conditions. 
 
4.1.2 16HBE14o- Cell Line 
 The 16HBE14o- cell line (HBE) was formed by transforming normal bronchial 
epithelial cells from a 1-year old by the SV40 large T antigen (Cozens, Yezzi et al. 1994).  
HBE cells have many similar properties to Calu-3 cells, but have been utilized less 
extensively in the study of drug transport and more extensively in the field of toxicology.  
HBE cells develop intercellular junctions when grown on permeable membranes under LCC 
and AIC conditions and the formation of these junctions varies with different growth 
conditions (Ehrhardt, Kneuer et al. 2002; Forbes, Shah et al. 2003).  As with Calu-3 cells, 
histochemical staining of HBE cells shows functional tight junctions (co-localized ZO-1 and 
occludin staining), desmosomes (desmoplakin staining) and zonulai adherents (E-cadherin 
staining) (Winton, Wan et al. 1998; Wan, Winton et al. 2000). 
 HBE cells express functional P-gp localized to the apical membrane (Ehrhardt, 
Kneuer et al. 2003).  Ehrhardt also showed immunocytochemical evidence of the expression 
of lung resistance-related protein and caveolin-1, while transmission electron microscopy 
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showed typical caveolae.  Functional β-adrenergic receptors are also present on the HBE cell 
surface (Abraham, Kneuer et al. 2004). 
4.1.3 A549 Cell Line 
 The A549 cell line was derived from a carcinoma from the lung of a 58-year old 
Caucasian male (Giard, Aaronson et al. 1973).  While Calu-3 and HBE cells are used to 
mimic the bronchial epithelium, the A549 line has been described as having characteristics of 
Type II alveolar cells (Lieber, Smith et al. 1976; Foster, Oster et al. 1998).  A549 cells form 
confluent monolayers in culture (Foster, Oster et al. 1998), however do not appear to form 
functional tight junctions (Winton, Wan et al. 1998).  The cells can internalize polystyrene 
microspheres (Foster, Yazdanian et al. 2001) and ultrafine TiO2 aggregates (Stearns, 
Paulauskis et al. 2001) and produce phase I metabolizing enzymes (Foster, Oster et al. 1998).  
A549 cells have been used in a number of in vitro toxicity studies, including the evaluation 
of the toxicity of diesel exhaust particles under LCC and AIC conditions (Bitterle, Karg et al. 
2006). 
4.1.4 Measures of Toxicity 
 The effect of DEP exposure on cells in culture is measured in a number of different 
ways.  As described in Chapter 1 (Section 1.8), there is evidence for a hierarchical oxidative 
stress response in cells exposed to DEP in culture.  The response begins with reactive oxygen 
species (ROS) being formed in the cell, which alter the oxidative state of the cell and induce 
expression of cytoprotective proteins.  As the oxidative stress in the cell rises, cytokines are 
produced and secreted, beginning an inflammatory response.  If the oxidative stress becomes 
too great, the cell undergoes apoptosis or necrosis.  There are other effects of DEP exposure 
 163
on cells, including genotoxicity (Pohjola, Lappi et al. 2003) and changes in cell proliferation 
(Bayram, Ito et al. 2006), but they were not examined in these studies. 
4.1.4.1 Toxicity of Deposition Devices 
 The effects of DEP exposure must be separated from the effects of the deposition 
method itself.  There are several potential consequences of the force of air flow over and 
across the cell layer and from the impaction of particles on the cell surface.  The forces could 
physically break connections between cells, compromise the cell membrane of individual 
cells, or be transduced to chemical signals within the cell.  Any change in the integrity of the 
intercellular junctions or cells themselves would result in an immediate decrease in the 
tightness of that layer.  This can be monitored by measuring the apparent permeability (Papp) 
of small, water-soluble molecules, such as disodium fluorescein (DF), across cell layers 
following exposure to the deposition device with and without deposition of particles.  
Immediate damage to the plasma membrane by the exposure method would also result the 
presence of cytoplasmic contents in the apical compartment.  One intracellular enzyme that 
can be used as a marker for membrane disruption is lactate dehydrogenase (LDH).  A simple 
colorimetric assay is commercially available that is based on the reduction of nicotinamide 
adenine dinucleotide (NAD) by LDH and the conversion of a tetrazolium dye by the reduced 
NAD (NADH) (Decker and Lohmannmatthes 1988). 
 Changes in transcription or translation, or other non-immediate effects, are much 
more difficult to elucidate.  Any longer-term changes that may be due to the impaction of 
particle on the cell surface are confounded with the changes caused by the presence of the 
particles themselves.  The impaction effects may be isolated by placing particles of identical-
size on the cell surface, such that no impact force occurred, for comparison.  However, the 
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need to develop a novel aerosolization and deposition method arose because placing particles 
of an appropriate size on cells by simple manipulation is not possible. 
4.1.4.2 ROS Formation 
 The presence of increased intracellular ROS is the first indication of potential 
oxidative stress.  Dichlorofluorescin diacetate (DCFH-DA) is used as a substrate for 
measuring intracellular oxidant production (Oyama, Hayashi et al. 1994).  DCFH-DA is lipid 
soluble and is, therefore, able to cross the cell membrane and enter the cytoplasm.  In the 
cytoplasm, it is hydrolyzed by esterases to dichlorofluorescin (DCFH), which is hydrophobic, 
and trapped within the cell. This non-fluorescent DCFH is then oxidized to fluorescent 
dichlorofluorescein (DCF) by cellular oxidants.  DCFH-DA has been used to quantify ROS 
in HBE (Baulig, Garlatti et al. 2003; Baulig, Sourdeval et al. 2003) and normal human 
bronchial epithelial (Matsuo, Shimada et al. 2003) cells in response to DEP exposure.  
Although DCFH-DA is often used to determine the overall oxidative state of a cell, there is 
some evidence that it is only useful in identifying concentrations of certain reactive oxygen 
and nitrogen species.  It has been reported that DCFH is converted to DCF by peroxynitrite 
(ONOO-) or the hydroxyl radical (•OH) alone, or by hydrogen peroxide (H2O2) in the 
presence of peroxidases, but not by superoxide anion (O2•-) or nitric oxide (NO) (Myhre, 
Andersen et al. 2003).  
4.1.4.3 Cytokine Release 
 If the oxidative stress level in the cells is sufficiently high, cytokines may be 
expressed and secreted.  Interleukin-8 (IL-8) is a primary inflammatory cytokine produced by 
many cell types including monocytes, macrophages, T cells, neutrophils, fibroblasts, 
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endothelial cells, epithelial cells, and others in response to stimuli (Oppenheim, Zachariae et 
al. 1991).  IL-8 is a potent neutrophil chemotactic and activating factor.  IL-8 secretion in 
response to DEP exposure has been measured for a number of cell types including HBE 
(Boland, Baeza-Squiban et al. 1999), normal human bronchial epithelial (Bayram, Devalia et 
al. 1998), and BEAS-2B cells (Steerenberg, Zonnenberg et al. 1998; Li, Wang et al. 2002). 
 The cytokine granulocyte macrophage-colony stimulating factor (GM-CSF) can 
induce proliferation, maturation, and function of hematopoietic cells (Gasson 1991).  GM-
CSF is produced by a variety of cell types including macrophages, T cells, B cells, 
endothelial cells and epithelial cells in response to various stimuli.  High and low-affinity 
surface binding sites have been identified on both hematopoietic and other cells.  GM-CSF 
secretion has also been measured in response to DEP exposure in a number of cell types 
including HBE (Boland, Baeza-Squiban et al. 1999; Baulig, Sourdeval et al. 2003) and 
normal human bronchial epithelial (Bayram, Devalia et al. 1998) cells.  Secretion of both IL-
8 and GM-CSF can be quantified by using commercially available enzyme-linked 
immunosorbent assay (ELISA) kits.  ELISA is often used to quantify the concentration of a 
certain protein in serum, plasma, or cell culture supernates (Crowther 2001). 
4.1.4.4 Cell Viability 
 The final step in the oxidative stress response is cell death, which occurs if the cell is 
unable to reverse the stress.  The cell death may be in the form of apoptosis or necrosis, 
depending on the severity of the stress and cell type.  Cell viability is often measured by the 
MTT assay.  The MTT assay functions by the conversion of yellow tetrazolium salt to 
purple formazan crystals by mitochondrial dehydrogenase, an enzyme only functional in 
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living cells (Mosmann 1983).  The absorbance of the solution resulting from solubilization of 
the purple crystals is, therefore, a function of the number of viable cells. 
4.2 Cell Culture and Exposure Methods 
4.2.1 Culture Conditions 
4.2.1.1  Cell Culture Media 
 Calu-3 cells (ATCC # HTB-55) were cultured in Minimal Essential Medium with 
Earle’s salts and L-glutamine supplemented with non-essential amino acids (0.1 mM), 
sodium pyruvate (1mM), antiobitc-antimycotic (100 units/ml penicillin G sodium, 100 µg/ml 
streptomycin sulfate and 0.25 µg/ml amphotericin B), and 10% fetal bovine serum (FBS, all 
from Gibco, Invitrogen Corporation, Carlsbad, CA). 
 HBE cells were cultured in Minimal Essential Medium with Earle’s salts and L-
glutamine supplemented with non-essential amino acids (0.1 mM), antiobitc-antimycotic 
(100 units/ml penicillin G sodium, 100 µg/ml streptomycin sulfate and 0.25 µg/ml 
amphotericin B), and 10% heat inactivated FBS (all from Gibco, Invitrogen Corporation, 
Carlsbad, CA). 
 A549 cells (ATCC # HTB-55) were cultured in Dulbecco’s Modified Eagle 
Medium:Ham’s F12 (1:1) with L-glutamine and 15 mM HEPES supplemented with 
antiobitc-antimycotic (100 units/ml penicillin G sodium, 100 µg/ml streptomycin sulfate and 
0.25 µg/ml amphotericin B) and 10% FBS (all from Gibco, Invitrogen Corporation, 
Carlsbad, CA). 
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4.2.1.2 Cell Growth Conditions 
 Cells were cultured in an incubator at 37°C, 85% relative humidity (RH), and 5% 
CO2.  During expansion, the cells were split 1:3 after reaching 70-85% confluency.  Cells 
were split by removing media, washing with phosphate buffered saline (PBS) twice and 
adding enough room-temperature trypsin-EDTA (0.05%, Gibco) to cover the cell surface.  
When most of the cells had detached (5-15 minutes at 37°C), the cell suspension was added 
to new media and seeded. 
 Cells employed in exposure experiments were cultured on Transwell-Clear (12 mm or 
6.5 mm diameter, 0.40 µm pores) or Snapwell (12 mm diameter, 0.40 µm pores) permeable 
culture inserts.  The inserts were not coated or treated in any way prior to seeding.  The cells 
were seeded at a density of 1.0-2.5 x 105 cells/cm2.  Some cells were grown with media on 
both the apical (AP) and basolateral (BL) sides, generating LCC conditions, and others were 
changed to AIC after 2 days by removing the AP media and reducing the amount of BL 
media to the level of the permeable membrane.  The exact media volumes that were used for 
each growth condition are shown in Table 4.2.  Media was changed every other day and the 
cells were used in experiments 7-11 days after seeding.  The passage numbers used, exact 
seeding densities, and days of growth before experimentation for each experiment are listed 
in Table 4.3.  
 For experiments involving cells grown in standard multiwell culture plates, cells were 
seeded at 1.0 x 105 cells/cm2 and media was changed every 2 or 3 days.  Experiments were 
performed at least 5 days post seeding. 
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Volume (ml, LCC) Volume (ml, AIC) Insert Base Plate 
AP BL AP BL 
12 mm Snapwell 12 Well 500 3500 0 2500 
12 mm Transwell 12 Well 500 1500 0 1000 
6.5 mm Transwell 24 Well 100 600 0 400 
Table 4.2. Apical (AP) and basolateral (BL) media volumes for permeable membrane 
inserts under liquid covered culture (LCC) and air interface culture (AIC) conditions. 
 
Device Cell Line Experiment Insert Passage Seeding Density (x 105 cells/cm2) 
Growth 
(days) Section 
VCI Calu-3 PERM 12 T 31 2.5 11 4.3.1 
VCI Calu-3 MTT 12 S 36 2.0 9 4.3.2 
TSLI Calu-3 PERM 12 T 32 2.0 9 4.4.1 
CDC Calu-3 PERM 6.5 T 39 2.0 9 4.5.1 
CDC Calu-3 ROS 6.5 T 36 2.0 9 4.5.2 
CDC Calu-3 CYT 6.5 T 39 2.0 9 4.5.3 
CDC Calu-3 MTT 6.5 T 36 2.0 9 4.5.4 
CDC HBE CYT 6.5 T 21 2.0 8 4.5.3 
CDC A549 PERM 6.5 T 82 2.0 7 4.5.1 
CDC A549 ROS 6.5 T 85 1.0 7 4.5.2 
CDC A549 CYT 6.5 T 81 2.0 8 4.5.3 
CDC A549 MTT 6.5 T 81 2.0 8 4.5.4 
CDC A549 LDH 6.5 T 80 2.0 9 4.5.5 
Table 4.3. Cell growth conditions for each aerosol exposure experiment performed.  
The device used to exposure the cells were the viable cascade impactor (VCI), the twin-
stage liquid impinger (TSLI), and the custom deposition chamber (CDC).   The 
experiments performed were determination of the apparent permeability of disodium 
fluorescein (PERM), detection of intracellular ROS (ROS), cytokine assays (CYT), 
viability assay by MTT (MTT), apical LDH detection (LDH).  The inserts used were 12 
mm Transwell-Clear membranes (12 T), 12 mm Snapwell membranes (12 S), or 6.5 mm 
Transwell-Clear membranes (6.5 T). 
 
4.2.2 Diesel Exhaust Particle Aerosol Exposure 
 The DEP aerosols described in Chapter 2 were delivered to cells using the deposition 
methods described in Chapter 3.  Aerosols were delivered to cells grown on permeable 
inserts by propellant suspension (PS) or compressed air expulsion (CAE) methods.  
Experiments conducted before a DEP quantification method was available employed 
estimated doses calculated from the emitted dose and the fractional deposition on blank 
inserts for that aerosol from Chapter 3.  Those experiments conducted after a quantification 
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method was developed used doses calculated from deposition on blank inserts that were 
exposed concurrently with the test inserts. 
 Often, device only control inserts were used (groups labeled DEV).  This required 
inserts to be placed into the deposition device, which was operated in the same manner as for 
experimental deposition studies, but without aerosol sampling.  This allowed determination 
of the effects, if any, of placement in the device and airflow on the cell surface in the device.  
Untreated control (groups labeled CTL) inserts were used in all experiments.  All of the 
aerosol exposed inserts were kept under AIC condition following exposure. 
4.2.3 Diesel Exhaust Particle Media Suspension Exposure 
 Cells were also exposed to DEP suspended in culture media.  This allowed 
comparison to DEP aerosols deposited and to results reported previously in the literature.  
The particle size distributions of the DEP in suspension were measured by laser diffraction 
technique. 
4.2.3.1 Suspension Preparation 
 Particles were suspended in culture media by adding media to a mass of DEP2 in a 
plastic culture tube.  The DEP did not readily suspend (i.e. poor surface wetting) and formed 
very large aggregates (clumps) that either floated or clung to the bottom of the tube.  The 
tube was tapped on the lab bench to free the clumps and bring them to the surface.  The 
particles were then ground against the side of the tube.  Following the grinding, which 
increased the surface area exposed to the liquid, no particles remained floating (i.e. good 
surface wetting).  The suspensions were then sonicated for 10 minutes to reach a stable 
aggregate particle size and diluted to achieve the desired exposure dose (10-100 µg/cm2 of 
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DEP).  The diluted suspensions were sonicated for 10 minutes to ensure even suspension of 
particles.  The suspensions were then added to the apical surface of the inserts and LCC 
conditions were maintained (groups labeled L10-100).  When the cells were exposed to 
liquid suspensions of DEP, there was an accompanying control that was media only (groups 
labeled LIQ), to determine the affects of the apical media alone. 
4.2.3.2 Suspension Particle Sizing 
Material and Methods 
 The particle size distributions of DEP suspended in media were measured using laser 
diffraction.  Laser diffraction sizing devices have a narrow range of light obscuration in 
which they function, so the suspensions that were sized were all 50 µg/ml.  The size 
distribution of suspensions in Calu-3 and A549 media (Malvern Series 2600) and HBE media 
(Malvern Mastersizer 2000) were measured 5-15 minutes after sonication and following 24 
hours of incubation at 37°C (n=3 for each).  The statistical significance of the differences in 
mean sizes between media type was determined using the one-way ANOVA, as described in 
Chapter 2 (Section 2.4.1.1). 
Results and Discussion 
 The DEP suspended in media had particle size distributions that were similar 
regardless of media type.  All of the distributions were broad and appeared multimodal, with 
particles detected up to approximately 60µm.  The largest mode had a peak located at 
approximately 20 µm with a smaller peak, or shoulder, at approximately 8 µm and one or 
more even smaller peaks in the size ranges below 5 µm.  Examples of two of these 
distributions are shown in Figure 4.1.  The distributions obtained by the Mastersizer 2000 
laser diffraction instrument (HBE media) were smoother, with more data points and a larger 
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particle size detection range, than those obtained with the Series 2600 laser diffraction 
instrument (Calu-3 and A549 medias).  Table 4.3 shows the D10, D50, D90 and span of the 
size distributions.  The values from the Calu-3 media suspensions and the A549 media 
suspensions are not significantly different.  However, the D10 is significantly smaller for the 
HBE media suspensions than the others (p < 0.05).  This difference may be explained by the 
instruments employed.  The Mastersizer 2000 instrument detected small particles that were 
not detected by the Series 2600 instrument.  This would also explain the slightly larger span 
and the slightly smaller D50 for the 16HBE14o- media suspensions. 
 Following 24 hours of incubation at 37°C, the particles had settled to the bottom of 
the tube, but were easily re-suspended with light mixing.  The measured size distributions are 
shown in Table 4.3.  Following 24 hours of incubation there was no change in the 
distributions for Calu-3 or A549 suspensions, indicating that the aggregates that formed 
during and directly after sonication were stable for at least 24 hours.  There were small 
increases in the D10, D50, and D90 for the HBE suspension following 24-hours of incubation 
that were significant for D10 and D50 (both p < 0.05), which may indicate a small increase in 
aggregation state in these suspensions. 
 
Media Incubation 
Time (hours) 
D10 (µm) D50 (µm) D90 (µm) Span 
Calu-3 < 1 2.8±0.5 10.7±3.7 24.2±3.5 2.1±0.4 
Calu-3 24 2.9±0.5 10.9±3.4 24.2±3.6 2.0±0.4 
16HBE14o- < 1 1.5±0.1 7.1±0.1 20.3±4.4 2.6±0.6 
16HBE14o- 24 1.6±0.0 8.5±0.0 26.0±0.0 2.9±0.0 
A549 < 1 2.8±0.2 9.6±0.8 23.7±2.0 2.2±0.1 
A549 24 3.0±0.3 10.5±2.1 23.5±2.3 2.0±0.2 
Table 4.4. Particle size distribution data obtained from laser diffraction for 50 µg/ml 
suspensions of DEP in different cell culture media (mean ± SD, n=3). 
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4.3 Viable Cascade Impactor 
 The VCI was used to deposit aerosols onto cell layers grown on permeable 
membranes, as described in Chapter 3 (Section 3.2).  Following deposition, permeability to a 
paracellularly transported marker was measured to determine if the sampling of aerosols by 
the VCI influenced cell layer integrity.  Cell viability following incubation with DEP 
deposited as an aerosol was also determined and compared to viability of cells exposed to 
DEP as a suspension in cell media. 
4.3.1 Materials and Methods 
4.3.1.1 Fluorescein Permeability 
 Calu-3 cells were grown on 12mm Transwells under AIC and LCC conditions, as 
described in Section 4.2.1.  TEER values were monitored throughout the growth on the 
inserts (EVOM, World Precision Instruments, Sarasota, FL).  For transport studies, standard 
media was replaced with clear media (MEM w/o phenol red plus NEAA and NaPyr, to allow 
for detection of fluorescent marker) in both AP and BL compartments and equilibrated for 1 
hour prior to exposure.  The AP clear media was removed and the inserts were placed in the 
VCI below the orifice plate of stage 4.  Aerosol consisting of micronized DF powder 
(NCw/P) delivered by insufflator (Penn Century, Philadelphia, PA) was sampled onto inserts 
by drawing air through the VCI for 30 sec at a flow rate of 60 l/min (n=3 for AIC and LCC).  
Inserts were also placed in the VCI, though which air was drawn for 30 sec at a flow rate of 
60 l/min, without aerosol sampling to serve as device only controls (n=3 for AIC and LCC).  
Powder deposition on the cell layer was detected visually.  Inserts with the AP clear media 
present were also placed in the VCI, though which air was drawn for 30 sec at a flow rate of 
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60 l/min (n=3 for AIC and LCC).  The cell inserts were then returned to a new base plate 
containing 1500 μl of pre-warmed clear media per well.  The apical media, if present, was 
removed and 500 μl of 575 μg/ml DF in clear media was added to the apical side of all 
inserts.  At 15, 30, 45, 60 90, and 120 minutes 500 µl aliquots were removed from the BL 
compartment and replaced with 500 µl of fresh clear media.  AP to BL permeability 
coefficients (Papp) for each molecular weight marker were calculated as follows: 
 
dtAC
VdCP
o
app =                                                         (4.1) 
 
where V (dC/dt) is the steady-state rate of appearance of the apically applied marker in the 
receiver chamber after initial lag time, Co is the initial marker concentration in the donor 
chamber, and A is the area of the Transwell.  Papp for LCC and AIC inserts that were not 
placed in the impactor and inserts with no cells were also calculated as controls (CTL, n=3 
for AIC and LCC).  Statistically significance of differences in mean permeability was 
assessed by Scheffe’s method. 
4.3.1.2 Cell Viability 
 Calu-3 cells were grown on 12mm Snapwells under AIC conditions as described in 
Section 4.2.1.  Two doses of PS DEP aerosol were delivered to inserts using the VCI (n=3 
per condition).  For exposure, inserts were placed in the petri dish beneath stage 5 of the VCI 
and the vacuum was applied for 10 s, in which time PS aerosols were sampled.  The PS 
aerosols were generated from a 0.75 mg/g DEP in HFA134a suspension with continuous 
valve.  The amount of suspension that was emitted was calculated by weighing the bottles 
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before and after actuation.  The lower dose was delivered by actuating the valve for ~ 1 s and 
emitted 0.8221 g of suspension (0.6 mg of DEP) and the higher dose was delivered by 
actuating the valve for ~ 1 s, 10 times and emitted 7.8201 g of suspension (5.8 mg of DEP).  
The doses delivered to the cell surfaces were estimated using the emitted dose and the 
fraction of DEP PS aerosol that deposited on blank 12 mm Snapwells beneath stage 5 of the 
VCI in Chapter 3 (3.1% per well, Section 3.2.2.3.).  Cell viability was monitored by MTT 
assay (TOX-1 Kit, Sigma) 24 hours post exposure and compared to viability of untreated 
(CTL, n=3) inserts.  For quantification, the crystals were dissolved, the solution was 
transferred to a cuvette, and the absorbance was read at 570 nm using a spectrophotometer 
(UV160U spectrophotometer, Shimadzu). 
 The experiment was repeated with an intermediate PS DEP dose delivered from a 
0.58 mg/g DEP in HFA134a suspension fitted with continuous valve (n=2).  The aerosol was 
generated by actuating the valve for ~ 1 s, 10 times, and delivered 6.4982 g of suspension 
(3.8 mg of DEP).  The MTT assay was performed 24h and 48h post exposure along with 
CTL inserts (n=2 per condition). 
 An MTT assay was also performed on Calu-3 cells grown under liquid cover in a 
standard 96-well culture plate after 24 hours incubation with DEP at various concentrations.  
Cells were seeded at a density of 1.9 x 104 cells/cm2 in 96-well plates and allowed to grow to 
visual confluency.  On day 5, the media was replaced with DEP suspended in media (1-500 
µg/ml, n=8 per concentration) and the cells were exposed to these suspension for 24 hours.  
An MTT assay was then performed and absorbance was read on a microplate reader at 595 
nm with background reading at 655 nm subtracted (Model 3550, Bio-Rad, Hercules, CA).  
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The statistical significance of the differences in viability was determined using the one-way 
ANOVA, as described in Chapter 2 (Section 2.4.1.1). 
4.3.2 Results and Discussion 
4.3.2.1 Fluorescein Permeability 
 The TEER values for the LCC and AIC grown cell layers are shown in Figure 4.2.  
The peak TEER values of the LCC cells were significantly higher than they were for the AIC 
cells (1000 Ω.cm2 vs. 550 Ω.cm2).  This indicates that the tight junctions formed in Calu-3 
cells grown entirely under liquid offered more resistance than AIC cells.  This behavior was 
seen previously in Calu-3 cells (see Table 4.1).  This difference in cell layer tightness is also 
reflected in the DF permeabilities.  The Papp values calculated for DF for each condition are 
shown in Figure 4.3.  All of the permeability values represented in Figure 4.3 are at least 10 
times lower than for the blank inserts (8.5±1.4 x 10-5 cm/sec).  The average Papp for the AIC 
cells was larger than for the LCC in each condition except for NCw/P.  The Papp for two of 
the three of these NCw/P LCC inserts were greater than 10 times the value of the other insert 
under the same condition (52.7x10-7 and 58.2x10-7 cm/sec vs. 3.3x10-7 cm/sec) and were 
much higher than any other inserts tested.  The two inserts exhibiting high permeability had 
holes in the cell monolayer, observed by light microscopy, indicating that the treatment had 
compromised their integrity.  The LCC cells placed in the VCI under the other two 
conditions (AC and NC) also showed an increase in Papp over the LCC control. The increase 
in the apically covered inserts was statistically significant (p<0.05).  The AIC cells placed in 
the VCI showed no significant differences from control. 
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 These data indicated that an aerosol could be deposited onto Calu-3 cell layers grown 
on Transwell inserts using the VCI without affecting the integrity of the monolayer, provided 
the cells were grown under AIC conditions.  Although the aerosol deposited was DF, not 
DEP, the resulting damage to the cell layer, if any, would be very similar. 
4.3.2.2 Cell Viability  
 The approximate deposited doses calculated for the inserts from the first experiment 
were 7 µg/cm2 (from the lower dose, 610 µg total DEP) and 70 µg/cm2 (from the higher 
dose, 5.8 mg total DEP).  Micrographs of the DEP on the cell monolayer are shown in Figure 
4.4.  The deposition pattern was the same on the surface on the cells as it was on the surface 
of blank inserts, as shown in Figure 3.5.  Viability, expressed as a percent of control, is 
shown in Figure 4.5a.  There was a trend of decreased viability of the cells as mass of DEP 
deposition increased, although the changes were not statistically different from control or 
each other (all p>0.05). 
 The approximate deposited dose calculated for the inserts from the second experiment 
was 46 µg/cm2 (from 3.8 mg total DEP).  The viability, as a percent of the control, is shown 
in Figure 4.5b.  Inserts incubated for 24 hours showed a 9% decrease in viability with respect 
to control that was not statistically significant (p>0.05).  Inserts incubated for 48 hours 
showed a 30% decrease that was significant compared to control (p<0.05). 
 The viability, expressed as a percent of control, for the cells grown in the 96-well 
plate and exposed a range of concentrations of DEP suspensions in media is shown in Figure 
4.6.  There was an increase in the absorbance for cells exposed to 10 to 150 µg/ml which was 
statistically different from control at 50, 100, and 150 µg/ml (p<0.05).  This increase was 
followed by a decrease in absorption at concentrations of 250 and 500 µg/ml (p<0.05), 
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indicating that the MTT assay is not solely measuring cell viability.  The degree of formazan 
crystal formation is also dependant on the metabolic activity of the cells (Mosmann 1983).  
Cells exposed to concentrations of DEP above 10 µg may have had an increase in metabolic 
activity over control cells.  The DEP was lethal in high doses, but in sub-lethal doses, the 
affects of metabolic activity may mask the viability measurement of Calu-3 cells by MTT 
assay.  In addition, the dose response of cells grown under liquid cover to suspended DEP 
may not reflect what would be seen in cells grown at the air interface or with DEP delivered 
as an aerosol.  The inability to completely remove the DEP during washing steps may also 
interfere with the MTT assay, but the background absorbance was measured and subtracted 
from the assay absorbance as a correction factor. 
4.4 Twin-Stage Liquid Impinger 
 The TSLI was used to deposit DEP aerosols onto the surface of cells grown on 12 
mm Transwells, as described in Chapter 3 (Section 3.3).  As with the VCI, monolayer 
permeability to a paracellularly transported marker was measured to determine if the 
deposition of aerosols on cell surfaces in the TSLI damages monolayer integrity. 
4.4.1 Fluorescein Permeability Materials and Methods 
 Calu-3 cells were grown under AIC conditions as described in Section 4.2.1.  PS DEP 
aerosols were delivered to inserts using the TSLI. The inserts were placed 1 or 2 cm below 
the orifice of the lower stage in the TSLI.  The TSLI was operated at 60 l/min for 5 s with 
deposition of DEP by CAE or without deposition (n=3 per condition).   The Papp of DF 
across each insert was measured, as in Section 4.3.1.1, 1 and 24-hours post exposure and 
compared to untreated control inserts (n=3).  The statistical significance of the differences in 
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permeability was determined using the one-way ANOVA, as described in Chapter 2 (Section 
2.4.1.1). 
4.4.2 Fluorescein Permeability Results and Discussion 
 DF permeabilities following aerosol exposure in the TSLI are shown in Figure 4.7.  
The inserts placed 1 cm from the lower orifice with DEP deposition showed a statistically 
higher permeability than control (p < 0.05), but the inserts placed 1 cm from the orifice 
without DEP deposition and inserts placed 2 cm from the orifice with DEP deposition did 
not.  This indicates that Calu-3 cells grown on Transwell membranes can be placed 2 cm, but 
not 1 cm, from the orifice for deposition of DEP without apparent changes in monolayer 
integrity.  It also shows that the impact force from the deposited particles was potentially 
more damaging to Calu-3 cell layers than the forces from the flowing air. 
4.5 Custom Deposition Chamber 
 The CDC was used to deposit DEP onto the surface of cell layers grown on 
permeable membranes.  As with the VCI and TSLI, permeability of a paracellularly 
transported marker was measured post-deposition to determine if the cell layers were 
physically damaged by the deposition.  The cell response to deposition of DEP aerosols was 
examined in greater depth than other methods because the CDC was considered the most 
promising option for delivering aerosols by inertial impaction with respect to cell surface 
coverage and dosing range.  The formation of intracellular ROS and basolateral release of 
selected cytokines was measured to compare to published data for cells exposed to DEP 
suspended in cell media.  Cell viability was also measured following exposure. 
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4.5.1 Exposure Conditions 
 All cells exposed to DEP in the CDC were grown on 6.5 mm Transwells, as described 
in Chapter 4 (Section 4.2).  The groups of cells that were exposed are listed below, with more 
in depth descriptions of exposure conditions to follow: 
CTL: Untreated control 
DEV: Device control, inserts placed in the CDC with air flow (10 sec), no aerosol deposited 
CAE: CAE DEP aerosols deposited in concentrations of approximately 20 μg/cm2 
PS10-100: PS aerosols deposited in concentrations of approximately 10-100 μg/cm2 
LIQ: Apical liquid control, cell media added to apical surface of inserts 
L10-100: Cell media with suspended DEP in concentrations that yielded 10-100 μg/cm2 
 Cells were exposed to CAE or PS aerosols by placement in CDC and running the 
vacuum for 10 s, during which time the aerosols were introduced to the inlet.  CAE aerosols 
were generated using ground DEP and an expulsion pressure of 50 PSI (344 KPa).  PS 
aerosols were generated with the aim of depositing 10-100 µg/cm2 of DEP onto the surface 
of inserts (groups labeled PS10-100).  PS aerosols were generated from a 1.0 mg/g DEP 
suspension by actuating a continuous valve for approximately 0.5 s, 1 (PS10), 5 (PS50), or 
10 (PS100) times.  Unless otherwise noted, the TSLI inlet was used upstream of the CDC to 
prevent large particles from entering the device.  Inserts with cells cultured on the surface 
were placed in three corner wells (labeled A6, D1, and D6) of a 24-well plate (Corning), 
while a blank insert was placed in the upper left well (A1) to determine the dose of DEP 
deposited.  Following deposition, the DEP that had deposited in the blank well was 
suspended in ethanol, sonicated, and the turbidity was measured to quantify deposited dose 
as in Chapter 2 (Section 2.2.2). 
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 As with the other devices, untreated control inserts (groups labeled CTL) and inserts 
placed in the CDC without aerosol deposition (groups labeled DEV) were also tested.  Inserts 
exposed to DEP as liquid media suspension (L10-100) and blank media (LIQ), as described 
in Section 4.3.2.1, were also tested in some cases.  The conditions tested in each experiment 
for each cell type are shown in Table 4.5.  The doses deposited on the blank inserts for 
conditions where a DEP aerosol was introduced are also shown in Table 4.5. 
 
Cell Type Calu-3 HBE A549 
Experiment PERM ROS CYT MTT CYT Papp ROS CYT MTT LDH 
CTL + + + + + + + + + + 
DEV + + + + + + + + + + 
CAE - 22 29 - 178 - 24 14 14 - 
PS10 - 12 26 10 17 - 16 21 21 22 
PS50 - 45 66 - 45 - 54 60 60 - 
PS100 96 95 116 80 280 87 122 134 134 115 
LIQ - + + - + - + + + - 
L10 - + + - + - + + + - 
L50 - + + - + - + + + - 
C
on
di
tio
n 
L100 - + + - + - + + + - 
Table 4.5. Cell exposure conditions employed for each experiment performed using the 
custom deposition chamber.  The experiments performed were determination of the 
apparent permeability of disodium fluorescein (PERM), detection of intracellular ROS 
(ROS), cytokine assays (CYT), viability assay by MTT (MTT), and apical LDH 
detection (LDH).  (-) indicates a condition was not used in that experiment, (+) or a 
number indicates that it was.  The numbers correspond to the calculated DEP doses 
(µg/cm2) on the blank inserts for the aerosol deposition conditions. 
 
4.5.2 Materials and Methods 
4.5.2.1 Fluorescein Permeability 
 Calu-3 and A549 cells were grown as described in Section 4.2.1 and the groups of 
inserts listed in Table 4.5 were exposed to DEP as described in Section 4.5.1.  In addition, 
some inserts were scratched (SCR) with a micropipette tip as a positive control for damaged 
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cell layers.  The Papp of the inserts to DF was measured, as in Section 4.3.1.1, less than 1 
hour after exposure.  The statistical significance of the differences in permeability was 
determined using the one-way ANOVA, as described in Chapter 2 (Section 2.4.1.1). 
4.5.2.2 Intracellular Reactive Oxygen Species Detection 
 Calu-3 and A549 cells were grown as described in Section 4.2.1 and the groups of 
inserts listed in Table 4.5 were exposed to DEP as described in Section 4.5.1.  All inserts 
were placed in the 37°C incubator for 4 hours following treatment.  Following incubation, 
the BL media and AP media, if present, were removed and both compartments were washed 
twice with PBS.  After washing, 0.05% Trypsin-EDTA (Gibco) was added to the BL (600 µl) 
and AP (100 µl) compartments and the cells were incubated at 37°C for 15 minutes to detach 
the cells from the membrane.  Following detachment, the cell suspensions and 200 µl of PBS 
were placed in microcentrifuge tubes and centrifuged at 2000 RPM for 7 minutes to pellet the 
cells.  The supernatant was removed and the cells were re-suspended in 100 µl of DCFH-DA 
in PBS (20 µg/ml) in a 96-well plate.  Following 30 minutes of exposure, the fluorescence of 
the microplates was read with an excitation wavelength of 485 nm and an emission 
wavelength of 535 nm (Plate Chameleon, Hidex, Turku, Finalnd).  The statistical 
significance of the differences in ROS formation was determined using the one-way 
ANOVA, as described in Chapter 2 (Section 2.4.1.1). 
4.5.2.3 Basolateral Cytokine Release 
 The BL release of IL-8 and GM-CSF in response to exposure to DEP aerosols in the 
CDC and as suspensions in culture media was measured by ELISA.  Several cell lines were 
exposed and the results were compared with data from previously reported studies.  Calu-3, 
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HBE, and A549 cells were grown as described in Section 4.2.1 and the groups of inserts 
listed in Table 4.5 were exposed to DEP as described in Section 4.5.1.  In addition to the 
conditions listed in Table 4.5, Calu-3 cells grown under LCC conditions on 6.5mm 
Transwells for nine days were exposed to blank media (group labeled LCC, n=3) and 10, 50, 
or 100 µg/cm2 DEP suspended in media (groups labeled LCC10-100, n=3 per condition).  
The TSLI inlet was not used upstream of the CDC for the HBE exposures.  All inserts were 
incubated at 37°C for 24 hours following treatment.  After incubation, 100 µl of BL media 
was removed from each insert and stored at -70°C.  To analyze IL-8 and GM-CSF, the media 
was thawed and ELISA assays were performed according to the manufacturer’s protocol 
(Quantikine, R & D Systems).  Calu-3 media was diluted 1:5 for the IL-8 ELISA and 
undiluted for the GM-CSF ELISA, HBE media was undiluted, and A549 media was diluted 
1:20.  The statistical significance of the differences in cytokine release was determined using 
the one-way ANOVA, as described in Chapter 2 (Section 2.4.1.1). 
4.5.2.4 Cell Viability 
 Calu-3 and A549 cells were grown as described in Section 4.2.1 and the groups of 
inserts listed in Table 4.5 were exposed to DEP as described in Section 4.5.1.  Cell viability 
was monitored by MTT assay (TOX-1 Kit, Sigma), as per the manufacturers protocol, after 
24 hours of incubation at 37°C.  The formazan crystals were dissolved in solubilization 
solution by 1 hour of incubation followed by pipetting the solution up and down onto the 
surface of the cells.  The solution was transferred to a cuvette and the absorbance was read at 
570 nm and 690 nm using a spectrophotometer (Shimadzu).  Viability was determined by 
subtracting the absorbance at 690 nm from the absorbance at 570 nm. 
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 Viability of A549 cells grown under liquid cover in a standard 96-well culture plate 
after 24 hours incubation with DEP at various concentrations was also measured by MTT 
assay (TOX-1 Kit, Sigma).  Cells were seeded at a density of 2.5 x 104 cells/cm2 in 96-well 
plates and allowed to grow to visual confluency.  On day 6, the media was replaced with 
DEP suspended in media (8-500 µg/ml, n=4 per concentration) and the cells were exposed to 
these suspension for 24 hours.  The MTT assay was then performed as above.  The statistical 
significance of the differences in viability was determined using the one-way ANOVA, as 
described in Chapter 2 (Section 2.4.1.1). 
4.5.2.5 Apical Lactate Dehydrogenase Release 
 Apical release of LDH was assayed in A549 cell layers grown on permeable inserts 
immediate after deposition of DEP in the CDC to determine if damage to cells occurred.  The 
LDH assay was done because there was evidence that the exposure method was having an 
affect on the cells independent of the exposure to the particles. 
A549 cells were grown as described in Section 4.2.1 and the groups of inserts listed in Table 
4.5 were exposed to DEP as described in Section 4.5.1.  In addition to the groups listed in 
Table 4.5, inserts were damaged by scratching (group labeled SCR) and poking (group 
labeled POK) with a micropipette tip to serve as positive controls for cells damage (n=3 per 
condition).  Scratching was done by marking an X on the cell surface and poking was done 
by pressing on the cell surface 3 times in different areas of the inserts. 
 Following exposure or treatment, the inserts were placed in a new 24-well plate 
containing 600 µl of PBS at 37°C.  150 µl of PBS was added to the AP sides of the inserts 
and was gently pipetted up and down 3 times to recover the LDH.  100 µl aliquots of the AP 
PBS were then added to microcentrifuge tubes and spun at 500 g for 5 minutes to remove 
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debris.  The amount of LDH was in each of the supernatants, relative to control, was 
determined by following the instructions of the assay kit (TOX-7, Sigma).  Briefly, a 33 µl 
aliquot from the supernatant was added to 66 µl of assay mixture in the wells of a 96-well 
plate.  The plate was kept out of light at 25°C for 25 minutes, after which the reaction was 
stopped by adding 10 µl of 1N hydrochloric acid (Aldrich).  The absorbance of each well was 
read at 485 nm.  The statistical significance of the differences in apical LDH was determined 
using the one-way ANOVA, as described in Chapter 2 (Section 2.4.1.1). 
4.5.2.6 Cell Imaging 
 CTL, PS100, LIQ, and L100 Calu-3 and A549 inserts were washed 1X in PBS and 
fixed in 2.5% glutaraldehyde (Sigma) in PBS at 4°C for 1 hour.  The inserts were then: rinsed 
in PBS (4°C); dehydrated by bathing in graded ethanol solutions (50%, 75%, 95%, and 
100%) for 10 minutes each; dried in a critical point dryer (make, model); sputter-coated with 
gold-palladium for 60 s (model E-5200, Electron Beam Services, Agawan, MA) prior to 
imaging by SEM (JEOL JSM-6300, JEOL America, Peabody, MA). 
4.5.3 Results and Discussion 
4.5.3.1 Fluorescein Permeability 
 The concentration of DEP deposited on the blank Calu-3 PS100 insert was 96 
µg/cm2.  The calculated DF permeabilities across the Calu-3 cell layers are shown in Figure 
4.8a.  There was a slight increase in the permeability of the both groups of inserts placed in 
the CDC (10.9±2.6 x 10-8 cm/s for DEV and 11.9±1.9 x 10-8 cm/s for PS100) compared to 
control inserts (7.7±1.9 x 10-8 cm/s) that were not statistically significant (p>0.05).  The 
permeability of SCR inserts was 7 fold larger than control (51.3±17.0 x 10-8 cm/s), showing 
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that extreme physical damage does compromise the integrity of Calu-3 layers.  The 
permeabilities of the CTL, DEV, and PS100 inserts were approximately 10-fold lower than 
seen in the CTL inserts from the VCI (9.0±0.7 x 10-7 cm/s, Section 4.3.1.2) and TSLI 
experiments (9.2±2.1 x 10-7 cm/s, Section 4.4.2).  The only significant difference between the 
experiments was the diameter of the Transwell used (6.5 mm for CDC and 12 mm for VCI 
and TSLI).  The data indicate that Calu-3 may form tighter layers when cultured on smaller 
diameter Transwells. 
 Deposition on the blank A549 inserts was 16 and 87 µg/cm2 for PS10 and PS100, 
respectively.  The calculated DF permeabilities across the A549 cell layers are shown in 
Figure 4.8b.  There was a slight decrease for the DEV inserts (9.5±1.8 x 10-6 cm/s) and a 
slight increase for the PS100 inserts (14.5±1.9 x 10-6 cm/s) over CTL inserts (12.1±1.8 x 10-6 
cm/s), but neither change was significant (p>0.05).  There was a significant (p<0.05) increase 
in DF permeability across SCR inserts (21.0±2.4 x 10-6 cm/s), showing that physical damage 
does compromise the integrity of A549 cell layers, although the proportional increase in 
A549 cell layer permeability following scratching (less than 2 fold) was less than was seen 
for Calu-3 cell layers (7 fold).  The Papp for DF across the A549 cell layers was 
approximately 10 fold lower than across blank Transwells (8.5±1.4 x 10-5 cm/sec, from 
Section 4.3.1.2) and the Papp for DF across the Calu-3 cell layers was approximately 100 fold 
lower than blank Transwells.  The A549 cells did produce a barrier to transport of DF, but 
that barrier is significantly less tight than the barrier created by Calu-3 cells.  This is 
consistent with the literature, where it has been reported that functional tight junctions are not 
formed in A549 cells (Winton, Wan et al. 1998). 
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 The data from the permeability experiments showed that deposition of fairly high 
doses (96 or 87 µg/cm2) of DEP onto the surface of AIC grown Calu-3 or A549 cell layers 
did not significantly damage the integrity of those cell layers as evaluated with the techniques 
described.  This does not, however, mean that there were no effects on the cells from the 
forces of particle impaction and air flow. 
4.5.3.2 Intracellular Reactive Oxygen Species Formation 
 The amount of DEP deposited on the blank inserts is shown in Table 4.4.  The 
fluorescence of the Calu-3 cell suspensions as fractions of CTL fluorescence are shown in 
Figure 4.9a.  There was a slight (8.6%), non-significant (p>0.05), increase in cellular 
fluorescence of DEV inserts over CTL.  There was a larger, dose-dependant increase in the 
cells onto which DEP aerosol was deposited.  This increase was linear (R2=0.994) when 
plotted as a function of dose (Figure 4.9b) and was statistically significant for the PS50 and 
PS100 inserts (p < 0.05). 
 There was a slight (14.7%), statistically insignificant (p>0.05) increase in cellular 
fluorescence of LIQ inserts over CTL.  This increase may indicate that placement media on 
the apical surface of cells grown at the air interface has an impact on ROS formation.  There 
was a linear (R2=0.96) dose-dependant increase in fluorescence, compared with LIQ control, 
for the L10-100 inserts and the dependency of the increase in fluorescence on DEP dose for 
the media suspended DEP was similar to that seen for the aerosol DEP (Figure 4.9b). 
 There were no significant changes in ROS detected by DCFH-DA exposure in A549 
cells (data not shown).  The dose response seen for the PS exposed Calu-3 cells is consistent 
with the hierarchical stress response to DEP exposure.  The increase in intracellular ROS in 
response to DEP exposure, as measured in these experiments, was not as high as has been 
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seen for cultured lung epithelial cells in the past.  Increases of approximately 3-fold and 8-
fold have been reported in 16HBE14o- cells for exposure to 10 µg/cm2 and 30 µg/cm2 of 
DEP for 4 hours (Baulig, Garlatti et al. 2003; Baulig, Sourdeval et al. 2003).  Increases up to 
10 fold have been reported for normal human bronchial epithelial cells exposed to 50 µg/cm2 
DEP for only 1 hour (Matsuo, Shimada et al. 2003).  The cells that were exposed to the DEP 
and the methods used to detect the fluorescence were different in those studies.  In the studies 
described here, the DEP could not be completely washed away, so some absorption of the 
excitation and emission light by particles during fluorescence detection was probable.  This 
would have masked some of the DCF presence.  This light blocking effect may be avoided 
by using flow cytometry to analyze individual cells instead of analyzing the cell suspension 
as a whole.  Flow cytometry was employed by Baulig, et al. and Matsuo, et al. in the studies 
mentioned above. 
4.5.3.3 Basolateral  Cytokine Release 
 The masses of DEP aerosol deposited on the Calu-3, HBE, and A549 cell layers for 
each condition is shown in Table 4.4.  Approximately 10, 50, and 100 µg/cm2 of DEP were 
delivered to the Calu-3 and A549 cells.  The doses deposited on the HBE cells were higher 
due to the absence of the TSLI inlet during sampling. 
Basolateral IL-8 Release 
 The concentrations of IL-8 in the BL media for Calu-3 cells in each condition are 
shown in Figure 4.10a.  There was a small increase (9%) in BL IL-8 secretion from DEV 
cells compared with CTL cells that was not significant.  There were significant increases in 
IL-8 in the BL media of CAE and PS10-100 cells that appeared to be dependant on DEP 
dose.  Similar doses deposited on the CAE (29 µg/cm2) and PS10 (25 µg/cm2) cells elicited 
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similar IL-8 release (44 and 45% increases over CTL).  The PS50 and PS100 cells exhibited 
larger IL-8 release (57 and 66 %, respectively).  These increases were not statistically 
different from each other (all p>0.05). 
 The release of IL-8 from the LIQ and L10 cells was approximately 7 fold lower than 
from the CTL cells (547 and 513 pg/cm2 compared to 3601 pg/cm2).  The L50 and L100 cells 
showed stimulated release of IL-8 compared to LIQ (87 and 115% increases) resulting in 
proportionally larger, but in absolute terms lower, increases than similar aerosol doses.  
These data indicate that while there was a dose dependant increase in BL IL-8 release from 
cells exposed to ≥ 50 µg/cm2 of DEP suspended in media, placement of apical media on 
Calu-3 cells grown at the air interface decreases the overall BL secretion of IL-8.  A 
redistribution of secretion to the AP side, which was not measured, may have contributed to 
the decrease in measured BL levels. 
 IL-8 release from the LCC cells was approximately 5 fold lower than from the CTL 
cells (1089 pg/cm2 compared to 3601 pg/cm2).   The LCC10 and LCC50 cells exhibited 
slight increases compared to LCC (51 and 35%) while the LCC100 cells had the largest 
proportional increase in IL-8 release of any group (197%).  These data point to the 
differences in response to DEP exposure for Calu-3 cells grown at the liquid and air 
interfaces. 
 The concentrations of IL-8 in the BL media for A549 cells in each condition are 
shown in Figure 4.10b.  The amount of IL-8 released from A549 CTL cells was lower (942 
pg/cm2) than from Calu-3 CTL cells (3601 pg/cm2) and the response to the CDC and DEP 
were slightly different.  The release from the DEV cells was much higher (200% increase) 
than from CTL cells.  This indicates a significant effect of placement in the CDC on cytokine 
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secretion from A549 cells.  There were significant dose-dependant increases in BL IL-8 for 
all A549 cells exposed to DEP aerosols.  The increases were proportionally larger (168-
455%) than those seen for Calu-3 cells. 
 The IL-8 released from the LIQ cells was almost equivalent to the release from CTL 
cells, but the response to liquid suspension DEP was not the same as for the aerosol.  There 
were slight, non-significant (all p>0.05), decreases in BL IL-8 secretion from the L10-L100 
cells compared to LIQ.  It appears that IL-8 release was not stimulated by exposure to AIC 
grown A549 cells exposed to DEP as an apical media suspension but was stimulated by DEP 
deposited on the apical surface as an aerosol. 
 The release of IL-8 in response to DEP exposure from cells of bronchial and alveolar 
origin has been measured in other laboratories, with varied results.  In general, increases in 
IL-8 release from bronchial epithelial cells and cell lines were seen in response to DEP 
exposure, but the extent of those increases was dependent on the dose, the cell type, and the 
laboratory (Table 4.6).  This is consistent with the data from the current study that showed 
increases in IL-8 release from Calu-3 cells.  Two different studies reported a decrease in IL-8 
release from A549 cells in response to DEP exposure greater than 1 µg/ml (Juvin, Fournier et 
al. 2002; Seagrave, Knall et al. 2004), which is consistent with the slight decrease seen for 
L10-100 A549 cells, but is inconsistent with aerosol exposed A549 cells.  
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Cell Type Dose (µg/ml 
or µg/cm2) 
Exposure 
Time (hr) 
IL-8 Change 
(%) 
Reference 
A549 2-20 24 -50 (Juvin, Fournier et al. 
2002) 
A549 0.1 to 1 18 40 (Seagrave, Knall et al. 
2004) 
A549 10 to 100 18 -25 to -75 (Seagrave, Knall et al. 
2004) 
16HBE14o- 10 48 361 (Boland, Baeza-Squiban 
et al. 1999) 
BEAS-2B 10 to 100 24 25 to 75 (Ohtoshi, Takizawa et al. 
1998) 
BEAS-2B 70 to 190 24 0-100 (Steerenberg, Zonnenberg 
et al. 1998) 
BEAS-2B 50 12 250 (Takizawa, Ohtoshi et al. 
1999) 
BET-1A * 22 440 (Abe, Takizawa et al. 
2000) 
BET-1A 10 to 100 24 0 to 270 (Hashimoto, Gon et al. 
2000) 
NHBE 10 to 100 24 185 to 570 (Bayram, Devalia et al. 
1998) 
NHBE 50 24 100 (Takizawa, Ohtoshi et al. 
1999) 
NHBE 10 to 100 24 0 (Madden, Dailey et al. 
2003) 
Table 4.6. Change in interleukin-8 (IL-8) release from cells exposed to DEP.  *Cells 
were exposed to DEP as an aerosol with an undefined mass. 
 
Basolateral GM-CSF Release 
 The concentrations of GM-CSF in the BL media for Calu-3 and HBE cells at each 
condition are shown in Figure 4.11.  There was a trend to dose-dependant increase in BL 
GM-CSF release from Calu-3 cells exposed to DEP as an aerosol.  There were large standard 
deviations, however, for all of the Calu-3 cell conditions.  The amounts of GM-CSF secreted 
by Calu-3 cells were close to the detection limit of approximately 0.2 pg/ml, and therefore 
results were difficult to interpret.  The only condition that was statistically different from the 
control was the PS100 inserts that exhibited a 4 fold increase in BL GM-CSF.  The amounts 
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of BL GM-CSF released by the liquid covered inserts (both AIC and LCC grown) were 
generally at, or below, the detection limit of the assay.  The amount of GM-CSF secreted by 
HBE cells was larger than for Calu-3 cells and the response to DEP exposure was different.  
The concentration was smaller for all treated cells than for CTL cells with no definitive dose 
response pattern. 
 Dose dependant increases in GM-CSF release from bronchial epithelial cells have 
been reported in response to DEP exposure, although they were dependant on cell type, dose, 
and individual laboratory.  Increases of 100% (Baulig, Sourdeval et al. 2003) and 1600% 
(Boland, Baeza-Squiban et al. 1999) have been reported for HBE cells exposed to 10 µg/cm2 
DEP for 24 hours.  These increases were not seen in the current study, and there are a number 
of variables that could be responsible for these differences.  These variables are discussed in 
the conclusion section (Section 4.6). 
4.5.3.4 Cell Viability 
 Viability of Calu-3 cells following 24 hours exposure to DEP is shown in Figure 4.12.  
There were no significant differences in the formazan crystal formation (all p>0.05), 
although there was a slight decrease for the DEV inserts and slight increases for the PS10 and 
PS100 inserts.  As mentioned previously in Section 4.3.2.2, the MTT assay measures more 
than cell viability, and the slight increases in formazan formation may explained by increased 
metabolic activity of the cells in response to DEP exposure. 
 The viability of A549 cells grown on Transwells and in a 96-well plate following 24 
hours of exposure to DEP are shown in Figure 4.13.  The A549 cells grown in a 96-well plate 
displayed the same dose response as Calu-3 cells (Figure 4.6).  The potential explanations are 
described in Section 4.3.2.2.  There was a small but statistically significant decrease in 
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formazan crystal formation in each of the treated A549 inserts (p < 0.05).  This indicates that 
the method of deposition of aerosols by the CDC is slightly toxic to A549 cells.  
4.5.3.5 Apical Lactate Dehydrogenase Release 
 The apical LDH release from A549 cells in each condition is shown in Figure 4.14.  
There was an increase in apical LDH over control for every condition.  The increase over 
control seen with the DEV group was not significant (p>0.05), but the increases seen in all of 
the other groups was (all p<0.05).  The damage appeared to be dependant on the dose of DEP 
deposited as well, with the PS100 group showing even more apical LDH than the two 
positive controls (SCR and POK).  This indicates that there was damage done to the A549 
cell layers by deposition of DEP aerosols in the CDC and that the air flow alone (DEV) 
likely caused some damage.  The fact that A549 cells are damaged by the deposition process 
further illustrates that the CDC is not an appropriate device to deliver aerosols to A549 cells 
for in vitro toxicology studies. 
4.5.3.6 Cell Imaging 
 Scanning electron micrographs of Calu-3 cells are shown in Figure 4.15 (100X), 
Figure 4.16 (1000X), and Figure 4.17 (10000X).  The cell layer appeared to be a single cell 
deep in some areas, with multiple cells in other.  The individual cells appeared heterogeneous 
in size and shape.  Microvilli could be seen on the surface of the occasional cell, with those 
on the CTL cells (Figure 4.17a) appearing slightly longer than those on the LIQ cells (Figure 
4.17b). It is unknown whether this is due to changes caused by apical fluid or due to 
differences in the reaction of the cells with the fixing and dehydration processes.  Although 
the cells were washed multiple times in PBS and alcohol, remaining DEP can be seen on 
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both the PS100 and L100 cells.  The doses of DEP for these two conditions were similar, but 
it appeared that more DEP remained on the surface of the PS100 cells after washing and 
fixing.  This may indicate that the DEP was more intimately associated with these cells than 
the L100 cells. 
 Images of the A549 cells are shown in Figure 4.18 (100X), Figure 4.19 (1000X), and 
Figure 4.20 (5000X).  The A549 cells appeared much more uniform in size and shape than 
the Calu-3 cells and appeared to be in a monolayer.  The divisions between the individual 
LIQ and L100 cells were not as pronounced as in the CTL and PS100 cells, but this was 
likely because of the difference in hydration during one of the steps in the fixing procedure.  
As with the Calu-3 cells, more DEP appeared to remain attached to the PS100 cells than to 
the L100 cells. 
4.6 Conclusions 
 Several markers of toxicity were measured in several lung epithelial cell lines 
following the deposition of DEP aerosols onto their apical surfaces using three deposition 
devices.  All three devices were used to deposit aerosols onto the surface of Calu-3 cells 
without disrupting the barrier properties of the cell layers, as measured by disodium 
fluorescein transport.  The same was true for deposition of aerosols onto A549 cells using the 
CDC, although A549 cells do not present a tight barrier to transport to begin with.  The 
changes in ROS formation, cytokine production, and viability in response to exposure to 
DEP as an aerosol in the CDC and as an apical liquid suspension for the three cell types are 
summarized in Table 4.5.  Three questions were considered when making conclusions about 
the cellular response data: 1) Was the cellular response to exposure to DEP deposited as an 
aerosol different from the response to DEP as apical suspensions? 2) Did the deposition 
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device or particle deposition affect the cells independently of the particles? 3) Did the 
presence of apical media affect the cells independently of the particles?  These questions are 
addressed below. 
Question 1 
 The cellular responses are summarized in Table 4.5.  In some cases the trends were 
the same for the aerosol and liquid suspension groups, and in some cases they were different.  
The differences are highlighted in Table 4.7 by being circled with a solid line.  The 
differences, when they occurred, could be attributed to effects of the deposition methods, 
differences in concentrations of dissolved chemicals, or differences in particle-cell 
interactions. 
Question 2 
 There was evidence that the deposition methods affected the cells independently of 
the properties of the particles being deposited.  There were small, non-significant, increases 
in the intracellular ROS formation in and BL IL-8 release from device only control (DEV) 
Calu-3 cells.  The effects, if any, on Calu-3 were small, so it is reasonable to assume that the 
cellular responses seen were a function of DEP exposure, not deposition by inertial 
impaction.  This was not the case for A549 cells.  There were significant differences in IL-8 
release from and viability of A549 DEV cells, highlighted by circling in a dashed line in 
Table 4.5.  This indicates that the air flow in the CDC did affect A549 cells.  This also means 
that the dose responses to DEP aerosol exposure seen in A549 cells was likely to be, at least 
in part, clouded by the affects of air flow and particle deposition.  The flow of air to and 
across the cells in the CDC produced both compressive stress and shear stress on the cell 
surfaces.  The forces involved in the compressive stress on membranes placed in the CDC are 
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discussed in Chapter 3 (Section 3.).  There are several potential mechanisms by which 
extracellular forces can affect cell layers. 
 The intercellular junctions may be broken by external forces, causing a disruption in 
the barrier layer.  For cell layers that form tight junctions, this phenomenon would be 
detected by a change in the permeability of a cell layer to paracellularly transported 
molecules (like DF).  A change in permeability may not be evident in cells, such as A549 
cells, that do not form tight junctions.  A549 cells do create a barrier to transport, but because 
that barrier is quite leaky, it may take considerable damage for a change in permeability to be 
evident. 
 The plasma membrane of a cell can be disrupted by external forces, causing necrosis.  
This phenomenon would be detectable by loss in total cell viability and release of 
cytoplasmic components (like LDH) into the apical compartment.  This was seen in the DEV 
A549 cells as well as those onto which DEP aerosols were deposited.  The LDH release from 
the PS100 A549 cells was greater than for cells that were severely damaged as positive 
controls (SCR and POK).  There slight decrease in viability in A549 DEV cells can be 
attributable to this phenomenon, although if could also be a combined effect with apoptosis 
as a downstream result of cell signaling pathways triggered by the forces. 
 A third potential mechanism by which cells are affected by extracellular forces is 
mechanotransduction.  Cytokine production in response to mechanical forces has been seen 
previously.  The potential role of cytokines in lung injury by ventilator use has been reviewed 
(Halbertsma, Vaneker et al. 2005) as have the potential mechanisms by which 
proinflammatory mediators are released in response to ventilation (Uhlig 2002).  Most data 
on cytokine release following external forces in the lung is from in vivo and ex vivo studies, 
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but some studies have shown a cytokine response to mechanical stress in vitro.  A549 cells 
showed an increase in IL-8, but not GM-CSF, expression and release in response to cyclic 
mechanic stretching (Vlahakis, Schroeder et al. 1999).  This cyclic stretching was over a 
prolonged period (24 hours), but there is evidence from other cell types that indicates 
changes in cytokine release can be triggered by seconds or minutes of mechanical stress.  
Mechanical stretching caused bronchial epithelial cells (BEAS-2B) to produce IL-8 as well, 
with activation of signaling molecules (MAPK) after only 5-10 minutes of stretching (Oudin 
and Pugin 2002).  Increases in MAPK phosphorylation were seen in normal human bronchial 
epithelial cells in response to compressive forces for 5 minutes (Tschumperlin, Shively et al. 
2002).  The apical pressure that elicited MAPK phosphorylation was 2942 Pa, while, as 
calculated in Chapter 3 (Section 3.5), the pressures induced from the air flow at the surface of 
the insert in the CDC are between 442 and 2636 Pa.  ERK (a MAPK) was phosphorylated by 
sheer stress in endothelial cells in as little as 1 minute (Jo, Sipos et al. 1997). 
 The physical mechanisms of mechanotransduction are rooted in the cytoskeletal 
structure of cells in conjunction with stretch-sensitive ion channels and other signaling 
molecules (Ingber 1997; Alenghat and Ingber 2002).  There is evidence that both MAPK and 
NF-κB may play roles in the increase in cytokine release caused by mechanotransduction.  
These are some of the same signaling cascades that can be stimulated by ROS and have been 
implicated in causing inflammation in response to DEP exposure. 
 Besides the effects seen in the DEV inserts, it is likely that the impaction of particles 
onto the surface caused, in part or in full, the changes seen in the cells from aerosol 
deposition.  The calculated forces from the deposited particles are small in comparison to the 
air if averaged over the entire surface, but the forces are imparted for each particle only over 
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the contact surface between the particle and impaction surface.  This may allow some 
particles to embed in the cell surface.  The properties of the apical surface of the cells 
including the depth, viscosity, and surface tension of any apical fluid layer that is present, are 
important in preventing this from happening.  The lack of an apical fluid layer may explain 
the adverse effect of particle deposition on two of the three LCC Calu-3 cell layers, in the 
VCI (Section 4.3.1.2).  As described in Section 4.1.1, it has been reported that the mucus 
layer on AIC Calu-3 cells is thicker than that of LCC Calu-3 cells, offering a more even 
distribution of apical forces over the surface.  It is not possible to control for the affect of 
particle deposition in the absence of particle interactions with the cell following deposition.   
Question 3 
 The air flow and deposition of particles by inertial impaction are not the only 
potential effectors of cellular response to DEP.  Others have reported, and the TEER and 
permeability data from Calu-3 cells in this work demonstrates, that bronchial epithelial cells 
grown at the air interface differ from cells grown under liquid cover.  If the apical presence 
of liquid can alter the differentiation of cells, it may be assumed that changes in the behavior 
of cells grown under AIC would occur upon addition of apical liquid.  The placement of 
apical liquid on the surface of cells grown at the air interface had a significant effect on at 
least one cellular response in Calu-3 (IL-8), 16HBE14o- (GM-CSF), and A549 (Viability).  
These effects are circled with a dotted line in Table 4.5. 
 Differences in response from cells exposed to DEP deposited as an aerosol and to 
DEP as a liquid suspension could also come from differences in exposure to the compounds 
adsorbed onto the DEP surface.  It is known that the organic extract of DEP can elicit the 
production of ROS and secretion of cytokines in bronchial epithelial cells in the absence of 
 198
particles (Bonvallot, Baeza-Squiban et al. 2001).  The dissolution of compounds from the 
surface of DEP would certainly be different for DEP deposited as an aerosol and for DEP 
suspended in media with heavy mixing and sonication.  Many of the compounds thought to 
be responsible for the toxic affects of DEP are slightly soluble in water.  The aqueous culture 
media surely becomes a solution of these compounds after mixing, sonication, etc. 
 The particle-cell interaction is known to be important to cell effects.   Particle size is 
an important factor in DEP interaction with cells, especially if endocytosis is important in the 
toxicity of DEP (ref).  DEP aggregate to a much greater extent in aqueous media (Section 
4.2.5.3), than they do as a deposited aerosol (Chapter 3).  In order to mimic the in vivo 
response, a particle should be presented to the cell surface in a manner that closely resembles 
the level of aggregation that a particle would have in vivo.   
 Different responses may be due to the distribution pattern of DEP by the CDC.  DEP 
are denser in the area of the cell layer directly below the jets, as shown in Chapter 3.5.  This 
may lead to saturation of IL-8 production and/or release from the cells below, and proximal 
to the jets.  Saturation would limit the maximum release in response to the highest 
concentration.  Another explanation for the non-linear dose response is the dose that is 
deposited is not the dose to which the cells are exposed.  Since the DEP deposits in piles 
beneath the jets, the tops of the piles do not contact cells or the apical mucous/fluid layer. 
 The conclusions are unaffected by the cause of the different responses.  The different 
methods of DEP exposure yield different results.  Each of these potential explanations 
involves phenomena that are likely to occur in the bronchial region in vivo.  Sites of high 
deposition in the bronchial region, such as bifurcations, will exhibit more deposition than 
other sites. 
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Aerosol Liquid Suspension 
Cell Line Test  Dose Response 
Control 
(DEV) 
Dose 
Response 
Control 
(LIQ) 
ROS ↑ ↔ ↑ ↔ 
IL-8 ↑ ↔ ↑ ↓ 
GM-CSF ↑ ↔ ↔ ↔ Calu-3 
Viability ↔ ↔ NA NA 
HBE GM-CSF ↓ ↔ ↑ or ↓ ↓ 
ROS ↔ ↔ ↔ ↔ 
IL-8 ↑ ↑ ↔ ↔ A549 
Viability ↓ ↓ ↔ ↓ 
Table 4.7. Response of the cells to exposure to DEP aerosols by the custom deposition 
chamber and liquid suspension DEP as compared to untreated control CTL cells 
(aerosol) or cells exposed to blank media (LIQ) (liquid suspension), and relative values 
for device only control (DEV) and LIQ inserts compared to CTL.  Arrows indicate 
direction of change, with ↔ indicating no change. 
 
 
 The objectives of specific aim 3, to examine the cellular responses to exposure to 
DEP aerosols and liquid suspensions, were addressed.  The data, showing the responses to 
DEP exposure by the two methods differ, support the hypotheses.  The conclusions from this 
chapter are considered in conjunction with the conclusions from Chapters 1 and 2 in Chapter 
5.  
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Figure 4.1. Typical particle size distribution by volume of DEP suspended in A549 
media (50 μg/ml) following 24 hours incubation at 37ºC (single measurements). 
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Figure 4.2. Transepithelial electrical resistance (TEER) values of liquid cover cultured 
(LCC) and air interface cultured (AIC) Calu-3 cell layers following seeding on 12 mm 
Transwells® (mean ± SD, n=12). 
 202
 LCC AIC
0.00E+00
2.00E-07
4.00E-07
6.00E-07
8.00E-07
1.00E-06
1.20E-06
1.40E-06
Control AC NC NCw/P
Condition
Pa
pp
 (c
m
/s
ec
)
* 
 
Figure 4.3. Apparent permeability (Papp) of liquid cover cultured (LCC) and air 
interface cultured (AIC) Calu-3 cell layers to disodium fluorescein after placement in 
the viable cascade impactor with apical cover (AC), no apical cover (NC), and no apical 
cover with powder deposition (NCw/P), (mean ± SD, n=3) *Mean value for LCC 
condition NCw/P is 38.0. 
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 (a) 
500 μm 
50 μm 
(b)  
Figure 4.4. Micrographs of DEP deposited in the viable cascade impactor (stage 5) on a 
Calu-3 cell layer grown on a 12 mm Snapwell™ at (a) 100 X and (b) 500 X, showing the 
region below a single orifice.  Arrows indicate the edge of the deposition pile. 
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Figure 4.5. Viability of Calu-3 cell layers grown on 12 mm Snapwells® and exposed to 
DEP deposited as an aerosol in the viable cascade impactor (stage 5), as assessed by 
MTT assay. (a) 7 and 70 μg/cm2 doses at 24 hours (mean ± SD, n=3) and (b) 46 μg/cm2 
at 24 and 48 hours (mean ± SD, n=2). 
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Figure 4.6. Viability of Calu-3 cells grown on a standard 96-well culture plate under 
liquid covered culture conditions and exposed to DEP for 24 hours, as assessed by MTT 
assay (mean ± SD, n=6). 
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Figure 4.7. Permeability of air interface cultured Calu-3 cell layers to disodium 
fluorescein after placement in the twin-stage liquid impinger, 1 cm and 2 cm from the 
nozzle, with (+) or without (-) DEP deposition (mean ± SD, n=3). 
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Figure 4.8. Apparent permeability (Papp) to disodium fluorescein for (a) Calu-3 and (b) 
A549 cell layers grown at the air interface following no treatment (CTL), placement in 
the custom deposition chamber (DEV), deposition of propellant suspension DEP 
aerosols (PS100), or damage by scratching (DAM), (mean ± SD, n=3). 
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Figure 4.9. Fluorescence of Calu-3 cells following 4 hours of DEP exposure and 30 
minutes of incubation with dichlorofluorescin diacetate (a) in each treatment group and 
(b) as a function of exposure dose (mean ± SD, n=3). 
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Figure 4.10. Concentration of interleukin-8 (IL-8) in the basolateral media of (a) Calu-3 
and (b) A549 cells following 24 hours of DEP exposure (mean ± SD, n=3). 
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Figure 4.11. Concentration of granulocyte macrophage-colony stimulating factor (GM-
CSF) in the basolateral media of (a) Calu-3 and (b) 16HBE14o- cells following 24 hours 
of DEP exposure (mean ± SD, n=3). 
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Figure 4.12. Viability of Calu-3 cells grown on Transwells® at the air interface exposed 
to DEP via the custom deposition device for 24 hours, as assessed by MTT assay (mean 
± SD, n=3). 
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Figure 4.13. Viability of A549 cells exposed to DEP for 24 hours, as determined by MTT 
assay.  Cells were grown on (a) standard 96-well culture plate under liquid cover (mean 
± SD, n=5) and on (b) Transwells® at the air interface (mean ± SD, n=3). 
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Figure 4.14. Lactate dehydrogenase (LDH) release to the apical surface of A549 cell 
layers grown on 6.5 mm Transwell inserts at the air interface and placed in the custom 
deposition chamber with no aerosol deposition (DEV) and with deposition of diesel 
exhaust particle aerosols generated from a propellant suspension of approximately 10, 
50, or 100 µg/cm2 (PS10, PS50, or PS100) as a proportion of release from untreated 
control (CTL) cells (n=3 per condition).  Cells that were damaged by scratching (SCR) 
and poking (POK) serve as a positive control (mean ± SD, n=3 per condition).  
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  d) 
b) 
c) 
a) 
Figure 4.15. Scanning electron micrographs of Calu-3 cells following exposure to DEP 
for 24 hours. (a) CTL (b) PS100 (c) LIQ and (d) L100 (100X). 
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b) 
c) 
a) 
Figure 4.16. Scanning electron micrographs of Calu-3 cells following exposure to DEP 
for 24 hours. (a) CTL (b) PS100 (c) LIQ and (d) L100 (1000X). 
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 a) b) 
Figure 4.17. Scanning electron micrographs of Calu-3 cells following exposure to DEP 
for 24 hours. (a) CTL and (b) PS100 cells (10000X). 
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 d) 
b) 
c) 
a) 
Figure 4.18. Scanning electron micrographs of A549 cells following exposure to DEP for 
24 hours. (a) CTL (b) PS100 (c) LIQ and (d) L100 (100X). 
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Figure 4.19. Scanning electron micrographs of A549 cells following exposure to DEP for 
24 hours. (a) CTL (b) PS100 (c) LIQ and (d) L100 (1000X). 
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c) 
a) 
Figure 4.20. Scanning electron micrographs of A549 cells following exposure to DEP for 
24 hours. (a) CTL (b) PS100 (c) LIQ and (d) L100 (5000X). 
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5 GENERAL CONCLUSIONS AND FUTURE WORK 
 There are many questions and concerns when attempting to make assumptions about 
human toxicology from studies performed in vitro.  These concerns are amplified for an 
insoluble inhaled toxicant such as diesel exhaust particle (DEP) because of the complicated 
interaction between deposition, particle properties, and toxicity.  Any data gathered from 
cells in culture must be considered carefully and may only be relevant to the particular cells, 
growth conditions, material, and exposure conditions used.  For these reasons, creating 
realistic exposure conditions with respect to both toxicant and cell is vital to a test system.  
The particles being tested should resemble the particles that deposit on the surface of the lung 
and the particles must be presented to the cell in a manner that relevant to in vivo deposition 
and in doses that are realistic.  The current prevalent methodology for in vitro DEP toxicity 
testing involves the placement of an aqueous suspension of DEP onto the apical surface of 
cells.  This method is acceptable for the identification of potential mechanisms for DEP 
toxicity in the lungs, but does not address issues specific to atmospheric DEP such as particle 
size and deposition as an aerosol.  The limitations of testing apical DEP suspensions have 
been identified and methods of depositing freshly generated DEP onto the surface of cells 
have been developed (Massey, Aufderheide et al. 1998; Wolz, Krause et al. 2002).  These 
methods may represent the most realistic deposition approach, but are difficult to perform 
and expensive since a diesel engine must be operated on site.  The work described in this 
dissertation presents an option for depositing DEP as an aerosol onto the apical surface of 
cells grown in culture without the inconvenience and expense of an engine on site.  The 
hypotheses tested by this work were: 
 
1. Diesel exhaust particles from a bulk source can be presented to cells in culture in a 
physiologically relevant manner, i.e. delivered as an aerosol to cells cultured at the air-liquid 
interface, to facilitate study of a realistic biological response. 
2. Cellular response, measured by formation of reactive oxygen species, production of 
proinflammatory mediators, and cell viability, to exposure to aerosols will be measurable and 
will differ from response to exposure to liquid suspensions. 
 
The specific aims of the work done to test these hypotheses were: 
 
1. Aerosol Generation: Generate and characterize diesel exhaust particle (DEP) aerosols in an 
aerodynamic size range that allows deposition onto cultured cells. 
 
2. Aerosol Deposition: Deliver DEP aerosols to cells in culture in a reproducible manner over 
a range of doses without affecting those cells. 
 
3. Evaluation of Cellular Response: Examine the formation of reactive oxygen species, the 
production of proinflammatory mediators, and the rates of apoptosis/necrosis in cultured lung 
epithelial and monocyte/macrophage cells following the deposition of DEP aerosols and DEP 
suspensions. 
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 Specific aim 1 was addressed in Chapter 2, which describes the generation of DEP 
aerosols by several methods and their characterization.  The resultant DEP aerosols were of a 
size range that is relevant to atmospheric DEP.  Specific aim 2 was addressed in Chapter 3 
(aerosol deposition) and part of Chapter 4 (affect of deposition on cells), which describe the 
delivery of DEP aerosols to the apical surface of cells in culture by inertial impaction.  
Delivery by inertial impaction proved to be disruptive to some cells (A549), but not others 
(Calu-3), showing that its usefulness is limited to certain cell lines.  Specific aim 3 was 
addressed in Chapter 4, which describes the measurement of intracellular reactive oxygen 
species (ROS), basolateral release of interleukin-8 (IL-8) and granulocyte macrophage 
colony stimulating factor (GM-SCF), and cell viability in several cells lines following 
exposure to DEP as apical media suspensions and as aerosols deposited by inertial impaction. 
 Taken together, the work supports the hypotheses.  DEP delivered as an aerosol to 
cells cultured at the air-liquid interface caused production of pro-inflammatory mediators 
(IL-8 and GM-CSF) in a dose dependant manner that differed from DEP delivered apically as 
a suspension.  The formation of intracellular ROS, however, was the same for both types of 
exposure.  There are several potential explanations why the differences were not seen in 
intracellular ROS.  The increases in ROS over control were very small (10-50%) in 
comparison to the increases seen in other cells in response to similar DEP doses (200-700%) 
(Baulig, Garlatti et al. 2003; Baulig, Sourdeval et al. 2003), indicating that the full extent of 
ROS production may not have been measured.  As stated in Chapter 4 (Section 4.5.3.2), the 
DEP was not washed away from cells completely, which may have muted the measured 
fluorescence.  The timing of the experiment may have also impacted the results.  The ROS 
measurement was done 4 hours after initial exposure, which may not have been the peak of 
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intracellular fluorescence.  Part of the oxidative stress response of a cell is to produce 
antioxidant defense proteins, so the cells may have had time to react to, and neutralize, the 
ROS.  In addition, the fluorescence was measured for the entire cell suspension and not 
individual cells.  It is possible that ROS production, and consequently cytokine production, 
was not the same for every cell and that the distribution of ROS over the cell surface would 
yield useful information. 
 There were differences in cellular response between the two exposure methods, so it 
is important to determine which of the methods more closely resembles the in vivo situation.  
The cellular response to exposure to DEP was potentially affected by a number of factors.  
These factors are related to: the particles themselves (particle size and shape, and adsorbed 
chemicals); the cells (cell and apical surface properties) and; the method used to expose the 
cells to the particles.  Particle size and shape and presence of adsorbed compounds are 
determined by the methods used to generate the particles and the methods used to deposit 
them on the cell surface.  The size and shape of a particle can influence the particle/cell 
interaction as well as have a large affect on the affective dose delivered to the cell surface.  
The presence of adsorbed compounds can drive the production of ROS and the cellular 
response to exposure.  The properties of the cells and the layer just apical to the cells are 
determined by the cell type that is chosen and the conditions used to culture the cells.  Cell 
and apical surface properties are very important in the cell/particle interactions, as well as the 
cellular response following those interactions.  The exposure method used determines the 
mechanism by which the particles deposit on the cell surface and can affect the cell/particle 
interactions and can have effects on the cells not related to the particles.  The extents to 
which different exposure methods represent in vivo exposure are estimated in Table 5.1  The 
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exposure methods represented in Table 5.1 are: apical media suspension; deposition of 
freshly generated DEP as an aerosol by sedimentation and diffusion (the CULTEX device); 
and deposition of re-generated aerosols by inertial impaction (the CDC).   
 
Factor In Vivo In Vitro, Media Suspension In Vitro, CULTEX In vitro, CDC 
Particle Size -10 nm to 10 µm, depending on lung location 
(3-5) Dependant on 
suspension method 
(2) Dependant on engine 
conditions 
(2) created (20 nm to 10 
µm) 
(3-4) deposited (1-5 µm) 
Particle Shape -Dendritic aggregates (?) Aggregates of unknown shape (2) Dendritic aggregates (4) Dense aggregates 
Adsorbed 
Compounds 
-Dependant on engine 
conditions 
(4) Potentially dissolved in 
media prior to exposure 
(2) Dependant on engine 
conditions, particles not 
aged 
(1) Unchanged for CAE 
(2) Potentially dissolved in 
propellant prior to exposure 
for PS, but should re-
adsorb during evaporation 
Cell Properties -Dependant on lung location 
(3) Dependant on cell 
type/line 
(3) Dependant on cell 
type/line 
(3) Dependant on cell 
type/line 
Cell Surface 
-Liquid layer of 10 nm to 
10 µm, dependant on 
location, covered with 
surfactant layer 
Dependant on cell type 
(3) For AIC grown cells 
(4) For LCC grown cells 
 
(3) Dependant on cell type 
 
(3) Dependant on cell type 
Deposition 
mechanism 
-Dependant on location 
-Inertial impaction, 
sedimentation, and 
diffusion from air 
(5) Sedimentation from 
media, addition of apical 
media must be accounted 
for in AIC grown cells 
(2) Sedimentation and 
diffusion from air 
(2-5) Inertial impaction 
from air, affect of air flow 
and impaction must be 
accounted for 
Table 5.1. Factors than influence the cellular response to DEP exposure and how 
representative the various exposure methods are of the ideal (In vivo exposure to 
atmospheric DEP). 1=Exactly the same, 2=Good representation, 3=Somewhat 
representative, 4=Poor representation, 5=Not representative. 
 
 It is postulated that the methods of aerosol generation and deposition described in this 
dissertation are a more representative model with respect to these factors than exposure to an 
apical liquid suspension.  The advantages of aerosol deposition over apical suspension with 
respect to factors in Table 5.1 are discussed below. 
Particle Size and Shape 
 DEP exist in the atmosphere in a range of sizes, from very small (10-30 nm) primary 
particles, where to largest number of particles exist, to sub-micron (100-500 nm) aggregates, 
where the largest mass of particles exist, to coarse mode particles (> 1 µm), where little 
number or mass exist.  As discussed in Chapter 2, DEP aerosols in size ranges that 
 225
approximate atmospheric DEP were generated.  At the small end of the size distribution (< 
50 nm), there was likely little difference in shape of aggregates generated and the shape of 
atmospheric DEP, as several spheres can only aggregate in a few configurations.  There were 
noticeable differences in the larger aggregates, however.  The aggregates produced by CAE 
and PS methods both appeared denser than the dendritic aggregates present in the 
atmosphere.  The particles that were deposited onto the surface of cells using the CDC were 
in the larger (> 1µm) end of the distributions.  Although the deposited aerosol particles were 
somewhat larger and more densely aggregated than typical atmospheric DEP, they were 
more representative of in vivo inhalation than the particles in apical suspension, which 
averaged more than 20 µm in diameter. 
 It is clear that where there are very large aggregates, the vast majority of primary 
particles do not interact with the cell.  The percentage of the primary particles interacting 
with the cell would depend on the cell’s ability to conform to the particle surface, but should 
roughly scale with aggregate surface area.  Surface area is a square function of diameter and 
the number of aggregates is a cubed function of diameter, so the surface of interaction for the 
same mass of DEP should scale roughly with the inverse of aggregate diameter.  This means 
that the area available for cell interaction for a 1 µm aggregates is 100 times greater than for 
the same mass of 100 µm aggregates.  This is going to affect the number of particles 
available for endocytosis and the concentration of adsorbed chemicals in the cell, as 
discussed below. 
Adsorbed Chemicals 
 The presence of adsorbed chemicals has been implicated in the toxicity of DEP and is 
of a potential source of a difference in cellular response by the different exposure methods.  
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As shown in Figure 5.1, the concentration of any chemical in the cell (Ctotal) is determined by 
the concentration due to absorption from endosomes containing DEP (C1) added to 
absorption from the surface of particles (C2) and absorption from the apical liquid layer (C3) 
minus the metabolism and clearance.  C1 and C2 increase as the surface area of the particles 
increases.  This does not necessarily mean that chemical concentration is higher in cells 
exposed to smaller aerosol particles than in cells exposed to larger particles in media 
suspension.  In the case of aerosol exposure, C3 is dependant on dissolution into a small 
volume of apical liquid following deposition. Suspension of particles in media creates a 
dilute aqueous solution of the adsorbed chemicals prior to exposure.  In this case, the 
concentrations of each compound in the media, and therefore C3, are dependant on the 
solubility of the compound as well as the suspension preparation and storage.  This makes it 
possible to expose cells to high doses of chemical with little particle interaction, divorcing 
the effects of the chemicals from the characteristics of the particles.  This is does not occur in 
vivo, where the quantities of lipophilic compounds like PAHs that are absorbed by the 
epithelium are dependant on the interaction of particle surfaces with the plasma membrane 
and/or the surfactant layer.  In addition, there is no standardized method for preparing and 
storing DEP media suspensions, so differences in media dissolution are likely to lead to inter-
laboratory differences in exposure doses to many of the adsorbed chemicals. 
Cell and apical surface properties 
 The exposure of cells in culture should mimic in vivo exposure in respect to the 
properties of the cells used.  The conditions used to culture cells of lung epithelial origin are 
known to contribute to the properties of those cells.  In vitro, cells can be cultured under 
liquid cover or at the air interface, and are used to test toxicology in both conditions.  Air 
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interface culture is not only intuitively superior to liquid covered culture (this is how 
epithelial cells grow in the human lung), but has been shown to produce cells with the most 
relevant morphology in vitro. 
Exposure method 
 Because particles of different sizes deposit in the different regions of the respiratory 
tract at different efficiencies, the ideal size or size range to use for in vitro exposure is 
dependant on the region that is being represented.  This was the principle behind the original 
use of the Viable Cascade Impactor (VCI) to sample aerosols onto the surface of cells.  Cells 
representing the upper airways, where larger particles tend to deposit, could be placed in the 
upper stages of the VCI.  The same logic could be applied to the lower airways and alveolar 
cells, which could be placed on the lower stages.  This approach is still valid for some cells 
and some experiments, although there were several obstacles.  While the particles do deposit 
on the surface of cells in the VCI a size-dependant manner, they do so in an uneven manner.  
The deposition is less even (more space between piles of smaller diameter) for the lower 
stages of the impactor because of the decreasing orifice sizes.  In the lowest stages only a 
small fraction of the cell surface is exposed to aerosol.  The uneven deposition was alleviated 
to a large extent by the construction of a custom deposition chamber (CDC).  The CDC did 
not alleviate the second obstacle in deposition by inertial impaction, which is the high air 
flow needed to deposit small particles.  As mentioned above, deposition of aerosols on the 
surface of cells by inertial impaction is limited by the air velocity required to impact the 
particles, so is limited to cells able to withstand the forces resulting from those velocities.  
The presence of an apical mucus layer protects the cells to some extent from these forces, 
which was the likely reason the A549 cells were affected while the Calu-3 were not. 
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 It is understood that the there are other methods for depositing DEP onto the surface 
of cells and producing DEP as an aerosol that may have advantages over those discussed.  
The CULTEX™ system has advantages over the CDC, but samples too slowly to deliver a 
concentrated aerosol like those described in Chapter 2.  Electronic precipitation may provide 
an alternative for depositing large masses onto cell surfaces quickly, but the affects of large 
electric fields on cells are not known.  DEP produced directly from an engine may be more 
representative of atmospheric DEP but requires an engine on site, which consumes lots of 
space and is expensive, and creates only a dilute aerosol.  There is room for improvement in 
the novel aerosolization and deposition methods presented in this work with regard to each of 
the six factors described above. 
Future Work 
 Future work extending this research could go in a number of directions.  Additional 
studies could involve: 1) Utilizing the DEP aerosols described in Chapter 2 for in vivo 
toxicology; 2) Generation of additional DEP aerosols based on those described in Chapter 2 
and further characterization of the aerosols; 3) Utilizing the deposition methods described in 
Chapter 3 to deposit aerosols other than DEP; 4) Utilizing the DEP aerosols generated in 
conjunction with the deposition methods to further study in vitro DEP toxicology. 
 The DEP aerosols that were described could be generated for in vivo studies.  The 
advantages of generating DEP aerosols from a bulk source rather than from an engine on site 
are the same for in vitro and in vivo studies.  These advantages have been recognized and led 
to the development of a method to generate small quantities (< 3mg) of DEP aerosol 
(MMAD = 0.55 µm, GSD = 2.17) from a bulk source for deposition in isolated perfused rat 
lungs (Gerde, Ewing et al. 2004).  There is the potential for further research into the 
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generation of PS DEP aerosols that are more representative of atmospheric particles than the 
aerosols described by Gerde et al. or in Chapter 2.  One way to potentially re-create both the 
size and shape of atmospheric DEP is to take advantage of the same aggregation phenomena 
that occur in the atmosphere.  It seems possible to create a majority of primary particles from 
a propellant suspension that had a volume fraction that was significantly lower than those 
tested here.  If a high proportion of primary particles could be generated, the particles could 
be aged together, during which time dendritic aggregates could be formed by diffusion 
limited colloid aggregation (DLCA).  The study of these phenomena would require 
optimization of the concentrations and times required for aggregation, but could potentially 
result in a method or methods that would produce DEP almost identical to those present in 
the atmosphere. 
 In order to fully characterize the PS aerosols, further chemical analysis could be done.  
The quantity of two model PAHs was measure in bulk DEP and compared to PS aerosols.  
This analysis did not address potential re-distribution of chemicals based on particle size.  A 
more exhaustive chemical analysis of particles that have been separated by size (by inertial 
impaction, for example) would determine if a re-distribution of organic chemicals did occur 
during the suspension/evaporation processes.  The chemical analysis of adsorbed compounds 
can be done by first extracting by ultrasonic agitation, Soxhlet extraction, or ideally by 
pressurized fluid extraction followed by analysis by high performance liquid chromatography 
(HPLC) or gas chromatography/mass spectroscopy (GC/MS) (Ryno, Rantanen et al. 2006). 
 The methods of depositing/sampling aerosols onto the apical surface of cells could be 
used in research not involving DEP.  The CDC could be used to deposit dry powder 
pharmaceutical aerosols onto the surface of cells for the determination of absorption and 
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transport rates that are dependant on the dissolution of the particles.  In fact, the methods are 
useful for studying any phenomena that may be affected by suspension of the particles of 
interest in liquid prior to exposure. 
 There is still a great deal of research that could be conducted in the comparison of the 
deposition of DEP aerosols and liquid suspension on the apical surface of cells in culture.  
The differences in cellular response seen with the two exposure methods should be examined 
to determine the cause of those differences.  The formation of intercellular ROS following 4 
hours of DEP exposure appeared to be the same, but the basolateral IL-8 and GM-CSF 
release at 24 hours were different.  The potential reasons for this have been discussed, but 
may relate to deficiencies in the ROS assay used, the timing of the assays, or differences in 
routes and concentrations of toxicant exposure.  The use of flow cytometry or fluorescence 
microscopy could prove useful in examining the ROS formation in individual cells, as 
opposed to the cell suspension as a whole.  There are obstacles to overcome in order to use 
either of these techniques to detect ROS in Calu-3 cells grown at the air interface.  The 
presence of apical mucus binds the cells, making it difficult or impossible to separate the 
cells with trypsin for individual analysis by flow cytometry.  The strong association of DEP 
with cells following exposure could also make accurate fluorescence detection difficult.  This 
obscuration also provides an obstacle to imaging by fluorescence microscopy.  The cells in 
which you expect ROS formation and fluorescence (those below deposited particles) have 
light blocked from above by the DEP and cannot be imaged from below because the 
permeable membranes are not clear enough for imaging. 
 Data from more time points after exposure could be generated.  The time points 
chosen (4 hours for ROS and 24 hours for cytokines and viability) were chosen because they 
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were the most commonly used in the literature.  A more comprehensive analysis could be 
performed if the release profile of cytokines from cells over time were known.  The addition 
of mRNA detection by Northern blotting, in situ hybridization, or RT-PCR could give 
temporal and potentially spatial resolution to the transcription of the genes responsible for 
cytokines and antioxidant response proteins.  These techniques could also be used to 
determine the reason for the severe depression of IL-8 release from Calu-3 cells exposed to 
apical media (Figure 4.10.a).  Is the overall metabolic or transcription rate of the cells 
depressed or are the cells busy with a separate response that could be detected by proteomics 
techniques? 
 In order to further elucidate the differences in exposure of cells to the toxicologically 
relevant chemicals adsorbed onto the surface of DEP, the solid phase extraction of the media 
suspensions followed by HPLC or GC/MS could be used analyze the concentration of  
compounds in media suspensions.  This would lead to a better understanding of the potential 
contribution of C3 (Figure 5.1) to the intracellular concentration of toxicants.  In order to 
gain an understanding of dose response in each deposition method, analysis of the apical 
liquid of aerosol deposited cells as well as the cytoplasm would also need to be performed.  
This, however, is probably not realistic because of the small volume of cytoplasm and apical 
liquid present on AIC grown cells. 
 The toxicity of exposure to DEP aerosols on cells other than those used in this work 
(Calu-3, HBE, A549) could be tested.  Primary epithelial cells are often used to test toxicity 
of inhaled material and can be cultured at the air interface (Gruenert, Finkbeiner et al. 1995).  
Macrophages and cell lines with macrophage properties are also often used, as they represent 
the clearance mechanism for particles in the alveolar region.  THP-1 (a human monocyte cell 
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line) cells were induced to attach to glass cover slips by culture with phorbol myristate 
acetate (PMA), but these cells did not remain attached to the surface following removal of 
the apical media and exposure to air flow in the CDC (own work, not shown).  It might be 
possible to deposit particles on a surface, then add induced cells to the surface and monitor 
the interaction.  It would need to be determined if the particles on the deposition surface 
remain unchanged by addition of the media required, but may represent a way to expose 
macrophages to DEP in the aerosol size range, rather than suspended in media. 
 DEP are potentially toxic to organ systems other than the lungs.  It was mentioned in 
Chapter 1 (Section 1.8) that translocation of ultrafine (< 100 nm) particles to systemic 
circulation is thought to contribute to the cardiovascular toxicity of inhaled PM (Nemmar, 
Hoylaerts et al. 2004).  The first, and perhaps most significant, barrier to the translocation of 
inhaled particles to the circulatory system is the lung epithelium and its apical fluid layers.  It 
would be of interest to develop a method to determine the rate of transport of DEP across cell 
layers grown at the air interface in vitro.  This method would require a very sensitive DEP 
detection method, perhaps even the use of radiolabeled particles (Dutcher, Sun et al. 1984). 
 The final, and perhaps most important, line of research that would follow from the 
work described in Chapters 2-4 is the comparison of the in vivo and in vitro response to DEP 
exposure.  The goal of in vitro toxicology studies is to shed light on the pathogenesis of 
disease.  It is important to determine whether the responses of cells grown in culture to DEP 
exposure are the same responses seen in human lungs.  It is not useful to know, for example, 
the in vitro response to certain intracellular concentration of PAHs if that concentration is 
never reached in the cells of the lungs.  This makes the dose response to DEP only relevant to 
doses seen by cells in the body. 
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 The estimations of the masses of DEP that are delivered to the cells of the lungs are 
difficult to make because of the uneven distribution of particles over the epithelial surface.  It 
may be possible to estimate these doses from the responses seen in vitro.  The concentration 
threshold for induction of an inflammatory response determined by in vitro studies 
(mass/area) could be compared to the threshold for an inflammatory response in vivo 
(mass/volume) to determine the concentrations that are likely being seen by the individual 
cells of the lungs.  For this comparison to be made, however, the in vitro studies must be 
relevant to the cells of the lungs.  It is this relevance which was addressed in this work, which 
showed that it is possible to measure the toxicity of DEP delivered as an aerosol, a 
physiologically relevant method, and that exposure to aerosols differs from exposure to 
particle suspensions. 
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Figure 5.1. Diagram showing the three potential routes that contribute to the 
intracellular concentration of toxicants adsorbed to the surface of DEP.  C1 represents 
the dissolution (Dis) from endosomes following endocytosis (End) of DEP; C2 
represents absorption directly from the surface of DEP; C3 represents absorption from 
the apical liquid layer following dissolution from DEP. 
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